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Abstract 
 
Genomic imprinting in mammals is the monoallelic expression of genes in a parent-of 
origin dependent manner.  Imprinting can be transient and tissue specific, indicative 
of its role in specific developmental regimes.  Placental specific imprinting has been 
found to be non-conserved between humans and mice.  A new model of human 
trophoblast, trophoblast stem cells (hTS), differentiated from human embryonic stem 
(hES) cells, allows analysis of placental specific imprinting during the earliest stages 
of placentation.  The use of cell lines to characterise imprinting in vivo is limited by 
epigenetic alterations during cell line derivation and culture.  hES cells may harbour 
exceptional dichotomy in epigenotype compared to their in vivo counterpart, the 
preimplantation embryo, due to their derivation from superovulated embryos during 
genome-wide epigenetic remodelling.  There are very limited options for analysis of 
imprinting in vivo in human tissue, and the most practical and available resource is 
human peripheral blood.  Imprinted gene expression and in normal healthy blood is 
currently uncharacterised.   
 
Analysis of the Kcnq1/KCNQ1 cluster, which contains six ubiquitous and eight 
murine placental specific imprinted transcripts, in hTS cells showed that imprinting 
was not conserved for the placental specific transcripts.  In addition, one of the 
ubiquitously imprinted transcripts was not imprinted in hTS cells or undifferentiated 
hES cells.  Subsequent genome-wide imprinting analysis in undifferentiated hES cells 
and human fetal mesenchymal stem cells (fMSC), not derived from superovulated 
conceptions or during genome remodelling, found abnormal biallelic expression of 
several imprinted genes, to an extent consistent between both types of stem cell.  In 
fMSC, differentially methylated imprinting control regions (ICRs) were unexpectedly 
normal.  In hES cells, however, both hypo- and hypermethylation was detected at 
several ICRs.  Imprinted gene expression following differentiation and expression of 
pluripotentiality conferring transcription factors were measured to further assess the 
potential of fMSC.  Imprinting did not change following differentiation, however, 
pluripotency transcription factor expression was almost negligible compared to that in 
hES cells.  Imprinting in peripheral blood was characterised by virtually undetectable 
expression of most transcripts, biallelic expression of those which could be detected 
and only a minority of genes remaining imprinted. 
 
These findings provide an overview of imprinted gene expression in human stem 
cells, complimenting previous work on hES cells.  Whilst imprinted gene expression 
is universally disrupted by cell culture, the results suggest that methylation at ICRs 
may be sensitive to derivation associated specifically with hES cells, as it was normal 
in the fMSC lines.  This lack of correlation between methylation at ICRs and 
imprinted expression was also mirrored in the hES cells as aberrant methylation 
patterns were stochastic, and did not correlate with the abnormal imprinted 
expression.  This indicates that the loss of imprinting in cultured cells is caused by an 
epigenetic mechanism other than aberrant methylation.  In peripheral blood, the often 
biallelic nature of imprinted gene expression limits the use of this tissue as a control, 
and also of this feature as an indicator of disease.  Six of the 36 transcripts analysed 
remained monoallelic in blood giving them potential as biomarkers, so their 
imprinting status in disease should be characterised further. 
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SYBR   Synergy Brands 
T   thymine 
TAE   Tris acetate EDTA 
TE   trophectoderm 
TNDM  transient neonatal diabetes 
tRNA   transfer RNA 
TSS   transcriptional start site 
UCSC   University of Santa Cruz 
UPD   uniparental disomy 
UTR   untranslated region 
WT   wild-type  
XCI   X chromosome inactivation 
X-Gal   5-bromo-4-chloro-3-indolyl-β-galactosidase 
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Gene name abbreviations 
 
Gene Whole name 
ATP10C ATPase type 10C, 
CDKN1C Cyclin Dependant kinase 
CPA4 Carboxypeptidase A4 preproproterin 
DIO3 Deiodinase iodothyronine type III, 
DLK1 Delta-like 1 homolog isoform 1 
DIRAS3  Distinct subgroup of the Ras family member 3 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GNAS Guanine nucleotide binding protein, alpha 
GNAS-XL GNAS extra-large 
GNAS- EXON 1A GNAS alternative exon 1A 
GRB10 Growth factor receptor-bound protein 10 isoform 
GTL2 Gene Trap Locus 2/MEG3 (non coding RNA) 
H19 Imprinted maternally expressed untranslated mRNA 
HTRA2  High temperature requirement protein A2, 
IGF2 Insulin-like growth factor 2 
INPP5F_V2 Inositol polyphosphate-5-phosphatase F 
IPW Imprinted in Prader-Willi, 
KCNQ1 KQT-like subfamily, Member 1, potassium voltage-gated channel,  
KCNQ1OT1 KCNQ1-Overlapping Transcript 1 
KLF14 Kruppel-like factor 14, 
MCTS2 Malignant T cell amplified sequence 2, 
MEST /PEG1 mesoderm specific transcript a/b (Isoforms1 and 2) 
MESTIT1  MEST intronic transcript 1 
NAP1L5 Nucleosome assembly protein 1-like 5/HERC3 
NDN Nectin 
NESP Novel erythropoiesis-stimulating protein 
NESPAS NESP antisense transcript 
PEG3 Paternally expressed 3 
PEG10 Paternally expressed 10 
PHLDA2 Pleckstrin-like homology domain, Family A, member 
2/IPL/TSSC3 
POU5F1/OCT4 (Pit-Oct-Unc) domain homeobox transcription factor 
SGCE  Sarcoglycan epsilon 
SLC22A18 Solute carrier family 22 (organic cation transporter), member 18/ 
tumor suppressing subtransferable candidate 5 (TSSC5) 
SLC22A1LS  SLC member 1-like antisense 
SNRPN small nuclear ribonucleoprotein polypeptide N 
TERT Telomerase active subunit 
TP73 Tumour related protein 73 
WT1  Wilms tumor 1 
ZAC1/PLAGL1 Zinc finger protein/PLAG1 Pleomorphic adenoma gene 1  
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Thesis Rationale 
 
 
Genomic imprinting is an epigenetic phenomenon affecting perhaps 50 human 
transcripts, and as such is an excellent model for the complex strategies employed by 
the cell to bring about precise regulation of gene expression.  In order to adequately 
explain how imprinting is executed, it is necessary to first detail separately the 
mechanisms through which normal gene transcription is regulated, namely, DNA 
methylation, histone protein tail modification, non-coding RNA interactions and 
changes to chromatin accessibility.   
Genomic imprinting is discussed in this thesis in the context of change from 
the normal state, i.e. monoallelic, parent-of-origin expression, to biallelic expression 
or silencing, as has been observed in certain human tissues and cell lines.  In order to 
illustrate the links between deregulation of imprinting and the potential mechanisms 
involved, several model imprinted gene clusters are described.  Each combines 
different aspects of the previously described epigenetic factors, whilst also 
demonstrating the central role of DNA methylation.  The importance of imprinting is 
discussed in terms of normal mammalian growth and development and also the 
consequences of its loss in human syndromes such as Beckwith Wiedemann Silver 
Russell, Prader Willi, and Angelman syndromes, and additionally in cancer.  
Imprinting is often transient, can be highly tissue specific and varied between 
mammalian species.  Much of the data on imprinting is from the mouse model.  
Placental-specific imprinting of certain transcripts is indicative of their importance 
specifically in pregnancy, but does not appear to be conserved between humans and 
mice.  This is consistent with the large differences between human and mouse 
placentation and pregnancy.  Events early in gestation are more similar between 
different species, and analysis of the human placenta has so far not been possible 
before approximately eight weeks of gestation.  The use of a model of early human 
trophoblast, therefore, will allow testing of whether placental specific imprinting in 
the human is present in earlier gestation.  This will be important to show whether 
these placentally imprinted genes are important in early human development, and 
provide evidence for whether the mechanism of placental-specific imprinting is 
distinct from that in the fetus, as in imprinted X-inactivation, and evolved separately.   
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Human stem cells hold the potential to treat degenerative disease.  It is important to 
characterise cells in vitro compared to the in vivo populations from which they were 
derived.  Deregulation of imprinting, from that found in normal, healthy, in vivo 
tissue, is almost always found in tumours, and has been suggested to have a causative 
role, clearly undesirable in a cell to be used therapeutically.  By analysing the allelic 
expression of imprinted genes in stem cells, the impact of in vitro culture on 
imprinting, and so potentially transformation, may be measured.  Additionally, the 
integrity of genomic imprinting in a cell may be a potential index for overall 
epigenetic stability.  Cellular characteristics are in-part dictated by epigenetics, 
informative of cellular potential for proliferation, differentiation or transformation 
and as such epigenetic characterisation is both valuable and important.  Both human 
embryonic stem (hES) cells and human fetal mesenchymal stem cells (fMSC) are 
primary cultured cell lines and potentially useful for clinical therapy.   
 hES cells are derived from superovulated embryos during genome-wide 
epigenetic remodelling, whereas fMSC are derived from seven weeks of gestation 
onwards, from natural conceptions.  The impact of superovulation and derivation 
during epigenetic remodelling on the epigenetic state of hES cells is unknown.  By 
comparing imprinting stability between the two cell types, it may also be possible to 
designate the cause of any deregulation either to derivation or to in vitro culture.   
The primary signal for imprinted expression is the monoallelic DNA 
methylation at key loci.  These so-called imprinting control regions act in cis to 
promote monoallelic expression.  A loss of allelic DNA methylation would cause 
either biallelic silencing or biallelic expression of genes in that region.  Methylation 
could feasibly be affected by methyl donor concentration in a sub-optimal cell culture 
environment, or as previously mentioned by cell line derivation during genome-wide 
remethylation.  Measuring methylation at respective ICRs will potentially allow 
correlation between imprinting deregulation.  
Imprinting in peripheral blood leukocytes is commonly used as a control 
tissue to assess imprinting in human adults.  A loss of imprinting of IGF2 in 
peripheral blood is being developed as a marker for colorectal cancer.  The relevance 
of imprinting in adult tissues, is in many cases unknown but, as previously 
mentioned, may be important  in cancer.  The analysis of imprinting in normal 
healthy adult individuals is important for a so-called loss of imprinting to be used as a 
clinical biomarker, and in peripheral blood this has not yet been carried out. 
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Chapter 1 -  Introduction 
 
1.1 Transcription 
Gene transcription is the mechanism through which DNA sequence encoding 
the instructions for cell division, growth, development and differentiation can be 
executed.  Complex, diploid genomes are interspersed with coding and non-coding 
sequences, dynamically linked by regulatory networks.  Their functionality is realised 
through gene transcription, and the messenger RNA (mRNA) produced may either 
itself have specific functions, or be translated to protein.  Both the historically named 
‘sense’ and ‘antisense’ DNA strands may be transcribed, resulting in significant 
overlap of transcripts in any coding sequence (Yelin et al., 2003; Carninci et al., 
2005).  The antisense strand is ‘read’ by RNA polymerase II (Pol II) to give a sense 
transcript, and vice versa, with antisense transcripts postulated as primary regulators 
of their sense partners (Katayama et al., 2005).  
RNA Polymerase II (Pol II) recruitment to the promoter of a gene is widely 
accepted to be the rate limiting step in transcription, and its enrichment along the 
transcriptional unit correlates highly with expression (Ptashne and Gann, 1997).  Pol 
II executes transcription in a sequence of linked steps (Figure 1.1).  Each step may be 
regulated by the cell, both in terms of the kinetics of transcript production, and also 
the type of transcripts produced, of which there may be alternatively spliced products, 
or variation in the position of the polyadenylation site.  Precise regulation of 
expression by the Pol II itself has recently been demonstrated in the Drosophila 
melanogaster genome, where Pol II accumulates at promoters, begins transcription 
and then stalls 50bp downstream of the transcriptional start site (TSS).  This 
arrangement allows important coding sequences such as heatshock genes to be poised 
for rapid activation, and is also found frequently at developmentally regulated genes 
(Zeitlinger et al., 2007). 
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Figure 1.1 Eukaryotic transcription.   
The assembly of an initiation complex at accessible chromatin, involving ‘Initiating’ 
Pol II, phosphorylated at serine 5 of its C-terminal domain, is followed by promoter 
release.  Elongating Pol II is phosphorylated at serine 2 (Kouzarides, 2007).  
Unwinding two helix turns, elongating Pol II moves through the DNA, although some 
evidence suggests the DNA is moved through immobilised Pol II (Iborra et al., 1996).  
The antisense strand is read 5’ to 3’, recruiting tRNA molecules to create messenger 
RNA (mRNA) matching the sense DNA strand.  The newly formed mRNA is spliced, 
poly-adenylated (+AAAA) and finally the complex is released from the template 
DNA. 
 
Transcription is highly compartmentalised in the nucleus.  Transcription 
‘factories’ contain most of the hyperphosphorylated, elongating Pol II in the cell, and 
actively transcribed genes co-localise with these in an oscillatory fashion, so that gene 
transcription occurs in pulses (Chakalova et al., 2005).  Active transcription may only 
be detected in a fraction of cells at any point in time (Osborne et al., 2004; Chubb et 
al., 2006).   
1.1.1 Sequence related regulatory motifs 
Coding regions are partitioned with introns of varying length, and flanked by 
untranslated regulatory elements.  The 5’untranslated region (UTR) either contains, or 
is adjacent to, a promoter sequence which acts to bind transcription factors through 
sequence motifs such as the TATA box.  The TSS of the main open reading frame 
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(ORF) lies immediately downstream of these motifs.  Other transcripts, which 
originate directly from the 5’ UTR, direct interactions between the main ORF mRNA 
and the ribosome, regulating translation (Iborra et al., 1996; Meijer and Thomas, 
2002).  The sequence of the 3’UTR is not highly conserved but contains vital 
elements which bind microRNA (21-25bp) molecules in a tissue specific manner, 
directly influencing transcription in cis  (He and Hannon, 2004).   Enhancers are 
predominately found upstream of the promoter, around 2.4kb away, although they can 
lie much further upstream, downstream or actually within the coding sequence.  They 
contribute to the activation of their target genes by binding additional factors, 
commonly transcriptional coactivator p300 (Blackwood and Kadonaga, 1998; Hatzis 
et al., 2006).  Insulators, enhancer blockers and barrier elements are DNA sequences 
which act to protect genes from positional effects, i.e. inappropriate 
expression/repression at boundaries of euchromatin and heterochromatin, through 
demarcation of genomic regions and the recruitment of chromatin modifying enzymes 
and factors such as CCCTC binding factor (CTCF) (Mukhopadhyay et al., 2004). 
The covalent modification of DNA by the addition of methyl groups is found 
almost exclusively at the cytosine of CpG dinucleotides.  80% of the CpGs in the 
genome are methylated and the propensity of 5-methylcytosine to deaminate to 
thymine has led to its gradual depletion (Coulondre et al., 1978; Sved and Bird, 1990; 
Bird, 2002).  As a result, the CpG dinucleotide is severely underrepresented, 
approximately 50 million exist in the human haploid genome, clustered so that vast 
stretches of sequence are CpG free.  CnG and CnN methylation is functional in plants 
and has been seen in the mouse embryo and ES cells (Chan et al., 2005; Haines et al., 
2001; Ramsahoye et al., 2000).  In addition, CpA methylation has been found to 
regulate gene expression in mouse neurons (see section 1.2.5.2).  Over half of all gene 
promoters overlap so-called CpG islands and promoter CpG methylation is integral to 
the regulation of transcription (see section 1.2.1)  (Antequera and Bird, 1993).  CpG 
island definition is somewhat arbitrary, but generally accepted to be >0.5kb stretches 
of DNA with a C and G content of >55 % and CpG content of >65 % (Takai and 
Jones, 2002). 
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1.1.2 Genomic content and structure 
 
Human genome 
Intergenic 
3.5% chromosome structural 
components 
70 % Interspersed 
repeats 
Centromeric 
heterochromatin 
(highly condensed, 
transcriptionally 
silent) 
Minor satellite 
(124bp) repeats, 
in tandem array 
(~2000)  
Retrotransposons 
Long terminal repeats 
Long interspersed 
nucleotide elements 
(LINE), AT rich (IAP) 
1 % 
Exonic 
24 % 
Intronic 
Pericentric 
heterochromatin 
>10,000 Major 
(234bp) satellite 
repeats 
Short interspersed 
nucleotide elements 
(SINE), GC rich (Alu) 
Table 1.1Overall structure of the human genome 
Coding regions make up a minority of the human genome.  Most sequence consists of 
different categories of repeats.  Some have a physical role in the structure of 
chromosomes, others are likely to be involved in chromatin conformation and gene 
regulation (Mc Clintock, 1951; Smit, 1996; Lander et al., 2001).  
 
Intronic and intergenic regions exhibit significant transcriptional activity, 
expressing both mature, polyadenylated, and non-adentylated RNA molecules (Cheng 
et al., 2005).  The function and significance of such non-coding molecules is 
unknown at present.  In most cases, repeat regions are heavily methylated, and 
associated with repressive histone modifications (Jones, 1999; Martens et al., 2005).  
Despite this, low level transcription from each class of repeat may be detected, 
maintained at a low level by RNA interference (RNAi) pathways, which detect and 
process double stranded RNA (dsRNA) and promote further histone modification 
(Jenuwein, 2002; Martens et al., 2005).  Retrotransposons include the coding regions 
for transposase, enabling them to replicate and reinsert elsewhere in the genome.  
They serve as recombination ‘hotspots’, creating areas of rapid DNA evolution and 
genomic shuffling, making them potentially mutagenic, but also an important 
component of genome evolution (Makalowski, 2000).  IAPs are particularly active, 
LINEs, less so, with perhaps 1 % of them having activity (Goodier et al., 2001).  
DNA transposons have a mutated form of transposase and are inactive (Smit, 1996).  
SINEs are thought only to be active in concert with LINEs, and in fact some evidence 
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suggests that any mRNA sequence may act as a retrotransposon due to LINE activity 
(Esnault et al., 2000).  The influence of repeats on transcription is likely to be an 
important source of regulation and variation.  Notably, LTRs often contain promoter 
and enhancer sequences, able to regulate gene expression in cis, and point mutation of 
the polyA tails of retrotransposons to A(A/U)UAAA) introduces sources of 
alternative polyadenylation signals for upstream coding regions (Makalowski, 2000). 
There are several canonical gene clusters in the human genome which are 
grouped according to their function e.g. the major histocompatability complex 
(MHC), epidermal differentiation complex (EDC) and the β-Globin locus (Marenholz 
et al., 2001; Plant et al., 2001; Horton et al., 2004).  Aside from these, coding regions 
of the genome tend to be organised according to expressivity, with regions of early 
replicating, widely expressed genes grouped together, enriched in C and G and 
depleted in LINEs (Caron et al., 2001; Lercher et al., 2002; Versteeg et al., 2003).  
CpG poor gene promoters are associated with genes which are highly tissue specific 
and tend to be inactive by default, selectively upregulated by interaction of both 
ubiquitous transcription factors e.g. those which bind to TATA and CAAT boxes, and 
tissue specific transcription factors.  CpG poor promoters are grouped in regions with 
higher LINE and AT content, and they replicate late in S phase (Lichtsteiner et al., 
1987; Maniatis et al., 1987; Mikkelsen et al., 2007; Weber et al., 2007; Zeitlinger et 
al., 2007). 
1.2 Epigenetics 
The accessibility of promoters and other 5’ regulatory regions to transcription 
factors and Pol II is dictated by chromatin architecture.  The timing and extent to 
which new gene expression programs are executed is precisely regulated through the 
interplay of a variety of molecular species which interact either directly or indirectly 
with chromatin.  This interaction with DNA does not alter the DNA sequence and is 
referred to as epigenetic. 
1.2.1 DNA methylation 
Most eukaryotic genomes are modified by DNA methylation, exclusive to 
cytosine residues.  It is a stable, heritable covalent addition which is propagated 
through DNA replication and cell division (Wigler et al., 1981; Stein et al., 1982).  
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1.2.1.1 Catalysis of DNA methylation 
 
Figure 1.2 Cytosine methylation and demethylation.   
 
The conversion of cytosine (C) to 5—methyl cytosine (5-mC) is catalysed by DNA 
methylatransferases (DNMT) 1, 3a and b.  DNMT1 has a 50 fold preference for 
hemimethylated over unmethylated DNA  and its activity is highly CpG specific 
(Fatemi et al., 2001).  DNMT3a is also able to methylate CpA, however, DNMT3a 
and b activity relies on concurrent DNMT3L binding  (Bourc'his et al., 2001; 
Bourc'his and Bestor, 2004; Gowher et al., 2005). 
 
All the DNMT enzymes form complexes with histone deacetylases (HDACs) 
to suppress transcription (Robertson et al., 2000; Rountree et al., 2000; Fuks et al., 
2001).   DNMT1’s preference and localisation to hemimethylated DNA is in part 
mediated by the methyl CpG binding SRA protein Np95 and proliferating cell nuclear 
antigen (PCNA) (Chuang et al., 1997; Sharif et al., 2007). DNMT3a and DNMT3b 
work in concert to remethylate the genome (see Figure 1.2), but are not mutually 
exclusive (Bestor, 2000; Li et al., 2007).  DNMT3b is specifically required to 
methylate minor satellite repeats and DNMT3a for methylation of imprinting control 
regions and the Xi specific transcripts (XIST) gene on the prospective active X 
chromosome in mammalian females, both dependent on DNMT3L  (Okano et al., 
1999; Bourc'his et al., 2001; Hata et al., 2002; Kaneda et al., 2004).  Knockout of 
DNMT3L in the male germline results in meiotic catastrophe.  Recovering sufficient 
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material to investigate the role of DNMT3L in imprinting in the male germline has so 
far proven a challenge, and data is inconclusive (Bourc'his and Bestor, 2004; Webster 
et al., 2005). 
Active demethylation of the paternal genome during preimplantation 
development, in addition to other evidence of demethylation in the absence of DNA 
replication are strongly indicative of a DNA demethylase (Zhang et al., 2007).  This 
molecule so far remains elusive (Ng et al., 1999; Wade et al., 1999; Jin et al., 2008). 
1.2.1.2 DNA methylation in plants, fungi and invertebrates 
Plants, fungi and invertebrates have a mosaic pattern of methylation, whose 
distribution and function varies between species.  The model organisms 
Caenorhabditis elegans, Saccharomyces cerevisae and Schizosaccharomyces pombe 
do not have DNA methylation.   Fungi which do have DNA methylation target it 
specifically to repetitive sequences, in which reside transposable elements, as does 
the flowering plant Zea mays, which has the highest level of DNA methylation 
observed amongst eukaryotes, correlating with the very high numbers of transposons 
scattered in its genome (Selker et al., 2003).  The targeted methylation in these 
classes prevents transposition and so seems to be a protective measure against further 
movement of these elements.  Arabidopsis thaliana, in addition to non-coding regions 
such as centromeres and pericentric chromatin, methylates gene bodies, as do 
invertebrates (Bird et al., 1979; Palmer et al., 2003). 
1.2.1.3 Distribution of genomic methylation in vertebrates 
The point at which the evolutionary switch from interspersed, genic 
methylation in lower organisms to the global methylation found in vertebrate species 
is not known.  It likely to be related to the added complexity of these higher species, 
for example, it may have promoted the development of innate immunity (Suzuki and 
Bird, 2008). Transposons and other repeat regions are methylated, although whether 
this again is a protective mechanism, or reduces transcriptional ‘noise’, is unknown 
(Bird, 1995; Walsh et al., 1998; Wilson et al., 2007).  The gross anomalies of 
centromeric structure seen in patients deficient in DNMT3b, (Immunodeficiency, 
centromeric instability, facial anomalies syndrome (ICF)) where these regions 
become severely hypomethylated, also indicate a role for DNA methylation in 
chromosome stability (Tagarro et al., 1994).  The function of gene body methylation 
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is unclear, but the hypomethylated state of gene bodies of the inactive X (Xi) 
chromosome compared to the active X (Xa) implies that it has a positive influence on 
transcription (Hellman and Chess, 2007).  Tissue specific differential methylation has 
been pinpointed to gene bodies, correlating positively with gene expression (Rakyan 
et al., 2008).  Telomere methylation may play a role in its protection from shortening 
during cell division (Yehezkel et al., 2008).   
1.2.1.4 CpG Islands 
The exception to mammalian genome methylation are CpG islands, and the 
approximately 1kb surrounding the transcriptional start site (Bird, 1986; Eckhardt et 
al., 2006).  CpG islands are associated with coding gene promoters, and also those of 
non coding (nc) regulatory RNA molecules such as XIST, KCNQ1OT1, and Air 
(Panning and Jaenisch, 1996; Sleutels et al., 2002; Umlauf et al., 2004).  CpG islands 
are thought to be protected from methylation by SP1 transcription factor binding, 
preventing access by DNMT proteins (Macleod et al., 1994; Brandeis et al., 1994).  
Unmethylated DNA tends to have an open chromatin conformation and be associated 
with transcriptionally permissive histone modifications such as lysine acetylation, 
histone subunit H3 trimethylation at lysine 4, enrichment of histone variant H2A.Z 
and for increased levels of Pol II (see section 1.2.3).  Unmethylated promoters 
therefore have at least the potential for active transcription, and ubiquitously 
expressed gene promoters are unmethylated at any developmental stage (Bird, 2002). 
There is a bimodal distribution of promoters in the genome according to CpG 
island density, CpG rich, which overlap CpG islands, and CpG poor (Takai and 
Jones, 2002; Weber et al., 2007).  Although data in the mouse suggests that CpG 
promoters are associated with widely expressed genes, and non CpG promoters with 
tissue specific transcripts, new studies suggest that promoter methylation state is more 
informative (Barrera et al., 2008).  Unmethylated promoters, both CpG rich and poor, 
were found to be associated with housekeeping genes (Rakyan et al., 2008).  
1.2.1.5 Methylated CpG Islands 
A subset of CpG islands are constitutively methylated.  One third of these lie 
within Alu elements, others are intragenic, however, some are located in gene 
promoters (Jaenisch and Bird, 2003; Yamada et al., 2004).  Densely methylated CpG 
islands in the promoter of a gene leads to stable silencing of expression of that gene, 
  25 
through prevention of transcription initiation (Colot and Rossignol, 1999).  Again, 
both CpG rich and poor methylated promoters are associated with similar functions, 
being linked with highly tissue specific genes (Rakyan et al., 2008).  It seems that the 
sparcity of available cytosines does not impact upon the ability of methylation to 
regulate a promoter, as suggested by Mikael Weber and colleagues, and that the 
maintenance of unmethylated, or methylated state, is important for the whole 
spectrum of promoters (Rakyan et al., 2008).   
1.2.1.6 Interactions of 5-methyl cytosine 
The interactions of methyl cytosine (5-mC) with potential binding partners 
can be both positive and negative (see Figure 1.3).  The DNA binding domains of 
certain transcription factors, such as YY1, GA-binding protein, Pol II and boundary 
elements such as CTCF are physically prevented from accessing the major groove of 
dsDNA by the methyl group (Nickel et al., 1995; Bird and Wolffe, 1999; Bell and 
Felsenfeld, 2000; Hark et al., 2000; Kim et al., 2007a).  In this way, methylation is 
able to directly prevent transcription.  Promoters which are differentially methylated 
in a tissue specific manner (tissue-specific differentially methylated regions, TDMRs; 
see also section 1.3.1.1) are enriched for methyl-sensitive transcription factor binding 
sites, such as Kruppel-like factor 4 (KLF4) motifs (Rakyan et al., 2008), promoting 
tissue-specific transcriptional regulation by DNA methylation. 
There are three families of proteins which specifically recognise and bind 
methylated DNA, collectively termed methyl-DNA binding proteins (MBP).  Firstly, 
methyl-CpG binding domain proteins (MBD), including  MBDs1, 2, 4 and MeCP2, 
recruit histone deacetylases (HDACs), promoting chromatin condensation as the 
indirect consequence of DNA methylation (Hendrich and Bird, 1998; Jones et al., 
1998; Nan et al., 1998; Wade et al., 1999).  MeCP2 contains both a methyl binding 
domain and transcriptional repression domain and is capable of silencing several 
hundred bp of surrounding chromatin (Jones et al., 1998).  The zinc finger proteins 
Kaiso, ZBTB4 and ZBTB38 also bind methylated DNA and repress transcription, 
although through an unknown mechanism (Prokhortchouk et al., 2001; Filion et al., 
2006).  Finally, proteins with SRA, PHD and RING finger domains have also been 
shown to preferentially recognise methylated DNA, in mammals these include Np95, 
97 and ICBP90.  As previously mentioned, Np95 is suggested to interact with 
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DNMT1, playing a role in the inheritance of DNA methylation patterns (Bostick et 
al., 2007; Sharif et al., 2007).   
 
Figure 1.3 DNA methylation can promote transcriptional repression by repelling 
DNA binding proteins, and recruiting methyl binding ones.  
Non methylated CpGs are accessible to transcriptional machinery, including 
transcription factors and histone modifying enzymes, creating at least the potential for 
transcription.  Many transcription factors contain CpG recognition sequences, 
resulting in their assembly CG rich regions such as promoters (Bird and Wolffe, 
1999).  Methylation of these domains prevents transcription factor binding, and may 
recruit methyl binding proteins leading to chromatin condensation and permanent 
silencing.  Nucleosome destabilising or repositioning has also been suggested as a 
potential mechanism of silencing (Davey et al., 1997). 
1.2.2 The Nucleosome 
Eukaryotic DNA is wrapped around histone octamers, consisting of two of 
each H2A, H2B, H3 and H4.  Each octamer is referred to as a nucleosome, and can 
accommodate 147 bp of DNA.  The promoters of actively transcribed genes are 
recognised as having an open chromatin conformation, ‘euchromatin’, with larger 
spaces between, or an absence of, nucleosomes, the incompatibility of transcription 
with the nucleosome being well established (Lorch et al., 1987).  The formation of 
higher-order chromatin structure through condensation and folding of nucleosome 
enriched DNA leads to formation of ‘heterchromatin’ and the repression of gene 
expression, allowing macromolecular processes such as cell division to occur 
accurately.   
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Figure 1.4 Chromatin conformation and active transcription 
Histone proteins are represented as yellow spheres, and the histone 
octamer/nucleosome as yellow cylinder.  Each nucleosome contains two each of 
histone monomers H2A, H2B, H3 and H4.  DNA is wrapped around nucleosomes as 
indicated, with the spacing and conformation of nucleosomes creating the structural 
‘chromatin’ molecule. 
 
The replacement of core histone subunits with variants is important for the 
formation of these higher-order structures.  H2A variant H2A.Z is a well studied 
example, and absolutely required for centromere structure and genome integrity 
(Rangasamy et al., 2004; Greaves et al., 2007).  H2A.X is abundant in meiotic 
nucleosomes, and is important in the execution of meiotic silencing of unsynapsed 
chromatin (MSUC), which encompasses meiotic sex chromosome inactivation, 
(MSCI), and protects against aneuploidy (Fernandez-Capetillo et al., 2003; 
Schimenti, 2005).   MacroH2A is enriched on the inactivated X chromosome, and 
acts to prevent SW1/SNF remodelling, PolII initiation and histone acetylation, 
promoting continuation of a heterochromatic state (Angelov et al., 2003; Doyen et al., 
2006). 
Transcription is dependent on Pol II binding to chromatin.  Sufficient Pol II 
binding, and the initiation of transcription, depends on a highly phased arrangement 
of nucleosomes.   
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Figure 1.5 Nucleosomes surrounding expressed transcriptional start sites 
A total of eight nucleosomes in the coding body of expressed genes are highly phased  
and this is correlated with Pol II binding.  The nucleosome ‘trough’ at the TSS is at 
least 100 bp long (Ozsolak et al., 2007). 
 
Promoters without any phasing of nucleosome arrangement tend not to be 
associated with significant levels of Pol II, and are not expressed.  Interestingly, 
promoters associated with stalled Pol II also have the same nucleosome phasing, 
despite the very low level of expression of these genes (Zeitlinger et al., 2007).  The 
key molecule seems to be the +1 nucleosome, which is at +10bp in the promoters 
with stalled Pol II, but at +40bp for expressed genes with fully elongating Pol II 
(Schones et al., 2008).  Thus, nucleosome positioning is important for Pol II binding, 
but not necessarily its activity.  Transcription is also associated with nucleosome 
depletion, notably at the -1 position. 
 The mechanism for nucleosome depletion is not well understood.  
Constitutive lack of nucleosomes upstream to the TSS may allow for rapid gene 
upregulation (Gal-Yam et al., 2006).  Remodelling complex recruitment by activator 
proteins may cause nucleosome sliding, TBP or other TFs may induce a bent structure 
in the DNA, the existence of poly(dA:dT) may cause a disfavourable DNA structure 
(Iyer and Struhl, 1995; Lomvardas and Thanos, 2001; Narlikar et al., 2002).  ATP-
dependent chromatin remodelling, involving remodelling and spacing factor RSF, 
facililates nucleosome sliding, disassembly and reassembly, whilst its ATP-dependent 
subunit SNF2H distributes the nucleosomes periodically (Loyola et al., 2001). 
1.2.3 Histone modification 
There are over 60 histone amino acid residues on which covalent 
modifications have been detected.  There are also a vast range of possible chemical 
additions and alterations, primarily occurring on the accessible histone N-terminal 
tails.  These include methylation, acetylation, phosphorylation, deiminiation (the 
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conversion of arginine to citrulline), ubiquitination, sumoylation, ADP Ribosylation 
and proline isomerisation (Kouzarides, 2007).  Gene promoters and enhancers may be 
distinguished by their differential binding of histone modifications.  Enhancers are 
associated with histone subunit H3 enriched with monomethylation at lysine 4 
(H3K4me1), whereas promoters are enriched with H3K4 trimethylation.  Both tend to 
be nucleosome depleted, indicative of their open chromatin conformation (Heintzman 
et al., 2007).  
 
 
Figure 1.6 Histone enrichment around the TSS 
Active gene promoters are associated with specific enrichment of core histone 
molecules.  Promoter regulatory sequences are associated with acetylated histones.  
The TSS is free from nucleosomes, with the -1 nucleosome specifically depleted.  
Flanking histones are hypoacetylated and enriched with the H2A variant H2A.Z.  
Coding region nucleosomes are enriched varying levels of with lysine methylation 
(Bernstein et al., 2005; Kouzarides, 2007).  Promoters are also associated with 
enrichment for H3K9/14-ac and H4K5/8/12/6-ac (Schones et al., 2008). 
1.2.3.1 The function of histone modification 
Chromatin immunoprecipitation (ChIP) combined with microarrays (ChIP on 
Chip), and recently ChIP-Seq, combined with sequencing, has revealed association of 
certain histone modifications with highly expressed regions, and others with those 
which are transcriptionally silent.  H3K4Me3, H3K36Me, H3K79Me and H3Ac are 
found 5’ to expressed genes, whereas H3K27Me3, H3K9Me, H4K20Me are enriched, 
and H3Ac depleted, in silenced chromatin in both the human and mouse genomes 
(Barski et al., 2007; Kouzarides, 2007; Mikkelsen et al., 2007).   
The association in the mouse genome of repressive marks such as H4K9Me3, 
H3K27Me and H4K20Me with major and minor satellite repeats, and IAP LTRs with 
H4K20Me3, is another indication that chromatin structure, gene repression and 
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histone modification are intricately linked.  Interestingly, although these patterns are 
also seen in the human, enrichment of H3K9 is not found at minor satellites, 
demonstrating a lack of conservation of certain aspects of this mechanism (Sullivan 
and Karpen 2004).  It seems that histone modifications are, in concert with DNA 
methylation, responsible for transcriptional state.  Changes in cellular environment 
are able to directly and rapidly alter gene expression patterns through histone tail 
modification (Metivier et al., 2003).  In addition to functioning in the regulation of 
transcriptional activation and repression, histone modifications also have roles in 
DNA repair, replication and chromosome condensation during the cell cycle 
(Kouzarides, 2007).  Sequences such as LINEs and SINEs are not associated with 
high levels of any specific histone modification enrichment showing that other 
mechanisms are important, and that the function of DNA methylation in stable 
repression does not always involve repressive histone modification (Martens et al., 
2005). 
1.2.3.2 Histone enrichment as an inheritable mark 
Certain highly regulated promoters in differentiated mouse and human cells 
are enriched with either activating H3K4Me3 or repressive H3K27Me3, spread over a 
considerable distance (Bernstein et al., 2005).  In human and mouse ES cells, 
developmentally regulated promoters were also enriched in this way (Lee et al., 
2006b).  As nucleosomes are randomly distributed on nascent strands during DNA 
replication, a model has been suggested where broad domains of modified histones 
exist as a mode of cellular inheritance.  Increased numbers of enriched nucleosomes 
maximise the chances of their being included on both new DNA strands, propagating 
the chromatin conformation pattern in the daughter cells (Henikoff et al., 2004). 
1.2.3.3 Mechanism of gene regulation by histone modifications 
The precise role each modification plays to regulate chromatin structure 
varies.  Acetylation, (specifically, H4K16), acts directly on DNA binding, 
neutralising the basic charge of lysine, reducing the strength of the nucleosome-DNA 
bond, causing the chromatin to unfold, promoting transcriptional activity (Shogren-
Knaak et al., 2006).  Dimethylation of lysine 79, located on a loop within the globular 
domain of histone H3 (H3K79Me2) alters the electrostatic potential and the 
molecular surface of the nucleosome, likely to affect structure and function 
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(Chodaparambil et al., 2007; Lu et al., 2008).  Di- and trimethylation of H4K20 
promotes chromatin compaction and H3K36Me suppresses inappropriate 
transcription from internal initiation sites (Carrozza et al., 2005; Lu et al., 2008).  
Interplay between specific modifications, e.g. H2B ubiquitination and H3K4Me3, 
adds another level of complexity to this dynamic system (Mateescu et al., 2004; 
Taverna et al., 2007).  Finally, steric prevention of protein binding to DNA by the 
presence of histone modification is a common mechanism of transcriptional 
regulation.   
1.2.3.4 Interactions with protein binding factors 
Specific histone modifications also act indirectly, through the recruitment of 
transcription factors and ATP dependent chromatin remodelling proteins.  The 
forkhead transcription factor FOXA1 binds to H3K4me1 and -me2 enriched enhancer 
sequences, decondensing the chromatin.  This leads to further transcription factor 
recruitment and gene activation (Lupien et al., 2008).  H3K9me3 is enriched at 
constitutive heterochromatic regions, such as transposons and at pericentromeric 
chromatin, where it acts as a binding site for heterochromatin forming protein HP1 
isoforms α  and β (Bannister et al., 2001; Fischle et al., 2005; Martens et al., 2005).  
During DNA replication, G9a and SUV39H1, which methylate H3K9, interact with 
DNMT1, forming a complex which promotes G9a loading onto the chromatin and 
concurrent CpG and H3K9 methylation, providing a further link between DNA 
methylation and repressive histone enrichments (Esteve et al., 2006).  Enrichment of 
H3K9me2/3 has also been identified at gene promoters, in cis with H3K4me3 (Vakoc 
et al., 2005).  Elongating Poll II is thought to recruit H3K9 methyltransferases, 
followed by association of newly methylated H3K9me2/3 with  the HP1γ isoform.  
Although the precise role of such enrichment is unknown, the methylation of H3K9 
clearly has dynamic roles, dependent on its location and specific molecular 
interactions (Vakoc et al., 2005).   
The polycomb group proteins (PcG) consist of two large complexes: 
Polycomb repressive complex 1 (PRC1) and PRC2.  PRC1 consists of M33, Bmi-1, 
Mel18 and Ring1A or Ring1B subunits, whereas PRC2 is comprised of Suz12, Ezh2 
and Eed (Kuzmichev et al., 2002; Levine et al., 2002).  Both complexes interact with 
HDACs and histone methyltransferases to mediate gene repression and chromatin 
condensation  (Otte and Kwaks, 2003; Ringrose and Paro, 2004).  Polycomb complex 
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PRC2 catalyses H3K27 methylation, whilst PRC1 binds methylated H3K27Me3 to 
promote condensation, and closely related trithorax group protein complexes (TrxG) 
methylate H3K4.  Polycomb- and trithorax-group complexes are therefore 
respectively associated with transcriptional repression and activation 
(Schuettengruber et al., 2007). 
1.2.3.5 Histone modifying enzymes 
 Specific enzymes have been identified each for addition and removal of 
histone modifications.  Histone acetylases, such as creb binding protein (CBP), and 
deacetylasees (HDAC classes I-III) are generally able to modify more than one lysine 
residue, whereas methyl- and phosphotransferases are highly specific, each conferring 
one particular modification (Kouzarides, 2007).  Methyltransferases, specifically 
active on specific lysine or arginine residues, may confer repressive or active marks, 
as outlined in Table 1.2.   
Modification Histone position Enzyme 
H3 4, 9, 27, 36, 79 MLL1-5, SET1A,B, 2, 7/9, ASH1,  
SUV39H1,2, SETDB1, G9A, CLL8, 
RIZ1, EZH2, NSD1, SMYD2, DOT1 
H4 20 SUV4-20H1,2, PRSET7/8 
H3 2, 8, 17, 26 CARM1, PRMT5 
Methylation 
 
 
H4 3 PRMT4, 5 
Table 1.2 Histone modifying enzymes.  
HDAC, histone deacetylase; PRMT, protein arginine methyltransferase; Activating 
modification/enzyme; Repressive modification/enzyme.  The table outlines examples 
of specific histone tail modifications, and the enzymes responsible for the catalysis of 
each.  The modifications and enzymes are listed in order, i.e. activating H3K4 
methylation may be catalysed by MLL1-5, SET1A,B, 2, 7/9 and ASH1 (Kouzarides, 
2007). 
1.2.4 Non-coding RNA 
The canonical fate of the messenger RNA molecule is to be translated into 
protein.  It has become increasingly apparent that there are a large number of 
transcribed genes which are either not coding at all, or which contain alternative, 
often antisense, transcripts and splice variants which are not translated, or are flanked 
by non-coding transcribed regions  (Okazaki et al., 2002).   
Lysine 
Arginine 
  33 
1.2.4.1 Short non-coding RNA 
Pre-mRNAs undergo 5’ and 3’ end processing, splicing, and are then 
transported from the nucleus.  Some ncRNAs are alternately spliced and processed to 
smaller products, such as small nuclear RNAs (snRNA), 100-300 nucleotides long, 
which are involved in RNA splicing and the maintenance of telomeres.  Small 
nucleolar RNAs (snoRNA) are involved in ribosome and ribosomal RNA (rRNA) 
processing and assembly (Reviewed in(Yazgan and Krebs, 2007). 
Antisense transcription across a gene is thought to be common and to directly 
regulate mRNA production (Katayama et al., 2005).  Double stranded RNA is 
cleaved by the enzyme DICER, leaving short interfering RNAs (siRNA) and 
microRNAs (miRNAs).  SiRNAs bind to complementary mRNA molecules, targeting 
them for degradation (Matzke and Birchler, 2005).  MiRNAs bind specficially to the 
3’ end of mRNAs, preventing their translation, and are estimated to regulate around 
30 % of human genes (Bartel, 2004).  These regulatory mechanisms are known as 
RNA interference, (RNAi) and are also important for  the formation of centric and 
pericentric heterochromatin, (Maison et al., 2002; Kanellopoulou et al., 2005).   
1.2.4.2 Long  non coding RNA 
The sequence of large non-coding (nc) RNAs are not highly conserved but 
their importance as regulators of gene expression across mammals is well established 
(Pang et al., 2006).  The most studied example is that of the 17 kb XIST nc RNA, 
which has both sequence dependent and sequence independent modes of action.  
5’conserved ‘A’ repeat sequences are required for physical coating in cis of the to-be 
inactive X (Xi), which leads to condensation of the entire chromosome (see section 
1.3.4), whereas the exclusion of transcriptional apparatus from Xi is A repeat 
independent (Wutz et al., 2002; Chaumeil et al., 2006).  ncRNA transcripts have also 
been shown to inhibit transcription directly by creating one complex with the 
promoter sequence, and another with transcription factor IIB, sterically preventing 
assembly of the transcription apparatus on the promoter (Martianov et al., 2007). 
Long ncRNA molecules may act to regulate gene expression indirectly, 
through RNA binding proteins, such as the translocated in sarcoma (TLS) protein.  
ncRNA transcription is induced by DNA damage, directing localisation of the TLS 
protein.  RNA-bound TLS then forms an inhibitory complex with CBP/p300 histone 
acetyltransferases, which results in gene repression (Wang et al., 2008).   
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1.2.5 Higher-order chromatin structure  
The influence of enhancers, insulators and other regulatory elements, which may be 
several kilobases away from their target gene, is exacted by the formation of 
chromatin loops.  This was discovered using two techniques - 3C, for Chromosome 
Conformation Capture, and RNA TRAP, which also identifies associated proteins.  
Qualification of cis and trans-interactions, respectively between regions on the same 
or on different chromosomes, was achieved, information only accessible previously 
using FISH (Carter et al., 2002; Dekker et al., 2002; Tolhuis et al., 2002).  3C and 
RNA TRAP analyses are target-based, but the development of 4C (Circular 3C) 
followed in 2006 which removed the need for region-specific primers (see 
 
Figure 1.7) (Simonis et al., 2006; Zhao et al., 2006). 
 
 
Figure 1.7 Circular chromosome conformation capture (4C) 
Crosslinking of the chromatin captures DNA sequences in contact with one another at 
that point in time.  Digestion of the DNA with a frequent-cutting restriction 
endonuclease separates out sequences into a manageable format, and ligating them 
ensures the continued association of crosslinked fragments after the crosslink has 
been reversed.  PCR using primers complimentary to a chosen region will amplify 
both known (brown) and unknown (blue) DNA segments. 
1.2.5.1 Intrachromosomal interaction 
Interaction of the mammalian β-globin locus with its control region (LCR) 
50kb away was identified using 3C.  A chromatin loop is formed, bringing the LCR 
into close proximity with the locus, vital for the extremely high levels of expression 
of B-globin in erythroid cells (Caron et al., 2001; Carter et al., 2002; Simonis et al., 
2006; Tolhuis et al., 2002; Zhao et al., 2006).  It has been postulated that the function 
of the LCR is to maintain association of the B-globin locus with a transcription 
factory (Ragoczy et al., 2006).  
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1.2.5.2 Interchromosomal interaction 
Interphase chromosomes occupy discrete territories in the nucleus, and are 
relatively static (Gerlich et al., 2003).  Their arrangement is non-random, and 
individual chromosomal fibres frequently leave the territory, mobile due to Brownian 
motion (Branco and Pombo, 2006). 
The interaction of one chromosomal domain with another, of a frequency 
above that calculated for a random meeting, has been linked with transcriptional 
regulation in several different systems e.g. counting and choice at the X inactivation 
centre (XIC), the mouse α- and β-globin clusters on chromosomes 11 and 7, and 
Interferon-γ on mChr10 with TH2 cytokine genes on mChr11, prior to their 
transcription in T helper cells (Bacher et al., 2006; Osborne et al., 2004; Spilianakis et 
al., 2005; Xu et al., 2006).  
Elegant combination of 3C and FISH by Richard Axel and colleagues 
demonstrated trans-interactions between the olfactory receptor genes: of which there 
are 1300 distributed on different chromosomes; and an enhancer on mouse 
chromosome 14.  A single odorant receptor is expressed per sensory neuron.  To 
achieve this specificity, one allele of the enhancer is methylated (CpA) in neurons.  
Stochastic trans-chromosomal interaction exploits the monoallelically active element 
to activate a single receptor per cell and a feedback loop establishes expression of that 
receptor (Lomvardas et al., 2006). 
1.2.5.3 Imprinted gene networks 
 Interrogation of microarrays with cDNA libraries generated using 4C has 
revealed intra- and interchromosomal interactions between the expressed (maternal) 
allele of  H19 and several other loci, which depended on monoallelic methylation of 
the H19 ICR.  It was noted that up to four chromosomes were able to simultaneously 
converge to interact with H19  (Zhao et al., 2006; Ling et al., 2006).  ZAC1 on hChr6 
interacts with almost 400 genes on various chromosomes.  Imprinted genes were 
overrepresented in the group of interaction partners for both ZAC1 and H19, although 
it is not known whether this is due to common biochemical pathways i.e. in growth, 
or to coordinate mechanisms of gene regulation (Varrault et al., 2006; Murrell et al., 
2004).  The control of the imprinted Igf2/H19 locus has also been reported to rely 
upon looping, mediated by CTCF (Kurukuti et al., 2006; Ragoczy et al., 2006). 
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1.2.6 Monoallelic gene expression 
Aside from genomic imprinting and X chromosome inactivation, discussed 
later (sections 1.4 and 1.3.4, respectively) monoallelic gene expression has been 
found to be widespread in the mammalian genome, at around 10% of total expressed 
transcripts (Gimelbrant et al., 2007).  At certain loci, the requirement of monoallelic 
expression in allowing sufficient specificity for cell signalling, such as in odorant or 
T-cell receptors, is well established (Serizawa et al., 2004; Serizawa et al., 2003).  
The monoallelic expression observed was random, i.e. from either parental allele, 
distinguishing it from imprinting, and varied within and between cells in different 
tissues (Gimelbrant et al., 2007; Wang et al., 2007; Pollard et al., 2008).  It has been 
suggested that random monoallelic expression increases inter-individual variation, 
and may have uncharacterised roles in the control of differentiation, development and 
disease (Krueger and Morison, 2008). 
1.2.7 Unifying epigenetics and DNA sequence 
It was recently noted that cohesin proteins, required for sister chromatin 
interaction during cell division, also play an important role in the regulation of gene 
expression in a wide range of organisms (Gause et al., 2008).  One mechanism by 
which such regulation may be executed is through the boundary element CTCF.   
CTCF is an 11 zinc finger protein conserved between prokaryotes and 
eukaryotes (Kim et al., 2007c; Day et al., 2007).  It binds DNA directly in a sequence 
dependent manner.  Diverse functions of CTCF continue to be identified, including 
those as a transcriptional repressor, enhancer blocker and chromatin boundary factor 
(Ohlsson et al., 2001).  Binding sites for CTCF are abundant in the genome.  Notable 
examples include those embedded in enhancer blockers at the imprinted IGF2/H19 
domain on hChr11 (mChr7), at heterochromatin boundaries and at the XIST promoter 
on the X chromosome (Pugacheva et al., 2005; Filippova et al., 2005).  Several flank 
the β-globin locus, where CTCF binding promotes the formation of activating 
chromatin loops specifically in erythroid cells (Tolhuis et al., 2002).   
Cohesins appear to have binding sites very similar to those of CTCF, and the 
colocalisation of cohesin subunits with CTCF at multiple genomic sites has been 
demonstrated in mice and humans (Parelho et al., 2008; Stedman et al., 2008; Wendt 
et al., 2008).  Cohesin-mediated control of gene expression is suggested to be as a 
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result of interplay between cohesion subunits, and CTCF in its role at insulator 
elements (Parelho et al., 2008; Bowers et al., 2009).     
Genomic sequence elements such as LINEs are also thought to directly impact 
epigenetic modification.  LINEs have been shown to promote spreading of ncRNA 
mediated gene silencing, such as that which occurs on the mammalian X chromosome 
and at imprinted genes (Allen et al., 2003; Lyon, 2003; Popova et al., 2006).  
1.3 Epigenetics in development and differentiation 
 
 
Figure 1.8 The first differentiation 
Several stages of mammalian preimplantation development are shown, highlighting 
the point at which totipotent blastomeres begin to differentiate.  The embryo then 
forms a morula, where the outer cells take on a polarised phenotype, according to 
their fate as part of the trophectoderm (TE).  Inner cells retain totipotency, and 
become the inner cell mass (ICM) of the blastocyst. 
 
The differentiation of totipotent blastomeres to ‘inner’ and ‘outer’ cells of the 
morula is not well understood.  The exposure of outer cells to the environment is 
likely to activate signalling pathways, influencing gene transcription.  It is suggested, 
however, that cell fate is decided earlier than this, perhaps at fertilisation i.e. embryo 
polarisation based on sperm entry, or asymmetric distribution of oocyte derived 
factors (Piotrowska and Zernicka-Goetz, 2001; Gardner, 2001).  Particularly strong 
evidence exists for pre-allocated fate in the four-cell cleavage embryo (Piotrowska-
Nitsche et al., 2005).   
Epigenetics play a primary role in the regulation of cellular phenotype (Reik, 
2007).  This can be illustrated simply through the possibility of a live birth through 
somatic cell nuclear transfer (SCNT) and more recently the reversion to pluripotency 
of differentiated cells, termed induced pluripotent stem cells (iPS) (Wilmut et al., 
1997; Takahashi and Yamanaka, 2006; Byrne et al., 2007; Okita et al., 2007; Wernig 
et al., 2007). 
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1.3.1 DNA methylation and development 
There is currently sparse information available regarding the role of 
epigenetics in differentiation before the blastocyst stage.  During murine blastocyst 
formation, the DNA of the ICM genome is remethylated, but the TE is not (see Figure 
1.9) asserting a fundamental difference between the two lineages (Santos et al., 2002).  
Bovine blastocysts exhibit equal levels of methylation between the trophectoderm and 
the ICM, showing some species differences exist in this developmental process, and 
illustrating that although levels of methylation are important, it is the precise sites 
methylated which confers phenotypic differences.    In the human, evidence exists 
that, at least in vitro, the trophectoderm is more methylated than the ICM following 
reprogramming, opposite to what is seen in the mouse (Fulka et al., 2004). 
 
 
Figure 1.9 Preimplantation development and cellular pluripotency in the mouse.   
Upon fertilisation the pro-nuclei of the haploid gametes are reprogrammed by the 
cytoplasm of the oocyte to produce a totipotent genome.  During the blastocyst stage, 
the cells of the inner cell mass (ICM) become remethylated, whereas the 
trophectoderm (TE) remains hypomethylated (Reik et al., 2001b; Santos et al., 2002). 
 
Reprogramming is characterised by waves of demethylation and 
remethylation, corresponding with the remethylation of tissue specific control 
regions, whilst the promoters of transcription factors required for early development, 
remain demethylated (Jones and Takai, 2001; Reik et al., 2001b).  During 
differentiation, promoter methylation of key developmental genes such as POU5F1 
and NANOG suppresses their transcription, possibly through a novel complex 
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containing DNMT3a and b, cementing cell fate away from pluripotency (Hattori et 
al., 2004; Li et al., 2007).  
1.3.1.1 Tissue specific DNA methylation 
Promoter CpG methylation plays an important role in the regulation of 
imprinted gene expression and X chromosome inactivation (See sections 1.4.2 and 
1.3.4).  There is also a significant correlation between promoter methylation and gene 
expression in normal human somatic tissues (Rakyan et al., 2008).  DNA 
modification patterns are highly tissue specific however, much of the variation in 
methylation, outside of imprints and the inactivated X, lies within exons, introns or 
intergenic regions such as transposable elements (Jones and Takai, 2001).  This 
brings into question both the importance of promoter CpG methylation in 
differentiation, and the perceived significance of transposon methylation.  Addressing 
these issues, several recent studies highlight tissue specific differentially methylated 
loci across the genome (Eckhardt et al., 2006; Khulan et al., 2006; Kitamura et al., 
2007; Illingworth et al., 2008).    Examination of genomic MeDIP assays by Stephan 
Beck and colleagues found 18 % of regions examined, including promoters, coding 
regions and intergenic DNA, to be differentially methylated in a tissue specific 
manner (tDMR).  Evidence for a universal role of promoter DNA methylation in 
transcriptional regulation remains elusive however, as both this study and another by 
Mikael Weber et al point out that most inactive promoters remain unmethylated 
(Weber et al., 2007; Rakyan et al., 2008) 
Raykan et al also analysed spermatozoan promoters, finding one third of the 
total promoter tDMRs identified to be specifically unmethylated in these cells.  4 % 
of methylated CpG island promoters were shown in another study to be involved in 
germ cell-specific gene silencing (Shen et al., 2007).  These observations hint that 
although the covalent nature of promoter DNA methylation may limit its use in rapid 
changes in gene expression, it has an important function in the more permanent 
silencing of genes which are germline and embryo specific.  
1.3.2 Histone modifications and development 
Histone lysine residue modification is, like DNA methylation, globally 
unchanged until the blastocyst stage in the mouse, at which point repressive mark 
enrichment occurs in the ICM (Sarmento et al., 2004; Erhardt et al., 2003).  
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Interestingly, at the four cell stage in certain embryos, arginine methylation at H3R-2, 
-17 and -26, was found to be significantly higher in blastomeres destined to become 
ICM, rather than TE (Torres-Padilla et al., 2007).  This enrichment is specifically 
catalysed by coactivator associated arginine methyltransferase (Carm1), and is 
associated with an increased level of transcriptional activity in these blastomeres, 
which, along with the difference in potential, is abolished in Carm1 knock-down 
cells, demonstrating a primary role for epigenetic modification in differentiation at 
this stage (Torres-Padilla et al., 2007). 
 Patterning of the developing embryo is defined through sequential activation 
of Hox genes (Iimura and Pourquie, 2007).  Transcriptional activation is achieved by 
the removal by PRC2 of repressive H3K27Me3, and the recruitment of H3K4Me2/3, 
enrichment at specific Hox gene promoters (Swigut and Wysocka, 2007). 
In human and mouse embryonic stem cells both H3K4Me3, H3K4Ac and 
H3K27Me3 are enriched on both alleles of certain developmental gene promoters, 
termed ‘bivalent’ domains.  These domains resolve upon differentiation to either 
H3K4Me3/H3K4-Ac upon gene activation, or H3K27-Me3/H3K9Me only should the 
gene become stably repressed (Bernstein et al., 2006).  The forkhead transcription 
factor FOXA1 mediates interaction between cell-type specific transcription factors 
and enhancers with H3K4Me1/2 enrichment to control the differentiation of several 
tissue types (Lupien et al., 2008). 
1.3.3 Non-coding RNA and development 
 Non-coding, antisense RNA transcription has also been linked to the 
sequential activation in cis of Hox gene expression (Sessa et al., 2007).  Polycomb 
group proteins repress transcription of intergenic ncRNAs in the Hox cluster.  Upon 
developmentally indicated activation, it is suggested that ncRNA transcription results 
in decondensation of the chromatin of Hox promoters and the surrounding region, 
followed by the exclusion of polycomb complexes, preventing re-repression 
(Chambeyron et al., 2005; Sessa et al., 2007). 
The appropriate expression of the XIST-TSIX long ncRNA duo on mammalian 
X chromosomes is absolutely required for female cells to be viable in development, 
as demonstrated by mutants of either gene (Marahrens et al., 1997; Lee, 2000; Sado et 
al., 2001).  The presence of more than one X chromosome in a wild-type cell (i.e. in 
normal females, XXY males, or other sex chromosome aneuploidies) results in XIST 
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RNA mediated inactivation of almost the entire X chromosome (Carrel and Willard, 
2005).  This occurs on all but one of the X’s, which is protected through concurrent 
TSIX expression, repressing XIST.  The result is one active X in each cell, achieving 
equivalent gene dosage to males (Lyon, 1961). 
1.3.4 X chromosome inactivation (XCI) 
Sex chromosome dosage compensation in homogametic species provides an 
elegant example of sequential combination of epigenetic modification in complete 
and permanent gene silencing.  The 1Mb X inactivation centre (XIC) on Xq13 
contains the sequence for three ncRNA genes:  XIST, TSIX and XITE (X-inactivation 
intergenic transcription element) (Penny et al., 1996; Marahrens et al., 1997; Lee and 
Lu, 1999; Ogawa and Lee, 2003).  XIST and its antisense TSIX are transcribed from 
the to-be inactive (Xi) and active (Xa) chromosomes respectively.  The XIC is 
proposed to interact in trans to mediate ‘counting’ and ‘choice’ (Augui et al., 2007).  
RNA FISH experiments show XIST RNA coating Xi which then recruits HP1, PRC2 
and associated repressive histone modifications (see Figure 1.21), resulting in 
condensation of the entire chromosome (Panning et al., 1997; Sheardown et al., 1997; 
Okamoto et al., 2004; Navarro et al., 2005).  The stepwise process of XCI which 
occurs during preimplantation development can be modelled on XCI in vitro during 
ES cell differentiation (see Figure 1.21).   
Two heterochromatic domains are formed in the human, one containing XIST, 
macroH2A and H3K27Me3, and the other H3K9Me2, HP1 and H4K20 (Chadwick 
and Willard, 2004).  TSIX, on Xa, prevents XIST expression in cis, through 
recruitment of H3K4Me2 and H3K9Me3 to the XIST promoter, keeping the 
chromosome active (Lee and Lu, 1999; Nesterova et al., 2003; Chadwick and 
Willard, 2004; Navarro et al., 2005).  XITE is thought to promote continued TSIX 
expression (Ogawa and Lee, 2003).  The mechanism controlling precise inactivation 
of all but one X is debated.  Both counting and choice of X chromosomes must occur, 
through either trans-association of specific regions on the X or perhaps in a purely 
stochastic manner via a second diffusable factor (Bacher et al., 2006; Xu et al., 2006; 
Augui et al., 2007; Monkhorst et al., 2008). 
In marsupial and eutherian females, the one of two X chromosomes is 
inactivated during embryo cleavage, estimated to begin in humans when there are six 
cells, and in the mouse when there are four (Okamoto et al., 2004). Marsupial XCI is 
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always paternal, is tissue specific and does not involve XIST or DNA methylation 
(Duret et al., 2006; Grutzner and Graves, 2004).  Preferential repression of the 
paternal X is known as imprinted X inactivation (Takagi and Sasaki, 1975).  This 
occurs in the entire embryo of eutherians, except humans, in early preimplantation 
development, to be replaced with random XCI in the embryo-proper and 
extraembryonic membrane–specific imprinted XCI, just before gastrulation (Daniels 
et al., 1997; Xue et al., 2002; Mak et al., 2004; Okamoto et al., 2004) 
 
Figure 1.10 X Chromosome Inactivation; Random vs. Imprinted 
During blastocyst expansion, between E3.5 and 5.5, Xist is lost from the Xp of the 
embryo proper, concurrently with repressive histone modifications.  This results in 
embryo-specific reactivation of Xp, and a matter of hours later random inactivation 
occurs.  Imprinted X inactivation is thought to be absent in the human, although some 
speculate its retention in early human trophoblast (Goto et al., 1997). 
 
DNA methylation at gene bodies is increased on Xa (Hellman and Chess, 
2007).  Random X inactivation is followed by CpG DNA methylation on Xi, and XCI 
is maintained through cell division by the action of DNMT1 in the embryo proper.  
Imprinted X inactivation, specific to extraembryonic membranes, is not associated 
with significant DNA methylation and the heterochromatic state is maintained by 
histone methylation (Sado et al., 2000; Wang et al., 2001). 
The situation regarding actual dosage of expression from the X chromosomes 
is more complex, and in both males and females, expression from the one active X is 
doubled in order to match that from the autosomes (Nguyen and Disteche, 2006; 
Gupta et al., 2006).  
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1.4 Genomic Imprinting 
Genomic imprinting is defined as the monoallelic expression of certain genes 
and gene clusters in a parent-of-origin dependent manner.  Like in the regulation and 
control of X-inactivation, its effectors are epigenetic, and its regulation in now known 
to involve several layers of epigenetic control.   
 
1.4.1 Discovery 
 Imprinting was first discovered in the 1980s, by a set of seminal experiments 
carried out independently in two research laboratories, Azim Surani, Sheila Barton 
and Michael Norris in Cambridge, UK, James McGrath and Davor Solter in 
Philadelphia, USA.  Diploid, uniparental embryos were created by replacing one 
parental nucleus with another from the same sex and replacing the embryo in a 
pseudopregnant female.  Bi-paternal and bi-maternal embryos were created in 
parallel, revealing opposite lethal phenotypes (Barton et al., 1984; McGrath and 
Solter, 1984; Surani et al., 1984).  Maternal uniparental embryos, or gynogenotes, 
developed embryonic tissues in a disorganised manner, but failed to generate 
significant placental material.  Paternal embryos, or androgenotes, grew highly 
developed trophoblast and yolk sac structures, but no discernable embryo.   
 
Figure 1.11 From Surani et al., 1984, creation of uniparental mice 
Normal murine gestation at day 10 is compared with embryos resulting from 
experiments creating gynogenotes, with only maternal genomic material, and 
androgenotes, with only paternal genomic material.  Gynogenote embryos have a 
reasonably well organised embryo, with a small yolk sac.  Trophoblast development 
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is almost completely absent, in contrast with androgenotes, which have a large mass 
of trophoblastic tissue and almost no embryo development. 
 
From this the authors concluded that the maternal and paternal genomes were 
not equivalent, each with a stringent requirement for the other (McGrath and Solter, 
1984; Surani et al., 1984).  Naturally occurring, and equally pathological, examples 
can be found in man.  Gynogenotes are equivalent to ovarian teratoma, a disorganised 
mass of embryonal tissue brought about through activation of an unfertilised egg.  
Androgenotes form as a hydatidiform mole, consisting of highly invasive trophoblast, 
occurring in the instance of fertilisaiton of an empty egg with two sperms, or loss of 
maternal contribution during cell division (Kajii and Ohama, 1977; de Grouchy., 
1980; Ohama et al., 1981; Mutter, 1997). 
  The precise regions of the genome involved in this non-equivalence were 
narrowed down through the creation of uniparental disomic mice, which had the 
normal contingent of biparental chromosomes except for one pair, or part of one pair, 
which would be derived from the same parent, e.g. the maternal chromosome 7, in 
which case the mouse would have maternal uniparental disomy 7, or mUPD7; pUPD7 
if the mouse had two of the paternal copy.  Interestingly, each of these types of mice 
had different phenotypes, according to the UPD chromosome.  Some were normal, 
indicating that the factors requiring complementation from the opposite genome were 
absent from these regions.  One of the most striking observations was that mice with 
pUPD often had an opposite phenotype to those with mUPD.  For example, pUPD11 
mice were 30% larger, and mUPD11 mice 30% smaller, than wild type (WT) 
(Cattanach and Kirk, 1985; Cattanach and Beechey, 1990). 
 Regions of non equivalence were narrowed down to small clusters and in 
some cases, single isolated genes (Barlow et al., 1991; Bartolomei et al., 1991; 
DeChiara et al., 1991).  To date there are 100 confirmed imprinted genes/transcripts 
in the mouse (including the miRNAs, but not the snoRNAs), of which 50 are 
maternally expressed, and 50 paternally expressed.  Approximately 51 of these are 
maintained in the human, but data is still accruing as technologies designed to 
identify new imprinted genes become increasingly sophisticated.  The Harwell mouse 
database and Otago human imprinting website store up-to-date information 
surrounding each imprinted gene found so far, including those for which data is 
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inconsistent or incomplete (http://igc.otago.ac.nz/home.html - last updated February 
2008; http://www.mgu.har.mrc.ac.uk/research/imprinting). 
1.4.2 The regulation of genomic imprinting  
Imprinted monoallelic expression is dictated by the allelic methylation of key 
loci, established during gametogenesis of the previous generation (Tremblay et al., 
1995; Wilkins, 2005).  So-called differentially methylated regions (DMRs) can be 
several kb in size and are usually associated with CpG islands.  The genome average 
for promoter association with CpG islands is 47%, whereas for imprinted gene 
promoters the association is 88% (Paulsen et al., 2000).  Targeted mutation of 
individual DMRs in mouse models has established several of the known DMR loci as 
definitive imprint control regions (ICRs), necessary for the appropriate expression of 
the imprinted genes under their control (see Table 1.3; N.B., when referring more 
generally to imprint control mechanisms, the term ICR is used for both putative and 
verified regions).  Evidence for human conservation of such a control mechanism can 
be gathered from the occurrence of imprinting disorders caused by putative-ICR 
mutations or altered methylation at DMRs, or through the manipulation of human loci 
in cells or mouse models (Buiting et al., 1999; Ohta et al., 1999; Horike et al., 2000; 
Paulsen et al., 2000; Arima et al., 2006). 
  46 
 
Gene/ 
cluster 
Locus Transcripts EXPRSS DMR METHL 
DIRAS3 1p31  Paternal Germline, promoter Maternal 
TP73 1p36  Maternal Germline, promoter Paternal 
NAP1L5 4q22  Paternal Germline, promoter Maternal 
Isoform 1  Paternal P1 germline promoter Maternal ZAC1 6q24 
Isoform 2 Biallelic P2 promoter, not a DMR N/A 
GRB10 7p11 GRB10  Paternal Germline, intronic CGI2 Maternal 
PEG10  Paternal Maternal PEG10 7q21 
SGCE Paternal 
Germline, PEG10 promoter 
Maternal 
CPA4  Maternal   
MESTIT1  Paternal 
MEST Iso 1  Paternal 
MEST Iso 2 Paternal 
Germline, MEST promoter Maternal 
MEST  7q32 
KLF14  Maternal Germline, promoter Paternal 
INPP5F_
V2 
10q26  Paternal Germline, promoter Maternal 
WT1 11p13  Paternal Germline ARR DMR  Maternal 
PHLDA2  Maternal 
SLC22A18  Maternal 
SLC22A1LS Maternal 
CDKN1C Maternal 
KCNQ1OT1  Paternal 
KCNQ1 11p15 
KCNQ1 Maternal 
Germline KCNQ1OT1 
promoter (within KCNQ1 
intron) - the KvDMR 
Maternal 
Germline intergenic DMD Paternal 
Somatic promoter DMR0 Maternal 
IGF2/H1
9 
11p15 H19 
IGF2  
Maternal 
Paternal 
Somatic intronic DMR2 Paternal 
Somatic GTL2 promoter  Paternal DLK1/ 
DIO3 
14q32 GTL2  
DLK1  
DIO3 
Maternal 
Paternal 
Paternal 
Germline intergenic (IG) 
DMR 
Paternal 
NDN  Paternal Promoter Maternal 
SNRPN  Paternal Maternal 
IPW  Paternal 
Germline AS-IC 
 
SNURF/ 
SNRPN 
15q11 
ATP10C  Maternal   
PEG3 19q13  Paternal Germline promoter Maternal 
MCTS2 20q11  Paternal Germline promoter Maternal 
NNAT 20q11     
NESP  Maternal Somatic NESP55  Paternal 
GNAS  Maternal Maternal 
Exon 1A  Paternal 
Germline 1A Promoter 
Maternal 
GNAS XL  Paternal 
GNAS  20q13 
NESPAS Paternal 
Germline XL/NESPAS 
Promoter 
Maternal 
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Table 1.3 Imprinted gene clusters and differentially methylated regions (DMRs) 
A summary table of the imprinted gene loci which have been most characterised to 
date.  EXPR = parental origin of expressed allele, METHL = parental origin of 
methylated allele.  Imprinted transcripts are often clustered, facilitating control by a 
single element  - an imprint control region (ICR), in cis.  Differential DNA 
methylation at ICRs canonically leads to transcriptional silencing, however, 
regulation at certain loci is more complex, involving silencing of genes through 
expression of ncRNAs on the unmethylated allele, for example - see section 1.4.2.  
Germline DMRs are established during gametogenesis, whereas somatic DMRs 
become differentially methylated following fertilisation, often in a tissue specific 
manner.  Those DMRs which have been experimentally established (albeit in mouse) 
as ICRs are shaded green (Thorvaldsen et al., 1998; Yang et al., 1998; Buiting et al., 
1999; Fitzpatrick et al., 2002; Lin et al., 2003; Williamson et al., 2006) ARR = 
antisense regulatory region. 
1.4.3 Imprint initiation signal 
The signal for the application of DNA methylation at to-be imprinted loci 
during gametogenesis, distinguishing the male and female germline, is still unknown.  
The sex of the genital ridge, and in the male also the sex chromosome complement of 
the primordial germ cells, act to promote parental-specific imprint establishment 
(Durcova-Hills et al., 2006).   
Imprints are acquired during gamete development, specifically catalysed by 
DNMT3a in conjunction with its non-enzymatic cofactor DNMT3L  (Hata et al., 
2002; Kaneda et al., 2004).  The KRAB zinc-finger protein Zfp57 has also been 
shown to be important for de novo imprint methylation, specifically at the Snrpn 
locus (Li et al., 2008b)  DNMT3a forms a tetramer complex with DNMT3L.  One 
suggestion for an imprint signal is that CpGs at a periodicity of 8-10 bp apart are 
significantly enriched at maternally methylated imprinted genes. The position of 
DNMT3a active sites within the DNMT3a/DNMT3L complex was shown to result in 
a specific periodicity of methyltransferase function, methylating CpG dinucleotides 
every 8-10 bp (Jia et al., 2007).  A requirement of DNMT3a-3L tetramers for such a 
sequence profile to carry out de novo methylation would enable specificity at ICRs in 
the female germline.  
The profile of modified histone residues at imprinted loci has been cited as 
another mechanism of methylation targeting.  DNMT3L specifically binds 
unmethylated H3K4 residues.  H3K4 methylation on the to-be unmethylated allele of 
imprinted loci is therefore protective against de novo methylation by DNMT3L-
DNMT3a complexes (Jia et al., 2007; Ooi et al., 2007).   
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Recently, and importantly, the transcription of coding sequences was shown to 
be required for the methylation of imprint control regions during oogenesis.  Nesp, 
transcribed from a novel upstream promoter, was shown to be required for maternal 
methylation of the Nespas/Xl ICR and Gnas Exon1A DMR.  Similar transcripts, again 
from more upstream promoters than those utilised somatically, at Grb10, Igf2r, 
Kcnq1 and Zac1 were also detected in oocytes (Chotalia et al., 2009).  The authors 
suggest that transcription may be a universal requirement for imprint initiation. 
1.4.4 Setting imprint DNA methylation 
In the germ cells of the new fetus, imprints are erased as primordial germ cells 
enter the genital ridge and are then re-set to reflect fetal sex (Figure 1.13).  In the 
male germline, the Rasgrf2 DMR, H19 DMR and Dlk1/Gtl2 IG-DMR begin to 
acquire methylation from E12.5.  Germline methylation of all three regions is 
complete by the prospermatagonia phase, corresponding to E17.5 of mouse 
development (Ueda et al., 2000; Li et al., 2004; Hiura et al., 2007).  In the female 
germline, where the majority of imprints are laid, imprint acquisition occurs 
throughout life.  Primordial follicles, arrested at diplotene of meiosis 1, a state known 
as ‘dictyate’, are gradually recruited into folliculogenesis, a process which takes 
several months, providing developing oocytes for monthly ovulatory cycles (see 
Figure 1.12).   
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Figure 1.12 Imprint initiation in the female germline 
DMRs methylated on the maternal allele acquire methylation in a step-wise, region-specific manner during folliculogenesis.  Follicle and oocyte 
growth stages are indicated, alongside meiosis progression timing, images are not to scale but oocyte diameter in the mouse and the human is 
indicated (Hiura et al., 2006).  Methylation levels are linked with oocyte diameter, where continued growth of the oocyte corresponds to 
increasing % of CpG methylation at each region.  Gene names in lower case correspond to data from mouse studies, upper case to human.  *It is 
not clear whether the methylation at the Snrpn DMR (the AS-IC) found at the primordial stage is due incomplete imprint erasure, perhaps acting 
as the imprint signal, or due to the early stage at which this ICR accumulates methylation (Obata and Kono, 2002; Lucifero et al., 2004; Hiura et 
al., 2006; Sato et al., 2007; Khoueiry et al., 2008; Chotalia et al., 2009). 
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Figure 1.13 The genomic imprinting cycle.   
ICR = imprint control region; PGC = primordial germ cell.  The allelic methylation 
status of a DMR, in this case maternally methylated, is shown alongside 
developmental progression.  Upon fertilisation, the pronucleus genome of the sperm 
and egg are demethylated, whilst ICR methylation is maintained.  The paternal 
genome is thought to be demethylated by an active mechanism (Mayer et al., 2000b).  
ICR differential methylation is maintained in the soma during genome remethylation, 
but erased in the germ-cell lineage during colonisation of the genital ridge at around 
E11.5 (Szabo and Mann, 1995; Lee et al., 2002; Ohta et al., 2004).  Erasure permits 
re-setting of imprints, following germ cell commitment according to the sex of the 
fetus.  
 
Following fertilisation, methylation at ICRs is protected during genome-wide 
demethylation by the protein PGC7/Stella (Nakamura et al., 2007).  During cell 
division and differentiation, imprints are faithfully propagated at first by oocyte 
specific DNMT1o, which enters nuclei at the eight cell stage, and later by somatic 
DNMT1, in conjunction with Zfp57  (Hirasawa et al., 2008; Li et al., 2008b). 
1.4.5 Cluster-specific imprinting regulation 
The regulation of imprinted genes is complex.  ICR DNA methylation 
executes monoallelic expression through cluster specific mechanisms, including 
antisense transcription, ncRNAs, the YY1 transcription factor, boundary elements, 
histone modification and alternative polyadenylation (Kim et al., 2007a; Wen et al., 
2008).  Recently it was also suggested that an imprinted gene network exists, 
involving interchromosomal interactions between loci (Arima et al., 2005; Varrault et 
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al., 2006).  Imprinted expression can be highly temporal and tissue specific.  Tissue 
specificity may reflect complete silencing in certain tissues, or more widespread 
expression which may be mono- or biallelic.   
Some general themes for imprinted gene clusters do exist, notably several are 
associated with expression of a long ncRNA molecule, and all with antisense 
transcription of one or more of C/D snoRNAs, miRNAs or piRNAs (Peters and 
Robson, 2008).  Imprinted domain chromatin is also often enriched with allelic 
histone modifications.  H3K9Me2, H4K20Me3 and H3K27Me3 are associated with 
the repressed allele, and H3K4Me3, H3K4Ac and H3K9Ac with the expressed allele 
(Fournier et al., 2002; Pauler et al., 2007; Pannetier et al., 2008).  The precise manner 
in which these epigenetic marks are recruited and interpreted allelically, however, is 
highly variable.  In order to describe some of the key elements of imprint regulation, 
several example loci will be introduced and described.  Genomic layout and 
transcriptional direction in each case is indicated with respect to centromeric and 
telomeric chromosomal regions, and run from left to right, from the p arm of human 
chromosome 1 to the q of 22, as displayed on the UCSC genome browser (NCBI 
Build 36.1; http://genome.ucsc.edu/cgi-bin/hgGateway).  Actual transcript 
representations are screenshots from UCSC, but drawings are only to scale where 
indicated.  
1.4.5.1 Mcts2, mChr2qH1 
The murine imprinted malignant T cell amplified sequence 2 (Mcst2) gene is a 
retrotransposed copy of X-linked Mcts1.  It was identified following a screen for new 
imprinted genes, using the premise that retrotransposition events leading ancestrally 
to gene imprinting are overrepresented for genes originating from the X chromosome, 
i.e. imprinted genes Inpp5f_v2, Nap1l5 and U2af1-rs1 share this characteristic.  In 
addition, these genes were found to be intronic to a ‘host’ gene, be associated with a 
DMR overlapping their promoter, and are all paternally expressed (Wood et al., 
2007). 
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Figure 1.14 Murine Mcts2 locus – Alternative polyadenylation   
The layout of the Mcts2/H13 locus in the mouse is shown.  Mcts2 is expressed in the 
opposite direction to H13.  A germline maternally methylated DMR, represented by 
open (unmethylated) and closed (methylated) lollipops, promotes paternal-specific 
expression of Mcts2 (blue box denotes expression, and arrow shows direction) (Wood 
et al., 2007).  Transcription of the Mcts2 gene interrupts transcription of H13, 
possibly due to enforced utilisation of a second polyadenylation (polyA) signal, 
shown as a grey triangle.  This results in paternal-specific expression of a short H13 
isoform, and maternal expression of a long H13 isoform, which utilises the canonical 
polyA signal (grey triangle at the telomeric end of the region) (Wood et al., 2008).   
 
 Newly transcribed mRNA molecules are polyadenylated to ensure safe 
passage to the cytosol.  Signals for polyadenylation usually take the form of either 
AAUAAA or AUUAAA, and the presence of multiple polyA sites in a gene are a 
source of transcript variation (Tian et al., 2005).  It is not known precisely how 
differential methylation and/or imprinted expression of the Mcst2 retrogene envokes 
alternative polyadenylation, and subsequent imprinting of the host H13 gene.  
Imprinting and differential methylation at NAP1L5, INPP5F_V2 and MCTS2 were 
confirmed in human fetal tissues, although it is not currently known whether 
regulation such as that seen in the mouse is conserved (Wood et al., 2007). 
1.4.5.2 ZAC1 hChr6q24  
The ZAC1 protein is a seven zinc finger transcription factor which acts to 
regulate the cell cycle, and is a putative tumour suppressor.  It is widely expressed 
during fetal development and over-expression of ZAC1 has been implicated in 
transient neonatal diabetes (TNDM) and several cancers (Kamiya et al., 2000; 
Abdollahi et al., 2003).  The murine Zac1 homologue has also been suggested to be 
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involved in an imprinted gene regulatory network, where Zac1 on mouse 
chromosome 10 (mChr10) interacts with Cdkn1c and Igf2/H19 on mChr7 and Dlk1 
on mChr12 (Arima et al., 2005; Varrault et al., 2006). 
 
 
Figure 1.15  Human ZAC1 locus –Tissue specific promoters 
The layout of the ZAC1 domain on hChr6 is shown, with two coding ZAC1 isoforms, 
and the non coding RNA HYMAI.  All are transcribed from the same DNA strand in 
the same direction.  Maternally silenced long ZAC1 isoform 1 is represented by the 
red rectangle, and the other expressed transcripts by blue rectangles. Isoform 1 is 
expressed from the maternally methylated ICR, promoter P1, represented by closed 
(methylated) and open (unmethylated) lollipops.  The short ZAC1 isoform 2 is 
expressed biallelically from the unmethylated P2 promoter.  The terms ‘long’ and 
‘short’ correspond to the transcript length, not to the genomic size of the gene, which 
is larger for the ‘short’ isoform from P2. 
 
Human imprinted expression of ZAC1 Isoform 1 is controlled by a maternally 
methylated imprint control region, known as the P1 promoter, of 1kb in length and 
encompassing a CpG island (Arima et al., 2006).  It is also the first exon of a ncRNA, 
HYMAI/Hymai for which provisional evidence exists of paternal expression in the 
mouse (Arima and Wake, 2006), but is not imprinted in the human (unpublished 
observations).  The non-imprinted ZAC1 isoform 2 is expressed from unmethylated 
promoter P2.  The expression from P1 and P2 is regulated in a tissue specific manner.  
In peripheral blood and in the pancreas, P2 transcripts predominate meaning that 
ZAC1 is effectively biallelically expressed in these tissues.  Elsewhere in the body, P1 
imprinted transcripts are the most abundant molecule of the two (Valleley et al., 
2007). 
1.4.5.3 IGF2/H19 hChr11p15  
H19 is a maternally expressed 2.5kb capped, spliced and polyadenylated 
ncRNA (Bartolomei et al., 1991).  It is ubiquitously highly expressed during fetal 
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development, yet no specific role for the H19 transcript, aside from IGF2 regulation, 
has yet been pinpointed (Leighton et al., 1995a).  Its influence on the paternally 
expressed imprinted gene IGF2, where both genes compete for the same enhancers, 
has led to proposal of H19 as a tumour suppressor, and this function has been recently 
demonstrated in the mouse (Yoshimizu et al., 2008).  Using 4C assays, H19 has been 
shown to allelically interact with a total of 114 interchromosomal regions, resulting in 
regulation of gene transcription in trans.   Imprinted gene loci were overrepresented 
in the regions identified (Zhao et al., 2006). 
IGF2 was the first imprinted gene to be discovered, and is a potent growth 
enhancer (DeChiara et al., 1991).  Mutation of IGF2, or the de-regulation of 
imprinting in this cluster, leading to a lack of its expression and biallelic H19, results 
in the growth restriction disorder Silver-Russell Syndrome (SRS; MIM 180860) 
(Gicquel et al., 2005; Bliek et al., 2006).  SRS is characterised by severe intrauterine 
growth restriction, asymmetry, clinodactyly and a triangular shaped face (Abu-Amero 
et al., 2008).  Conversely, biallelic IGF2 expression leads to the over-growth disorder 
Beckwith Wiedemann syndrome, involving fetal overgrowth, macroglossia and  
omphalocele (BWS; MIM 130650) (Cooper et al., 2005). 
  In the human, IGF2 is expressed from five promoters, yielding five 
transcripts of varying size (Monk et al., 2006b).  Transcripts P2-4 are conserved in 
the mouse but transcript P1, as shown in Figure 1.16, is human-specific.  P0 is also 
conserved, but expression is not confined to the placenta as in the mouse, and it is 
most highly expressed in fetal skeletal muscle in the human.  All human IGF2 
transcripts are expressed paternally in fetal tissues except pancreas, where they are 
biallelic (Monk et al., 2006b).   
The tissue-specific expression of H19 and IGF2 is co-ordinately regulated.  
Both are highly expressed during fetal development in the endoderm and mesoderm 
of the fetus, and in the placenta.  Postnatally, H19 expression is vastly down 
regulated.  IGF2 P2-4 are down-regulated whilst P0 remains expressed and imprinted.  
In the adult liver biallelic IGF2 P1 transcripts predominate (Wu et al., 1997; Ohlsson 
et al., 1994).  
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Figure 1.16 Human IGF2/H19 - Enhancer blocking boundaries 
DMRs are shown as closed (methylated) and open (unmethylated) lollipops.  In the 
human, IGF2 has five transcript variants, initiating from five different promoters 
(Monk et al., 2006b).  The UCSC track of the two longest transcripts P1 and P0, the 
latter of which initiates from somatic DMR0, is shown (Monk et al., 2006b).   
Somatic DMR2 is located between the last two exons of IGF2, which are common to 
all transcripts.  The  2 kb imprint control region (ICR), or H19 DMD, for this cluster 
is 2 kb upstream of the H19 TSS.  All three DMRs are paternally methylated (Murrell 
et al., 2008).  Enhancers, conserved between human and mice, are shown as grey 
(endodermal) or green (mesodermal) diamonds (Gabory et al., 2006).  H19 and IGF2 
promoter sequences compete for enhancer access (Leighton et al., 1995b).  On the 
maternal allele, CTCF binding to the unmethylated ICR prevents IGF2 access qand it 
is repressed (red box), allowing H19 expression (wavy arrow and blue box).  On the 
paternal allele CTCF cannot bind to the methylated ICR, IGF2 is expressed 
(transcript specific straight arrows and blue box) and H19 repressed (red box).  
 
The ICR of this region acts as an insulator through interaction with CTCF.  
On the methylated paternal allele, CTCF does not bind, and regional enhancers 
interact with the IGF2 promoters, leading to IGF2 expression.  Mouse data shows 
that methylation spreading from the ICR to the H19 promoter, recruitment of MBD3 
and recently ncRNA expression, lead to H19 silencing (Ferguson-Smith et al., 1993; 
Reese et al., 2007; Schoenfelder et al., 2007).  On the maternal allele, the 
unmethylated ICR binds CTCF, which creates an inhibitory chromatin conformation, 
possibly in conjunction with cohesin (Wendt et al., 2008).  This prevents access of 
IGF2 to the enhancers, promoting instead H19 expression.  In the neonatal mouse 
liver it has been demonstrated that CTCF is able to bind any of four maternally 
unmethylated DMRs, (murine DMR1 is not conserved in the human), and promotes 
formation of higher order chromatin loops, recruiting PRC2 and the methylation of 
H3K27 (Murrell et al., 2004; Kurukuti et al., 2006; Li et al., 2008a; Qiu et al., 2008).   
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1.4.5.4 GNAS, hChr20q13  
GNAS is a complex locus in both mouse and man, characterised by 
differentially spliced upstream exons, and allelic promoter methylation leading to 
imprinting of four of the five genes in this region (Holmes et al., 2003). The GNAS 
gene itself is ubiquitously expressed and encodes Gαs, which mediates cAMP 
signalling between membrane-bound receptors and intracellular pathways (Plagge et 
al., 2008).  Paternally inherited GNAS mutations cause 
pseudopseudohypoparathyroidism (PPHP), whereas maternal transmission results in 
pseudohypoparathyroidism (PHP), or PHP type 1a, which is similar but patients are 
resistant to parathyroid hormone (PTH).  Both diseases are characterised by short 
stature, obesity, inappropriate ossification, and varying levels of learning disability.  
A third disease in this category, PHP type 1b, which manifests only in PTH 
resistance, is caused by loss of GNAS in tissues where it is maternally expressed, due 
to hypomethylation of the GNAS EXON 1A DMR (Davies and Hughes, 1993; Plagge 
et al., 2008).  GNAS-extra large (XLαs) differs from Gαs only in its amino terminal, 
and acts in the same way but expression is limited to the endocrine and nervous 
systems.  Outbred XL mutants are growth retarded and suckle badly, resulting in a 
failure to thrive and high neonatal mortality, similar to mUPD20q13 or paternal 
deletion, in humans (Plagge et al., 2004; Genevieve et al., 2005).  
 
 
Figure 1.17 Human GNAS cluster - complex splice variants 
Except for NESPAS, all the first exons as represented by rectangles, are spliced onto 
the downstream GNAS exons, as indicated by the lines linking the exons to ‘GNAS 
Exons 2-13’ (in purple).  NESP alone is maternally expressed, the furthest upstream 
transcript.  NESPAS (ncRNA), GNAS XL, and GNAS EXON1A (ncRNA) are all 
paternally expressed.  GNAS itself is predominately biallelic.  The three DMRs, 
germline NESPAS/XL promoter, germline EXON1A promoter, and somatic NESP55 
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intronic DMR, are shown as sets of closed (methylated) and open (unmethylated) 
lollipops.   
 
Four of the five transcripts expressed in this cluster splice onto Exon 2 of 
GNAS, and three (GNAS, EXON 1A and XL) share an ORF.  NESPAS is transcribed 
from the antisense strand.  NESPAS/XL is the ICR at this locus, controlling 
differential methylation at NESP55 and EXON 1A, and subsequent allelic expression 
of each transcript (Williamson et al., 2006).  The mechanism through which this 
control is executed is unclear, but the transcription factor YY1 has been shown to 
play a role, possibly in maintenance of methylation (Kim et al., 2007a).   
The DMR at NESP55 is somatic, formed during embryonic development 
(Coombes et al., 2003).  Maternally expressed NESP encodes a neuroendocrine 
secretory protein (NESP55) and includes the downstream GNAS exons, but utilises its 
own ORF and the downstream exons remain untranslated.  Its expression profile is 
similar to XL but its function postnatally seems limited to behaviour, specifically 
responses to novelty (Ischia et al., 1997; Plagge et al., 2005).  As previously 
mentioned, the Nesp transcript is indespensible for setting imprinting of this locus in 
the oocyte (Chotalia et al., 2009). 
Expression of GNAS itself is predominately biallelic, as reflected by promoter 
hypomethylation on both alleles, however, maternal-specific expression is found in 
the murine anterior pituitary gland, thyroid, ovary and kidney tubules, and in human 
thyroid, controlled by the germline EXON 1A DMR, where methylation corresponds 
with expression, possibly mediated through the EXON 1A transcript (Germain-Lee et 
al., 2002; Williamson et al., 2004; Plagge et al., 2008). 
1.4.6 Evolution 
The emergence of gene imprinting is estimated to have occurred between 210 
and 180 million years ago, after the divergence of metatherian (marsupial) and 
eutherian mammals from pretotherians (the monotremes).  It also evolved 
independently in flowering plants such as Zea mays and Arabidopsis thaliana, here 
restricted to the endosperm, a placenta-like organ.  A lack of conservation in the 
number of imprinted genes found in marsupials, mouse and man, indicates that 
different imprints evolved at different times, supported by a large variety of 
regulatory mechanisms in place to execute imprinting (See section 1.4.2) (Hore et al., 
2007).  Imprinting evolved concurrently with maternally-centred fetal support, 
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namely the placenta and lactation.  This, combined with the dichotomy of growth 
seen in maternal and paternal imprint mutants, led to the suggestion that imprinting 
arose to balance conflict between the maternal and paternal genomes, a balance 
whose importance must outweigh the dangers of functional haploidy. 
1.4.6.1 An ovarian time-bomb 
The evolution of imprinting has several theories associated with it.  The 
ovarian time bomb hypothesis cites imprinting’s function as a barrier to 
parthenogenesis, and the formation of ovarian teratomas (Solter, 1988; Varmuza and 
Mann, 1994).  It is likely that imprinting has been beneficial to mammals for this 
reason, but as parthenogenesis may proceed following manipulation of just two 
imprinted domains, it is unlikely that this was the primary pressure for its evolution 
(Wu et al., 2006). 
1.4.6.2 Facilitating meiosis 
It is possible that gene expression differences, including genomic imprinting, 
may have arisen secondarily to differential marking of parental chromosomes.  It has 
been hypothesised that the pairing, and segregation, of sister chromatids during 
meiosis may be facilitated by marking of the chromosomes, i.e. by methylation  
(Pardo-Manuel, V et al., 2000).  Any benefits conferred by methylation occurring 
near a transcriptional start site, i.e. alternation in gene dosage, would be selected for, 
resulting in a subset of transcripts whose monoallelic expression became necessary. 
1.4.6.3 Host-defence hypothesis 
The host-defence hypothesis states that imprinting evolved to combat 
retrotransposition within the genome (Barlow, 1993; Yoder et al., 1997).  In theory, 
monoallelic expression would  reduce transcript levels of the duplicated sequence.  
The use of promoter methylation both in retrotransposon silencing and imprint 
regulation, and the fact that several imprinted genes are retrotransposons, i.e. they 
have an intronless ORF and can be identified by their homology to an intron-
containing parent gene, are in support of this theory (Walsh et al., 1998; Parker-
Katiraee et al., 2007; Wood et al., 2007)  Alternatively, retrogene imprinting may be a 
non-functional bi-product of already existing control elements, as in the case of 
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PEG10, which although robustly imprinted in marsupials, mouse and man, incidences 
of pUPD and biallelic expression are phenotypically normal (Suzuki et al., 2007). 
1.4.6.4 The Conflict Theory 
The premise of the conflict theory is that maternally expressed imprinted 
genes act to curb the growth of the fetus and the placenta, preserving the mother’s 
fecundity and the viability of other fetuses she may be carrying, or wishes to carry in 
the future.  In this way she propagate her genes as much as possible.  Paternally 
expressed genes, to the same aim, promote the growth of the fetus and the placenta, 
possibly to the cost of other fetuses, which may not be his, both in the current and in 
future pregnancies (Moore and Haig, 1991) .  The theory is supported, and elegantly 
demonstrated, by the example of the first imprinted gene to be discovered in the 
mouse, insulin-like growth factor 2 (Igf2/IGF2), and its receptor, Igf2r (Barlow et al., 
1991; DeChiara et al., 1991).  The Igf2 protein is a potent enhancer of growth, and 
Igf2r, which acts as an Igf2 sink, a growth suppressor.  In marsupials and in the 
mouse, Igf2/IGF2  is paternally expressed, Igf2/IGF2R is maternally expressed, 
although it is not imprinted in humans (O'Neill et al., 2000; Killian et al., 2001).  
Disruption of imprinting of Igf2r or Igf2 leads to opposing phenotypes in the mouse 
(see Figure 1.18) (Lau et al., 1994; Sun et al., 1997).  The importance of IGF2 
expression is demonstrated in humans by BWS, which can be caused by over-
expression of IGF2 and characterised by pathological overgrowth of the fetus and 
placenta, and its partner SRS, potentially caused by IGF2 silencing and presenting as 
severe intrauterine growth restriction (IUGR). 
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Figure 1.18 Theoretical model for reciprocal phenotypes through opposite 
imprinting mutations in the mouse.   
M = maternal allele, P = paternal allele.  Biallelic Igf2, or a lack of expression of its 
receptor, would in theory lead to excess available Igf2 protein and increase growth.  
Both biallelic Igf2r, or lack of Igf2, would lead to a deficiency in Igf2 and decrease 
growth (Lau et al., 1994; Sun et al., 1997). 
 
The phenotypes resulting from disruption of allelic expression of several other 
imprinted genes in the mouse are also consistent with the conflict theory, including 
paternally expressed Mest, Peg3 and insulin, where a lack of expression results in 
IUGR, and maternally expressed H19, whose ablation leads to fetal overgrowth (Reik 
et al., 2001a; Tycko and Morison, 2002).  In the large imprinting cluster on human 
chromosome 11, maternally expressed PHLDA2 has been shown to have a negative 
correlation with birth weight (Apostolidou et al., 2007).   
The successful propogation of genetic material does not end with birth, but 
must continue into the next generation.  The paternally expressed gene Peg3 has 
recently been linked with male sexual behaviour, where males with a knock-out (KO) 
of Peg3 and did not exhibit increased or improved sexual behaviour following 
experience, as is found in WT mice.  In addition, the KO males did not follow 
olfactory female urine cues appropriately, reducing copulation opportunities (Swaney 
et al., 2007).  It is thought that paternal expression of Peg3 in the adult hypothalamus 
may mediate these activities in normal mice, ensuring reproductive success. 
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1.4.6.5 The placenta 
 The placenta, particularly the invasive trophoblast lineages, is an important 
focus for potential parental conflict.  It is directly responsible for bringing into contact 
the maternal and fetal blood supplies, facilitating nutrient exchange and determining 
resource allocation (Reik et al., 2003).  
Human embryos implant interstitially in a highly invasive manner.  
Trophoblast cells of the implanting blastocyst fuse to form a syncytium, resulting in a 
two layered structure of multinucleated syncytiotrophoblast and cellular 
cytotrophoblast.  Protusions of syncytiotrophoblast interdigiate into the decidualised 
endometrium, forming contacts with the maternal blood supply.  Extravillous 
cytotrophoblast columns form from the tips of anchoring villae, attached to the basal 
plate, and extend through the syncytium.  Invasive cells break away from these 
columns and migrate to colonise maternal spiral arteries.  Interstitial trophoblast cells 
invade to expand the placenta from its edge outwards (Johnson and Everitt, 2000).   
The placenta is also the organ with the most varied morphology between 
mammalian species, and mouse placentation is completely different to that of the 
human (Boyd 1994).  Genome-wide expression analyses of early and late placenta 
show striking selection for high expression of evolutionarily new genes, such as those 
which are rodent specific, during mid-gestation, with specificity increasing as 
gestation continues, so that late-genes are primate specific (Knox and Baker, 2008).   
Differences are due to the broad range of reproductive strategies employed by 
different species, including variation in gestational length and parity, perhaps 
accounting for the lack of conservation of imprinting in the human and mouse 
placenta (Monk et al., 2006a).  Almost all imprinted genes known to date are 
expressed in the placenta (Coan et al., 2005).  Mest, Peg3 and Igf2 have been shown 
to be promoters of placental growth (Lefebvre et al., 1998; Li et al., 1999; Constancia 
et al., 2002).  Murine Igf2 is expressed from several different promoters, one of 
which, P0, is placental specific (Constancia et al., 2002).  Deletion of P0 reduces 
placental size close to that of complete Igf2 KO, i.e. around 40% smaller than normal 
(Constancia et al., 2002). 
Invasion is in-part controlled by the decidua which expresses a wide variety of 
IGF binding proteins, balancing invasion and fetal provision (Bowen et al., 2002; 
Gude et al., 2004).  This can be demonstrated by ectopic pregnancy, when invasion is 
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far more extensive in the absence of the decidua (Personal communication, Dr Kate 
Hardy).  Decidual control is accentuated by maternal-specific imprinted gene 
expression in the placenta and in the fetus.  Paternally expressed MEST is thought to 
play a role in angiogenesis in human trophoblast and decidua (Mayer et al., 2000a).  
In the mouse, deletion of maternally expressed H19, Igf2r, Cdkn1c, Mash2 or Phlda2 
in mice results in placental hyperplasia (Eggenschwiler et al., 1997; Takahashi et al., 
2000; Frank et al., 2002) 
The importance of transport systems in nutrient acquisition is highlighted by 
the imprinting of several soluble nutrient carriers, including murine placental-specific 
Slc22A2, Slc22A3, and Slc22a18/SLC22A18 and Slc22a1ls/SLC22A1LS in both 
mouse and human (Zwart et al., 2001).  Maternally expressed growth suppressors 
may reduce nutrient supply through action in the placenta, or reduce nutrient demand, 
through the fetus (Constancia et al., 2004).   
1.4.7 Differences between the human and the mouse 
1.4.7.1 Placental-specific imprinting 
The human does not always make a good model for the mouse.  Several 
murine imprints are not conserved in the human (see Table 1.4).  There are large 
differences between mouse and man in the structure and physiology of the placenta.  
In addition, conflict at the placenta is increased in the multiparous mouse, whose 
pregnancy usually produces between five and 15 fetuses, depending on the strain of 
mouse, and where pregnancies may occur from two separate matings simultaneously.  
These differences may mean that certain imprints are no longer required, and a large 
proportion of the imprints which are not conserved, i.e. are biallelic in the human, are 
imprinted specifically in the placenta of the mouse.  
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Gene (murine notation) Mouse Human 
Igf2r, Air Imprinted Not imprinted/No 
orthologue 
Pon 2, 3 Asb4,  Imprinted in placenta Not imprinted 
Nap1l4, Osbpl5, Cd81, Cars, 
Ltrpc5, Tssc4, Ascl2, Mash2 
Imprinted in placenta Not imprinted 
Ampd3, Th, Dhcr7 Imprinted in placenta Not imprinted 
Xist/Tsix Imprinted in placenta and 
preimplantation embryo 
Not imprinted 
Table 1.4 Conservation of imprints in human and mouse.  From 
http://igc.otago.ac.nz, (Monk et al., 2006a; Schulz et al., 2006) 
 
1.4.7.2 Imprinting and imprinted XCI  
Murine placental specific imprinting relies upon sequential application of 
ncRNA and histone modification, and is independent of DNA methylation (Lewis et 
al., 2004; Umlauf et al., 2004; Wagschal and Feil, 2006).   Mechanistically, this is 
reminiscent of imprinted XCI in the mouse, which occurs genome-wide in early 
development, but is maintained only in the placenta (Sado et al., 2000; Reik and 
Lewis, 2005).  Imprinted XCI evolved at the divergence of the monotremes, and 
seems to be the ancestral method of dosage compensation, but does not occur in 
humans.  These observations have led to the suggestion that imprinted XCI and 
placental-specific imprinting may be linked.  Random XCI and imprinting in the 
embryo, maintained by DNA methylation and conserved in humans, evolved later, 
possibly due to increased pressure for sex chromosome dosage compensation, and 
increased parental genome conflict, respectively (Huynh and Lee, 2001; Reik and 
Lewis, 2005; Duret et al., 2006).  
1.4.7.3 Non-conservation is not limited to the placenta 
  Increased parental conflict between the human and the mouse, perhaps due to 
differences in morphology between the murine and human placenta, is commonly 
cited as the reason for divergence in their imprinting.  The abundance of placental-
sepcific imprinted genes in the mouse is highly supportive of this theory.  This may 
be an overrepresentation, for two reasons (i) the placenta is an important organ for 
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imprinted expression and is a site of expression of many imprinted genes and (ii) it 
has been the most studied.   
The placental-specific independence from DNA methylation, linking murine 
imprinting with more ancestral gene regulation, is likely to be true of other genes 
which are widely expressed but imprinted in a specific tissue.  Imprint DMRs are laid 
down before lineage specification, and are therefore not capable of mediating tissue 
specificity alone.  Igf2r is imprinted in the mouse and not in the human, but is not 
placental-specific.  Both humans and mice display differential methylation at the 
Igf2r/IGF2R intronic CpG island DMR2, but IGF2R is biallelic in the human.  No 
evidence for DMR2 exists in marsupials, but they express IGF2R specifically from 
the maternal allele (Killian et al., 2000).  In the mouse, maternal expression is 
controlled in cis by the ncRNA Air, whose paternal expression does appear to be 
mediated by DMR2 (Sleutels et al., 2002).  Without allelic enrichment of permissive 
histone modifications, as in the mouse brain, Igf2r is biallelically expressed despite 
differential DNA methylation at DMR2 (Yamasaki et al., 2005).  Permissive H3K9 
and 14Ac, H4K5,8,12 and 16Ac mark the maternal Igf2r promoter elsewhere in the 
mouse.  No such histone enrichment is present in the human, indicating that these 
modifications ultimately control Igf2r/IGF2R imprinting (Vu et al., 2006).  Finally, 
differences in genomic structure of human and mouse imprinted domains may 
enforced dichotomy between the two species in the regulation of imprints (Arnaud et 
al., 2003; Hutter et al., 2006). 
1.4.8 Imprinting after birth 
There are a number of imprinting syndrome phenotypes which cannot easily 
be reconciled with the conflict theory, notably Prader-Willi syndrome (PWS; MIM 
176270) and Angelman Syndrome (AS; MIM 105830).  Several of the symptoms 
associated with PWS and AS manifest during and after weaning, leading to the 
suggestion that parental conflict continues postnatally.  The persistence of imprinting 
of certain genes into child- and adulthood is also suggestive of later functionality.   
After weaning, the father has a vastly increased role in provision of food for 
the offspring.  This has led to the recent suggestion that some imprinted genes exist to 
control appetite, functioning specifically after the mother’s primary role in gestation 
and lactation has ended, i.e. at weaning (Ubeda, 2008).  Ubeda suggests that 
maternally expressed genes which act before weaning are resource inhibiting (RI) and 
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that a second set of maternally expressed genes exist which are resource enhancing 
(RE), and act after weaning.  This is combated by RE genes expressed paternally 
before weaning, and RI genes expressed paternally after weaning.   
PWS, caused by paternal inheritance of deletions on hChr15q11-13, or by 
mUPD and is characterised by poor suckling, hypotonia and low weight after birth, 
but upon weaning by an insatiable appetite, leading to obesity.  AS  is cause by 
maternal inheritance of deletions on hChr15q11-13, or by pUPD respectively and 
children actually delay weaning, having an extended suckling period.  Both 
syndromes are associated with mental disabilities.  Consistent with Ubeda’s theory, 
loss of paternal RE expressed before weaning, and RI after weaning, would result in 
reduced demand for resources by the offspring before, and an increase in it after 
weaning, as seen in PWS.  In AS, maternally expressed RI are lost, manifesting in 
extended suckling (Ubeda, 2008).  The functions of genes in this cluster are unknown, 
and the involvement of any specific gene in such a mechanism has not been 
established, however, their expression in the brain is supportive of such a theory, 
enabling influence on the hypothalamic-pituitary axis for appetite, and cerebellum for 
behaviour. 
1.4.9 Imprinted genes and cancer 
Cancer cell genomes are characterised by global hypomethylation and locus 
specific hypermethylation of CpG islands.  Hypomethylation leads to the activation of 
oncogenes, through a reduction in promoter methylation, and in genome instability 
(Feinberg et al., 2006; Esteller, 2007).  The specific down regulation of tumour 
suppressor genes is thought to result from hypermethylation at their promoters.  
Types of cancer can be identified by the methylation status of certain tumour 
suppressor genes, and a database of this information is available online 
(http://www.pubmeth.org).  The regulation of imprinted genes through promoter 
methylation renders them susceptible to cellular methylation changes, which may 
subsequently alter their transcription  
In fact, loss of imprinting (LOI) is the most prevalent epigenetic alteration in 
cancer (Jelinic and Shaw, 2007).  Cases of LOI identified in tumours are likely to be a 
result of global methylation changes and genetic mayhem intrinsic of transformed 
cells.  The precise regulation of imprinting, through monoallelic DNA methylation, 
means that any change in methylation, whether it be a gain or a loss from that 
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particular locus, would result in their dysregulation, making them perhaps more 
vulnerable to disruption than genes which are not imprinted.  The differentially 
methylated regions at the IGF2 locus on hChr11 become decoupled during 
tumorigenesis, and changes in methylation lead to biallelic IGF2 through a 
mechanism specific to cancer (Murrell et al., 2008).  A loss of imprinting 
encompasses two situations:  
 
 A switch from monoallelic to biallelic expression 
 A switch from monoallelic expression to total silencing 
 
Imprinted genes identified as growth promoters tend to be paternally 
expressed, consistent with the conflict theory, whereas maternally expressed genes, 
associated with growth repression, are synonymous with tumour suppressor function.  
Genome-wide LOI results in the development of multiple tumours in mice, so at least 
for some genes, LOI actually causes cancer (Holm et al., 2005).  If some of these 
causative genes are paternally expressed, the implication is that a LOI means biallelic 
expression, resulting in increased expression of a growth factor and promoting 
proliferation.  In the case of maternally expressed genes, LOI would involve 
silencing, and concurrent loss of growth control.   
Data obtained through creation of cell lines harbouring complete loss of either 
maternal or paternal imprints was consistent with this model (Hernandez et al., 2003).  
For example, in vivo, biallelic expression of IGF2 in humans has been linked with a 
propensity for colorectal cancer development and shown to be present in a large 
variety of cancers (Rainier et al., 1993b; Cui et al., 2003; Woodson et al., 2004).  
Biallelic Igf2 expression has also been shown to actually increase transcript levels, 
with concomitant promotion of tumour growth, in mouse models (Sakatani et al., 
2005). 
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1.5 Stem Cells 
 
Many mammalian cell types may be expanded ex-vivo.  Cell culture conditions 
are largely dictated by historic success, and although an array of elaborate and cell-
type-specific culture milieu are in use today, most primary cells reach crisis and 
senesce before passage fifteen (Sherr and DePinho, 2000).  Cancer cells have an 
immortal phenotype, and the majority of established mammalian lines are cancer cell 
lines, or primary cells which are virally transformed, conferring immortality.  The 
concept of the pluripotent stem cell was first identified in teratocarcinomas in the 
1960s.  Embryonic carcinoma, or EC cells were found to be highly expandable, albeit 
usually aneuploid, and to be able to generate multiple lineages (Kleinsmith and Pierce 
GB., 1964).  Transformed cell lines are invaluable for vaccine and antibody 
development, the study of cancer physiology and of tissue culture itself, but cannot be 
not be used in transplantation. (KLEINSMITH and Pierce, 1964) 
 Treating injury and disease by transplanting tissue from one person to another 
(i.e. an allograft) is limited by the supply of organs, highlighting the value of a 
therapy using ex vivo resources.  The use of cells was pioneered in the 1950’s by 
E.Donnall Thomas, who used bone marrow to repopulate the haematopoietic system.  
Blood banks, and to a lesser extent bone marrow, being more painful to isolate, are a 
key resource for the medical community.  The presence of stem cell populations in 
bone marrow was not realised when it was initially used for therapy, however, further 
investigation of the regenerative capacity conferred by the tissue resulted in discovery 
of the haematopoietic stem cell (Siminovitch et al., 1963).  The author’s observations 
of self renewal and multilineage differentiation hinted for the first time of the 
existence of a naturally occurring, and non pathological, immortal stem cell.   
The stem cell is unique in that it is inherently able to proliferate over many 
passages without transformation.  Given the right conditions, it is also able to 
differentiate into several different tissues, rendering it an invaluable resource for 
therapy.  Asymmetric cell division is a stem cell hallmark however, stem cells may 
also divide in a symmetric manner to expand cell number, in the instance of in injury, 
or during development (see Figure 1.19).  A loss of stem cell self renewal is thought 
to contribute to ageing (Morrison and Kimble, 2006).  There are many different types 
of stem cell, and it is likely that a stem cell niche exists in every tissue of our bodies.  
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Each type of cell has distinct properties, and both the location and ontogeny of the 
cell’s origin will influence cellular phenotype. 
1.6 Embryonic stem cells 
Embryonic stem (ES) cells were first isolated from a mouse embryo in 1981.   
These unique cells, present during the earliest stages of life, have the capacity to 
differentiate into every lineage in the adult organism, i.e. they are totipotent.  In fact, 
cells from cleavage embryos up to and including the eight cell stage, are each capable 
of creating a mouse (Evans and Kaufman, 1981).  
 
 
Figure 1.19 Stem cell self renewal/differentiation.   
Stem cells are able to divide asymmetrically, producing a copy of itself, and a more 
differentiated daughter cell.  Environmental stimuli are involved in further 
differentiation of progenitor cells towards a specific cell type.  Both mouse 
embryonic stem (mES) cells and human embryonic stem (hES) cells have a shortened 
G1 (Becker et al., 2006).  This acts to inhibit the time differentiation-inducing 
mitogen activated protein kinase (MAPK) and cyclin signalling are able to influence 
the cell cycle, promoting self renewal over differentiation (Orford and Scadden, 
2008). 
 
 Totipotency may be measured by introduction of mouse ES cells into 
blastocysts, where they are able to contribute to all adult tissues, including germ cells 
(Bradley et al., 1984).  In vitro, ES cells harbour inherent ability to aggregate into so-
called embryoid bodies (EBs), which consist of cell types of all three germ layers, and 
when inserted into blastocyst are able to contribute to all lineage, including the germ 
cells  (Nagy et al., 1990).  Despite clear parallels between the early embryo and ES 
cells, it is likely that these ES cells are a cell culture phenomenon, distinct from their 
origins the moment they are removed from them.   
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It wasn’t until the establishment of assisted reproductive technologies (ART), 
namely in vitro fertilisation (IVF), that human embryos could be studied outside the 
body.  In 1998 Jamie Thomson and co-workers derived the first human ES cell lines 
at the University of Wisconsin.  As in the mouse, the cells were derived from the 
inner cell mass of preimplantation blastocyst, and were able to grow stably in culture 
over many passages (Thomson et al., 1998).  
1.6.1 Ethical considerations of the use of human embryos in research 
The development of IVF, cemented in the repertoire of reproductive strategies 
by the birth of Louise Brown in 1978, is hinged on several crucial steps, the first of 
which is the stimulation of the patient’s ovaries in an attempt to increase the chance 
of success.  Whilst the freezing of oocytes is possible, embryos are far more robust.  
In most clinics, therefore, it is standard practise to fertilise all of the recovered eggs.  
Embryos are graded and one to two transferred, the rest are cryopreserved or may be 
discarded if they are very malformed or arrested.  Essentially, this practise assumes 
the following: 
“The enhanced chance of a successful pregnancy and of fulfilling a wish for a 
child outweighs the moral value of each of the embryos” 
          (Devolder, 2005) 
1.6.1.1 Assisted reproduction techniques 
Babies conceived by ART, in general, are at an increased risk of 
complications, including preterm delivery and low birth weight, even after correction 
for the high incidence of multiple birth (Schieve et al., 2002).  In addition to 
superovulatory therapy and cryopreservation, a plethora of technology is available to 
the sub-fertile individual or couple.  Intracytoplasmic sperm injection (ICSI) is 
commonly used, and has also been attempted with immature sperm (Georgiou et al., 
2007).  In vitro maturation of oocytes is an important technique to implement, as it 
may avoid the use of superovulation, shown to result in imprinting errors (Fortier et 
al., 2008; Sato et al., 2007).  Each manipulation bypasses several steps of natural 
selection, making difficult to define the actual effects of ART.   
ART involving embryo culture, such as IVF and ICSI, are under particular 
scrutiny, as studies in animal models demonstrate the sensitivity of the early embryo 
to culture conditions (Bowman and McLaren, 1970; Khosla et al., 2001; Lane and 
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Gardner, 2003).  Notably, the use of fetal bovine serum, a common addition to tissue 
culture media, has been linked to Large Offspring Syndrome, a common disorder in 
cattle and sheep which have undergone embryo culture (Young et al., 1998; Young et 
al., 2001).  The link between culture and phenotype is thought to be, at least in part, 
epigenetic.  Evidence for this includes an increase in the incidence of certain 
imprinting disorders (BWS and AS) following ART, particularly ICSI (Cox et al., 
2002; Debaun et al., 2003; Gicquel et al., 2003; Orstavik et al., 2003; Arnaud and 
Feil, 2005; Maher, 2005; Doornbos et al., 2007).  Interestingly a small study carried 
out in New Zealand indicated that children born through IVF actually grew to be pre-
pubertally taller, perhaps due to an increase in serum IGFI and II, and had a better 
lipid profile, compared to their non-IVF peers (Miles et al., 2007)  
1.6.1.2 Embryo donation 
Based on statistics from North America, approximately 10% of the population 
are subfertile (http://www.asrm.org/).  Should infertility be treated in an 
overpopulated world?  Additionally, treating subfertile couples may propagate 
susceptibility to infertility.  These issues aside, infertility and the introduction of ART 
means that there are now upwards of three million IVF babies worldwide and it 
represents an incredibly valuable and life changing opportunity for those unable to 
have children conventionally (Andersen et al., 2008).   
The IVF process creates an excess of embryos.  For example, in the UK in 
2006, 194,600 embryos were created from 41,863 treatment cycles.  Of these 
approximately half were transferred back to the mother, or cryopreserved, however a 
total of 99,307 were discarded, and 3187 donated to research 
(http://www.hfea.gov.uk/docs/). 
1.6.2 Legislation 
Worldwide, levels of permitted ES cell research are highly variable (see Table 
1.5) Restrictive policies range from complete prohibition (e.g. in Ireland) to 
preventing derivation of ES cell lines, but allowing research on imported lines, as in 
Germany. 
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Permissive Flexible Restrictive 
UK, Australia, Belgium, 
China, India Israel, Japan, 
Singapore, South Korea, 
Sweden 
Brazil, Canada, France, 
Iran, South Africa, Spain, 
The Netherlands, Taiwan 
Austria, Ireland, Norway, 
Poland, Germany, Italy, 
USA 
Table 1.5 Worldwide ES cell research(http://www.mbbnet.umn.edu/scmap.html) 
Currently, the National Institutes of Health (NIH) in the USA allocates federal 
funding to lines fulfilling the then-President’s criteria: those derived from discarded 
IVF embryos before August 9, 2001, including 22  from Wisconsin, 17 from Harvard 
University, and others from Singapore, Israel, India, Sweden and South Korea, a total 
of 71 cell lines (http://stemcells.nih.gov).  Sixteen are currently available from the 
National Stem cell bank (http://nationalstemcellbank.org/) for non-profit and 
academic research.  The line between flexible and permissive research policy lies 
within the derivation of new lines, where only ‘permissive’ countries allow the 
creation of embryos for research.  Under the Administration of President Obama it 
seems likely that US-wide policy may be brought into line with the State of California 
which is able to support ES cell research through state funding, and to allow once 
more the derivation of hES cell lines.  In terms of the provision of hES cells for 
therapy, in the UK it is estimated that 150 genetically diverse hES cell lines would be 
required to provide an HLA match for any prospective patient (Taylor et al., 2005). 
1.6.2.1 Research in the UK 
There are over 30 UK derived hES cell lines, eight of them have been 
deposited in the UK Stem Cell Bank.  The Human Fertilisation and Embryology 
Authority (HFEA) is responsible for granting research licences and reviewing policy.  
The UK, a permissive country, has allowed the production of a human blastocyst by 
cell nuclear replacement (CNR), has been achieved.  This is known as ‘therapeutic 
cloning’, and is the first step in the production of a personalised supply of stem cells.  
To avoid ethical controversy, several research strategies are also focussed on the 
production of ES cell lines which do not involve the destruction of viable embryos 
e.g. using in preference those which have arrested during development, or even the 
use of individual blastomeres, which may be removed from the embryo with no overt 
detrimental effects.  Controversially, at least three centres (Newcastle University, 
Kings College London and Warwick University) have been granted 12 month 
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licences to conduct human-animal cytoplasmic hybrid research (www.hfea.gov.uk).  
The research proposes to introduce somatic nuclei from human cells into enucleated 
eggs from other animals i.e. cows.  These valuable studies will permit investigation 
into hES cell lines and development of the early embryo, without the need for human 
eggs, which are in very short supply. 
Currently hES cells are used for research only, and concerns over line 
comparability (see section 1.6.4), and the use of animal products in their derivation 
and culture has prevented their use in therapy.  Recently, licences for hES cell 
production under Good Manufacturing Practice (GMP) conditions have been granted 
in Sheffield and Birmingham (www.hfea.gov.uk).  GMP states that lines must be 
entirely xeno-free, and as such have the potential to be utilised in human therapy  
(Rodriguez et al., 2006).  In the USA this year several private sector companies have 
sought FDA approval for the use of their embryonic stem cell therapies, which if 
granted will be the first step on the road to the clinic (Nature Medicine Editorial, 
2008). 
hES cell research is an incredibly active field, with 40% of HFEA research 
licences granted betweem 2006-7 for hES line derivation (www.hfea.gov.uk).  hES 
cells are a model for human development and differentiation, but also for disease 
systems.  Embryos discarded following preimplantation genetic diagnosis (PGD) 
have allowed the derivation of disease-specific hES lines, e.g. cystic fibrosis, and the 
use of somatic cell nuclear transfer from individuals carrying a disease widens this 
area of research further, providing valuable disease models (Mateizel et al., 2006; 
Pickering et al., 2005) 
1.6.3 Human ES cell characteristics 
Human ES (hES) cells may be derived from the blastocyst through pronase 
treatment or immunosurgery of the trophectoderm.  Alternately they can be grown as 
an explant culture, where the ICM/ES cells outgrows the trophectoderm until a 
homogenous culture is left.  hES cells require a layer or feeder cells in order to grow, 
commonly mouse embryonic fibroblasts (MEFs) but unlike mES cells to not require 
exogenous application of leukaemia inhibitory factor (LIF).  ES cells grow as 
colonies, and may be maintained without differentiation up to a certain cell density, at 
which point they must be passaged in order to maintain pluripotency (see Figure 1.20) 
(Thomson et al., 1998). 
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Figure 1.20 hES cells in culture 
(i) hES cells do not exhibit contact inhibition, and grow as round, flat colonies on 
feeder cell layers.  (ii) At a certain density, cells in the centre of the colony begin to 
grow on top of one another, increasing cell-to-cell contact (iii) This subtle change in 
environment results in phenotype alteration and the formation of dense spheres of 
differentiating cells.  (iv) Cells cultured without MEFs aggregate to form embryoid 
bodies.  Images of hES line SHEF4, as cultured by Ramya Udayashankar and Dr 
Claire Kershaw at the University of Sheffield, included with permission. 
 
ICM totipotency is conferred during preimplantation development, when the 
fully differentiated nuclei of haploid gametes are reprogrammed into the nuclei of 
cells capable of creating each lineage of a new organism, as previously discussed  in 
section 1.3.1.  hES cells, derived from the ICM of the blastocyst, retain this 
totipotency both in vitro and in vivo.  This can be demonstrated by their ability to 
form teratomas following subcutaneous xenografts into SCID mouse recipients 
(Thomson et al., 1998).  In vitro, culturing hES cells without feeders in suspension 
results in the formation of embryoid bodies (EB) (see Figure 1.20).   
For hES cells to be used in therapy, they must first be differentiated to the 
tissue of choice.  This involves either direct application of exogenous factors to 
promote differentiation to a certain lineage, or may include intermediate an EB 
formation step (Harun et al., 2006).  hES cells seem to be totipotent in vitro, differing 
from mES cells by their spontaneous expression of trophectoderm markers (hCGβ) 
when cultured to EBs, and ability to differentiate into trophoblast lineages, which 
mES cannot do, meaning mES are ‘pluripotent’ by definition  (Deb et al., 2006; 
Harun et al., 2006).  Of particular clinical interest to stem cell therapy is their in vitro 
differentiation of hES to pancreatic β-cells, cardiomyocytes,  and neurons  (Kehat et 
  74 
al., 2004; Tabar et al., 2005; Denning et al., 2006; Kroon et al., 2008).  hES cell 
ability to differentiate into absolutely every cell type in the adult body has not been 
established, however, these apparent limitations are likely to be in our knowledge of 
differentiation culture, rather than the capacity of the cells to differentiate.   
1.6.3.1 Gene expression and pluripotency 
The early embryo expresses certain transcription factors to high levels, which 
are then permanently down-regulated during development, leaving primordial germ 
cells (PGCs) as the only pluripotent cell type (Yeom et al., 1996).  When cultured in 
vitro, PGCs give rise to embryonic germ (EG) cells, which share a similar phenotype 
to ES cells (Shamblott et al., 1998).   
The early embryo, PGCs and hES cells express unique profile of transcription 
factors, DNA methylation, histone modifications, and likely several other mechanistic 
players, whose interplay maintains a stable, pluripotent state.  POU (Pit-Oct-Unc) 
domain homeobox transcription factor POU5F1 (formerly OCT4), homeobox 
NANOG and SRY-box-containing gene 2 (SOX2), are three of the key factors.  They 
act in a network, creating a positive feedback cycle to maintain their own expression, 
whilst promoting self-renewal and pluripotentiality, preventing expression of 
developmental genes (Boyer et al., 2005; Fong et al., 2008).  Upon differentiation to 
the trophoblast lineage in the ICM, or hES differentiation to EBs, regulatory regions 
of POU5F1 and NANOG are rapidly methylated, corresponding with their 
downregulation (Yeo et al., 2007) 
Investigation of common expression profiles, carried out by the International 
Stem Cell Initiative found the expression of SSEA3, SSEA4, TRA-1-60, TRA-1-81, 
GCTM2, GCT343, CD9, CD90, HLA class1, DNMT3B, GABRB3 and GDF3 to be 
shared amongst hES cell lines (Adewumi et al., 2007).  The importance of some of 
these factors was demonstrated in 2006 when Shinya Yamanaka and colleagues were 
able to trigger reprogramming and the return of mouse fibroblasts to a pluripotent 
state using retroviral induction of just four.  The cells were named induced pluripotent 
stem (iPS) cells (Takahashi and Yamanaka, 2006).  24 ES specific factors were 
induced the mouse fibroblasts, and any ES-like cells generated selected by their 
expression of Fbx15.  Factors were then removed sequentially until the minimum 
genes required (Pou5f1, Klf4, Sox2 and C-Myc) for induction and maintenance of the 
ES phenotype were identified.  In 2007, optimisation of the technique produced iPS 
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cells able to contribute to chimeric offspring and gave identical gene expression 
profiles, as well as having key characteristics such as bivalent chromatin.  These cells 
were selected using Nanog and Pou5f1 instead of Fbx15 (Okita et al., 2007; Wernig 
et al., 2007).  The derivation of human iPS cells followed shortly, using a similar 
cocktail of factors and selection criteria: POU5F1, SOX2, KLF4 and c-MYC, with 
NANOG selection by Yamanaka, and POU5F1, SOX2, NANOG and LIN28 by the 
Thomson group (Takahashi et al., 2007; Yu et al., 2007).  The success of iPS 
production in humans is another way in which personalised stem cell therapy may be 
achieved. 
1.6.3.2 Epigenetics and stem cells 
Much of the work on epigenetic profiles of ES cells has been carried out in the 
mouse.  Replication timing correlates closely with chromatin state, where early 
replicating regions are associated with an open chromatin conformation.  The mES 
cell genome was shown to be predominately early-replicating, in contrast to fully 
differentiated cell types (Azuara et al., 2006).  Interactions of histone complexes and 
linker proteins with mES cell DNA was found to be highly dynamic, and this 
characteristic was correlated with developmental plasticity (Meshorer et al., 2006).   
High levels of H3K9 acetylation and H3K4 acetylation and methylation and low 
levels of H3K9 methylation is seen in mES cells, which is reversed upon 
differentiation (Azuara et al., 2006; Meshorer et al., 2006).  H3K4 di- and 
trimethylation was found to co-localise with CpG islands and active promoters, whilst 
H3K36Me3 was found along actively transcribed genes, corresponding with 
transcript elongation.  H3K9Me3 and K4K20me3 were found to be associated with 
transpososns, repeats and minor satellites (Mikkelsen et al., 2007).    
  hES cells demonstrate a low level or transcription of many developmental 
genes, and a unique profile of histone modifications was found at their promoters.  
Repressive H3K27Me3 and permissive H3K4Me2 enrichment were found together at 
the promoters of certain genes in mouse and human ES cells (Azuara et al., 2006; 
Bernstein et al., 2006; Mikkelsen et al., 2007).  Such modifications are each 
associated with opposing chromatin conformations, preventing and promoting 
transcription respectively.  The term ‘bivalent chromatin’ was therefore coined for 
these domains.    The authors revealed four subsets of genes, those whose promoters 
were:  
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 Bivalent, i.e., associated with both H3K4Me3 and H3K27Me3 
 Enriched with just H3K4Me3 
 Enriched with just H3K27Me3 
 Enriched with neither modification 
 
Bivalent chromatin was suggested to confer a poised transcriptional profile 
where resolution of the domain, to either activate or permanently repress transcription 
(i.e. upon differentiation), would merely require depletion of one or other of the 
marks.  Although initially identified in ES cells, bivalents are not restricted to this cell 
type, and are found to be present in other stem cells such as HSC, and in fully 
differentiated adult cells, albeit at a much lower frequency (Attema et al., 2007; 
Mikkelsen et al., 2007).  The association of Pol II with bivalent regions has been 
revealed recently.  It is held in a stalled position through PRC1 catalysed 
ubiquitination of H2A (Stock et al., 2007).   
The vast majority of the genes which were found in ES to not be enriched 
with either H3K4Me3 or H3K27me3, are methylated at the DNA level (Fouse et al., 
2008).  Methylated promoters were overrepresented for genes associated with stimuli 
response and cell signalling, corresponding with their transcriptional repression, 
whilst genes associated with survival and proliferation were unmethylated (Fouse et 
al., 2008) 
1.6.4 hES cell line variation 
The ability of an isolated inner cell mass to form a stable stem cell line is 
linked to its ability to form a well organised embryo (Dr Stephen Minger, personal 
communication).  As the embryos secured for research are, by definition, considered 
to be of relative low quality, the success rate of ES cell derivation is variable.  One 
study estimates success at around 5%, using a mixture of frozen cleavage embryos 
frozen blastcocysts (Cowan et al., 2004).  Embryos subject to preimplantation genetic 
diagnosis are discarded depending on their genotype, and as such may be very high 
quality embryos.  Differences in the specific ART used to produce each embryo, e.g. 
IVF or ICSI, may also impact the ES cells derived.   
The ICM of the blastocyst is not a pool of identical cells, so positional effects, 
as well as the point of expansion at which cells were isolated, may also contribute to 
variation in the precise phenotype of hES lines generated.  hES cell lines are a 
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heterogeneous group, and may each have specific properties or sensitivities (Abeyta 
et al., 2004).  Variation in doubling time, and in differentiation kinetics both in vivo 
and in vitro have been observed, although direct comparison on a large scale is 
difficult to achieve (Reubinoff et al., 2000; Heins et al., 2004).   The International 
Stem Cell Forum (www.stemcellforum.org) set out to achieve this aim, resulting in 
the International Stem Cell Initiative, and its comparison of 59 lines, from 17 labs in 
11 countries (Adewumi et al., 2007) 
1.6.5 Cell culture protocols 
Independent establishment of hES cells in a large number of labs across the 
world has led to an equally large variation in hES cell culture protocol (Allegrucci 
and Young, 2007).  Derivation may be carried out by enzymatically digesting the 
trophectoderm, or removing it manually.  Passaging, i.e. the reduction in density 
through splitting the cell culture, is carried out using enzymes, either trypsin or 
collagenase, and some labs prefer to avoid enzymes, carrying out labour intensive 
manual dissection instead.  Cell culture media vary widely, and studies have shown 
certain additions, e.g. serum, to have different effects on gene expression profiles 
(Skottman et al., 2006).  The adaptation of cells to their specific culture environment 
may mean that changing it, i.e. to homogenise cell culture methods, may not be a 
feasible option for certain cell lines.   
1.6.6 Effects of cell culture 
1.6.6.1 Genetic effects 
Cell culture over a long period, corresponding with high passage number, 
often results in chromosomal instability.  Gain of hChrs12, 17 and X are common in 
hES cells, an observation verified independently across different labs with different 
hES lines (Brimble et al., 2004; Draper et al., 2004; Baker et al., 2007).  Other studies 
found oncogenic changes specifically at high passage, of promoter methylation, 
mitochondrial mutations, duplication of regions of chromosomes 1, 17 (including the 
MYC gene), and 20, and deletions on 18 and 13 (Maitra et al., 2005).  Aneuploid hES 
cell lines grow more rapidly than their normal counterparts, consistent with culture 
driven selection pressure for these chromosomes, likely due to the presence of growth 
promoting genes.   
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The link between aneuploidy and transformation means that it is important to 
try to prevent it, and mechanical dissociation of ES cell colonies rather than the use of 
enzymes, is thought to be less stressful, although such treatment does not prevent 
chromosomal changes completely (Buzzard et al., 2004).  The disaggregation of hES 
colonies to single cell colonies seems to be particularly stressful to the cells, and has 
been directly linked with chromosomal changes (Brimble et al., 2004). 
1.6.6.2 Epigenetic effects 
Passaging hES cells has an effect on the overall level of DNA methylation 
within the culture, in a cell-line specific manner.  There is not an overriding pattern to 
changes in methylation, with some CpG’s losing methylation over time, and some 
gaining it (Maitra et al., 2005; Bibikova et al., 2006).  Dimethylsulphoxide (DMSO), 
commonly used during cryopreservation, has been shown to alter genome-wide DNA 
methylation in mES EBs through upregulation of Dnmt3a mRNA (Iwatani et al., 
2006a).  
1.6.6.2.1 X Chromosome inactivation (XCI) in hES cells 
Female hES cells can be divided into two groups; those which do not express 
XIST, and are presumed to have two active X chromosomes, and those which do 
express XIST (Adewumi et al., 2007).  X chromosome inactivation (XCI) is complete 
by the blastocyst stage in the human in vivo, so part of the process of ES cell 
transition from an ICM cell to an ES cell is reactivation of Xi.  The completion and 
maintenance of this state is influenced by in vitro culture.   
 
Category of hES 
cell phenotype 
‘Pristine’ 
undifferentiated 
Differentiated Adapted to 
culture 
XCI status Two active X 
chromosomes 
Post XCI Post XCI 
XIST expression Not expressed XIST expressed Not expressed 
XCI potential of 
hES 
Able to carry out XCI Maintains XCI Maintains XCI 
Table 1.6 XCI status of hES cells 
Table showing the differences between X chromosome inactivation status and the 
phenotype of hES cells.  The dichotomy in the number of activated X chromosomes 
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in female hES cell lines it due to whether they have adapted to culture or not (Silva et 
al., 2008)   
 
hES cells retaining the ability to undergo XCI, do so during differentiation.  
The XCI process during hES cell differentiation is thought to reflect non-imprinted 
XCI of preimplantation development in both the human and the mouse, and is often 
used as a model system.   
 
Figure 1.21 Kinetics of in vitro XCI during differentiation 
The steps of in vitro XCI are shown, according to the days of hES differentiation.  
The X inactivation centre, (XIC) is proposed to interact in trans to mediate counting 
and choice (Augui et al., 2007).  XCI is complete after approximately 10 days, but 
DNA methylation of Xi occurs after approximately 20 days differentiation (Hypo-me 
H3K4, deac H3K9, H3K9me, later H3K4deac (Heard et al., 2001).  Xist stabilisation: 
(Sheardown et al., 1997). HypoAC H4& CpG meth: (Keohane et al., 1996).  
MacroH2A:(Mermoud et al., 1999). PolII exlusion: (Chaumeil et al., 2006). 
 
 Growing hES cells in vitro for an extended time results in XCI (Silva et al., 
2008).  The status of X inactivation in hES cells therefore serves as a measure of how 
much the cells have adapted to culture.  XCI involves several epigenetically regulated 
steps, as shown in Figure 1.21.  Defining which epigenetic effectors are involved in 
initiate cell-culture mediated XCI, may help to find those most susceptible to cell 
culture pressures. 
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1.6.6.2.2 Genomic Imprinting in hES cells 
As an epigenetic phenomenon, with some functional links to carcinogenesis, 
genomic imprinting has been of particular interest to stem cell science.  The 
appropriate regulation of imprinted genes is vital during in vivo growth and 
development, and so likely to be equally important in ES cell differentiation.  In 
addition, overall epigenetic status of the cell may be reflected by the extent to which 
imprinting is correctly controlled.   
 As previously described, a loss of imprinting (LOI) may involve complete loss 
of expression, or the reactivation of the silenced allele, resulting in biallelic 
expression.  There are several layers of epigenetic control at any imprinting cluster, 
DNA methylation, histone modification, ncRNA expression, etc, and perturbation of 
any of these may result in LOI. 
 Studies of imprinting in mES found that LOI was widespread, so it was a 
surprise when a preliminary study of hES cells, investigating the monoallelic 
expression of SNRPN, IPW, H19, IGF2, KCNQ1OT1, SLC22A18 and NESP, found 
their imprinting status to be predominately normal (Dean et al., 1998; Humpherys et 
al., 2001; Rugg-Gunn et al., 2005).  Biallelic H19 was observed at high passage in 
one line, and SLC22A18 consistently exhibited low level expression from the ‘other’ 
allele.  More in-depth investigations have established that there is a universal, but 
highly gene specific, loss of imprinting in hES cells (Kim et al., 2007b) 
Monoallelic Biallelic Variable btwn lines and samples 
KCNQ1OT1 TP73 MEST Isoform 1 
KCNQ1 IGF2R MEST Isoform 2 
CDKN1C WT1 MESTIT1 
MAGEL2 SLC22A18 PEG10 
SNRPN  PHLDA2 
NDN  H19* 
PEG3  IGF2 
NESP  GTL2 
  IPW** 
  ATP10C 
  GNAS 
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Table 1.7 hES cell line imprinted gene expression status.  
Genes known to be imprinted were examined in 1 (Sun et al., 2006), 22  
(Kim et al., 2007) and 46 (Adewumi et al .,2007) hES cell lines, utilising expressed 
single nucleotide polymorphisms in informative lines.  Key: hChr1, hChr7, hChr11 , 
hChr14, hCh15, hChr19, hChr20.   *H19 was found to be consistently monoallelic in 
the study by Sun and colleagues, but was variable in other studies. **IPW was found 
to be consistently monoallelic by the International Stem Cell Initiative, but variable 
by Young and colleagues.  This may reflect differences in either the sample used for 
analysis, as imprinting status was shown by both studies to vary within lines, or 
differences in the actual stem cell lines included in each study, although it should be 
noted that many overlapped  (Sun et al., 2006; Adewumi et al., 2007; Kim et al., 
2007b). 
 
Evident from Table 1.7, there is no pattern in the genomic location of genes, 
both in terms of their chromosome and the cluster they reside in, as to whether their 
imprinting status is stable or variable.  As previously discussed, the mechanisms of 
imprinting control vary between clusters, and currently it is not clear whether there is 
a common pathway leading to LOI, which is sensitive to in vitro culture. 
SNRPN, DLK1, and H19 have been shown to maintain differential 
methylation at their ICRs in hES cells (Plaia et al., 2006).  In the study be Young and 
colleagues, KvDMR was differentially methylated in all samples examined, 
correlating with maintained imprinting of most of the genes in its cluster, but not with 
biallelic SLC22A18.  Other ICRs and regulatory CTCF binding regions, controlling 
expression of PEG3, H19 and GTL2, displayed varying levels of methylation.  Some 
samples retained DMR status but others were hypo- or hypermethylated.  Curiously, 
these samples did not correlate with those which displayed LOI.   For these clusters it 
seems that methylation, although disrupted, is not the mechanism behind LOI, 
highlighting the importance of examination of histone modifications, especially at the 
KvDMR (Umlauf et al., 2004). For TP73, IGF2R, MEST, PEG10 and GNAS, there is 
a correlation between DNA methylation status and LOI, where a loss of methylation 
was observed in those samples displaying biallelic expression. 
The status of imprinting in the human preimplantation blastocyst is clearly 
difficult to analyse.  SNRPN, MEST and IGF2 have been shown to be monoallelic in 
the human blastocyst (Lighten et al., 1997; Huntriss et al., 1998; Monk and Salpekar, 
2001).  The terminology ‘loss’ of imprinting can therefore be confidently applied to 
the biallelic nature of MEST and IGF2 transcripts in hES cell lines, and clearly either 
the derivation or culturing process has perturbed expression of these genes away from 
their in vivo state.  For other genes, however, ‘lack’ of imprinting is more appropriate.  
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Although we can infer imprinting status from that seen in the mouse, and in human 
first trimester tissues, until further studies are carried out we do not know that these 
genes were monoallelic before hES derivation.  For those transcripts which are not 
detectable until after implantation e.g. H19, NDN, IPW and KCNQ1, it may not be 
possible to find out (Salpekar et al., 2001).  This is particularly true in the case of 
genes which display tissue-specific imprinting, such as and GNAS and MEST Isoform 
2 (Kosaki et al., 2000; Germain-Lee et al., 2002).  Studies of imprinting in embryoid 
bodies showed that certain genes are up-regulated, IGF2, DCN and H19 particularly, 
during EB formation but no changes in allelic expression were observed (Sun et al., 
2006). 
Whether imprinting is a reflection of overall epigenetic stability or not 
remains unknown.  Interestingly, a study into cell transformation in vitro found that 
imprinted genes became preferentially de-regulated, compared to non-imprinted 
transcripts.  CDKN1C and H19 promoters became hypermethylated, resulting in 
biallelic silencing.  It should be noted, however, that this was in a pathological model 
and may be more related to cellular transformation than the effects of in vitro culture 
(Pantoja et al., 2005). 
1.7 Human Mesenchymal Stem Cells 
Bone marrow contains two stem cell populations; haematopoietic and 
mesenchymal.  Haematopoietic stem cells (HSC) maintain a supply of 
myeloerythroid and lymphoid precursors, and are thought to be present in the bone 
marrow at a rate of 0.01 to 0.05 % (Eckfeldt et al., 2005).  Mesenchymal stem cells 
(MSC) form part of the HSC niche, and are used to condition their culture medium in 
vitro.  MSC are present at a rate of between 0.01 to 0.001%, and as well as 
structurally and biochemically supporting haematopoiesis, they provide a stem cell 
population for bone (Pittenger et al., 1999) 
 MSC are rather ill-defined, and although strictly distinguished from HSC 
through complete lack of classical HSC antigens CD34, CD14 and CD45, their 
characterisation is based on expression of various mesenchymal markers, and 
adherence to plastic.  Notably, they express vimentin, fibronectin and laminin, and are 
CD73 and CD29 positive (Ryan et al., 2005).  
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Figure 1.22 Human fetal mesenchymal stem cells in culture 
MSC have a flat, stellate morphology, similar to fibroblasts.  They grow without 
feeders but require regular passaging as confluency results in a loss of potential.  
Cells derived at the Institute of Reproductive and Developmental Biology, Imperial 
College London, by the Fetal Medicine Group. 
 
A more abundant source of MSC was identified in tissues of the early human 
fetus, by Nick Fisk and colleagues in 2001.  Samples of bone marrow, peripheral 
blood and liver, from first and second trimester terminations, revealed a fetal MSC 
(fMSC) population of as much as 0.4% of total cell count (Campagnoli et al., 2001).  
They readily differentiate to osteoblasts, myoblasts, adipocytes and chondrocytes, and 
may be expanded for over 70 population doublings before senescence (Campagnoli et 
al., 2001; Chan et al., 2006) 
1.7.1 Potential of MSC 
The paucity of markers available to definitively identify mesenchymal stem 
cells mean that several independent research groups are working on cells which have 
an overt MSC phenotype, but due to their origin or derivation process, are given 
different names.  This makes it difficult to consolidate data regarding MSC potential 
and differentiation capacity.   
It may be that all MSC-like cells are the same, but are sensitive to culturing 
techniques and so display different properties in different hands.  Alternatively, MSC 
populations may be largely heterogenous group of cells, some of which have stem 
cell properties.  This hypothesis is supported by the cells isolated through extended 
MSC culture by Catherine Verfaillie and colleagues, known as multipotent adult 
progenitor cells. (MAPC) co-purify with MSC but have a slightly altered antigen 
display phenotype.  They are reported to be pluripotent, both in vivo and in vitro, and 
to have the capacity to undergo over 100 population doublings without sensescence 
(Jiang et al., 2002; Reyes et al., 2002) 
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The third, and perhaps most likely option, is that cells derived from each MSC 
niche, varying in ontogeny and location, harbour individual differing characteristics.  
Whilst the vast majority of MSC reside in the bone marrow, their presence in the fetal 
circulation results in transfer to amniotic fluid umbilical cord, and possibly even 
maternal circulation.   
Table 1.8 Sources of mesenchymal stem cells 
Mesenchymal stem cells, although predominately found in the bone marrow, have a 
wide range of sources.  Some of the cells characterised appear to have an increased 
differential potential, possibly due to the ontogeny of the cells, reflected in differing 
gene expression profiles between cells from different sources (Wagner et al., 2005). 
1.7.1.1 fMSC in therapy 
Most of the literature available concerning MSCs and their use in therapeutic 
strategies concern adult bone marrow derived cells.   Autologous adult human MSC 
have been shown to promote wound healing, improve cardiac output, and to enhance 
growth and reduce fracture in children with type III Osteogenesis Imperfecta (OI) 
(Horwitz et al., 2002; Chen et al., 2004; Wu et al., 2007).   
fMSC have been shown to have an increased proliferation index and 
differentiation capacity compared to their adult counterparts (Guillot et al., 2006a; 
Ilancheran et al., 2007; Zhang et al., 2008).  Their derivation earlier ontologically 
than adult MSC may confer this difference in potential, as in fetal HSC, which have a 
2-3 log higher proliferative potential compared to their adult counterparts (Ho et al., 
2005).  As such, fMSC represent a very important potential resource for mesodermal 
disease therapy.  In vivo, intra-uterine transplantation of mismatched fetal liver MSC 
into a fetus in the second trimester with OI demonstrated engraftment in bone and 
MSC source Common 
name 
Differentiation 
capacity 
Reference 
Bone marrow BM MSC 
MIAMI 
Mesoderm  (D'Ippolito et al., 2004; Miura 
et al., 2006) 
Fetal tissues fMSC Mesoderm  (Guillot et al., 2006b) 
Amniotic fluid AF MSC Ectoderm, endoderm 
mesoderm  
(De Coppi et al., 2007) 
Endometrium MMC Cardiac muscle (Hida et al., 2008) 
Adipose tissue ASC Mesoderm (Boquest et al., 2006) 
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differentiation of the cells, as well as a possible growth enhancing effect (Le et al., 
2005). 
One of the most challenging routes of fMSC research is to attempt intrauterine 
surgery, injecting the cells at the site of injury.  OI is a serious and debilitating 
disease, and much harm comes to the fetus during development in utero and birth.  
Improvements in bone density, as previously demonstrated, due to fMSC engraftment 
may prevent the injuries which occur in utero, before normal treatment can be 
administered (Horwitz et al., 2002).  In addition, the smaller the fetus, the smaller the 
dose of cells required.  It has been shown that human fetuses are able to mount an 
immune response from the beginning of the second trimester (Le Blanc et al., 2005).  
The derivation and expansion of fMSC from first trimester amniotic fluid would 
allow autologous cell therapy in these children 
1.7.1.2 MSC stability in culture 
The derivation of MSC at a point in ontogeny past genome-wide remodelling 
(see Figure 1.23) may mean they are more stable in culture than hES cells. 
 
Figure 1.23 Cellular potential declines during development 
During preimplantation development, each cell of the conceptus is totipotent.  
Morulation coincides with cell fate decision of outer cells to become trophectoderm.  
The inner cell mass remains pluripotent but further embryological development 
requires lineage commitment.  hES cells are derived at the blastocyst stage, and 
fMSC from the fully formed fetus, however developmental naivety is played against 
genome-wide epigenetic remodelling.   
 
Data available currently is on adult MSCs, which do not appear to share the 
chromosomal instability of hES cells, and although mouse MSCs are tumorigenic, 
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there is only one known incident of human MSC transformation  (Rubio et al., 2005; 
Tolar et al., 2007; Meza-Zepeda et al., 2008).  Epigenetically, there is little 
information, although one study showed the maintenance of tissue-specific 
methylation from the time of derivation to several passages later (Noer et al., 2006).  
A preliminary study measuring the promoter enrichment of histone modifications 
H3K4Me3 and H3K27Me3 found not change after extended culture (Noer et al., 
2008).  
 
1.8 Summary 
Transcription is the mechanism through which the coding sequence is acted 
upon, dictating cellular phenotype.  It is a multifactorial process, involving a vast 
array of effectors.  Many of these are utilised in the transcriptional phenomenon of 
genomic imprinting, which is parent-of-origin monoallelic expression. 
Imprinting is a complex epigenetic mechanism which controls both growth, 
development and behaviour.  Imprinting is regulated through the interplay of various 
epigenetic factors, including DNA methylation and non-coding RNA expression.  
Correctly regulated imprinted expression is important in cell growth, and is often lost 
in tumourigenesis.   
Human stem cells are an important resource for research into human 
physiology and as tools for regenerative therapy in the clinic.  The growth and 
differentiation phenotype of cells is controlled in part by epigenetics, including 
imprinting, and is often altered duing in vitro culture.  Derivation and culture 
techniques inherently vary between different cultured cell lines and some lines may 
be more epigenetically stable in vitro than others. 
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Chapter 2 – Materials and Methods 
2.1 Human embryonic stem cell samples 
Human embryonic stem cells (hES) were derived for this PhD and other 
research from spare embryos, discarded following IVF treatment as outlined 
previously (Thomson et al., 1998).  Briefly, zona-free blastocysts were plated on to 
50 µl microdrops of mEFs covered by embryology mineral oil (Ovoil; Vitrolife AB, 
Sweden) with human embryonic stem cell (hES) medium and incubated at 37 °C in 5 
% CO2 in air.  Cells were maintained daily by replacing half of the medium and areas 
of differentiation were removed with a sterile pipette.  Undifferentiated colonies were 
picked and transferred to fresh feeder preparations.  After 5-10 passages, collagenase 
digestion was used to detach undifferentiated hESC colonies, cells were then washed 
by centrifugation in hES culture medium and transferred to new feeders. 
Snap frozen hES cell pellets were obtained from Professor Harry Moore at the 
University of Sheffield (named SHEF) and from Dr Stephen Minger at Kings College 
London (KCL) (named WT/CF) under material transfer agreements with relation to 
Human Fertilisation and Embryo Authority (HFEA) Licence numbers RO115 
(Sheffield) and RO113 (KCL).  The hES tissue culture was carried out at the 
University of  Sheffield by Katherine Amps and at KCL by Zhenling Luo. 
2.2 Human fetal mesenchymal stem cell samples 
Human fetal mesenchymal stem cells (fMSC) were collected and expanded as 
described previously, from consenting patients undergoing first-trimester termination 
of pregnancy (Campagnoli et al., 2001).   Collection was carried out by the Fetal 
Medicine Group, led by Professor Nicholas Fisk/Dr Pascale Guillot at the Institute of 
Reproductive and Developmental Biology (IRDB), and was approved by the Research 
Ethics Committee of Hammersmith and Queen Charlotte's Hospitals.  Polkinghorne 
National guidelines were complied with in relation to the use of fetal tissues for 
research.   Fetal blood was obtained by ultrasound-guided fetal blood sampling 
(cardiocentesis, cordocentesis or embryoscopic cannulation), and fetal liver and bone 
marrow from products of conception.  This work was carried out in collaboration with 
Professor Nick Fisk, Dr Pascale Guillot and Dafni Moschidou and the IRDB, but  
fMSC tissue culture was carried out by myself , both at the IRDB and at ICH. 
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2.3 Human tissue sample collection 
All fetal and placental samples had been collected previously and form part of 
the Moore Fetal Tissue and Moore Placental trio cohorts.  Fetal tissues were from 
first trimester termination of pregnancy and placental trios from term placenta and 
parental peripheral bloods.  Ethical approval for fetal tissue collection was granted by 
Hammersmith, Queen Charlotte's & Chelsea and Acton Hospitals Research Ethics 
Committee, Project Registration No 2001/6028 (fetal tissue) 2001/6029 (placental 
trios). Where required as part of control experiments and optimisations, RNA was 
extracted from stored fetal and placental material, as outlined in section 2.8.  Adult 
bone marrow RNA was purchased directly from Clontech Laboratories Inc (CA).  
The RNA had been isolated from the bone marrow of six individuals aged between 38 
and 59 years who had died suddenly. 
2.4 hES cell tissue culture 
SHEF lines are cultured in T25 flasks with 5ml ES media containing 80% 
Knockout Dulbecco’s modified Eagle’s medium (DMEM) (Gibco), 20% Knockout™ 
Serum Replacement (Gibco)(Xu et al., 2001), 1m glutamine (Gibco), 0.1mM β-
mercaptoethenol (Sigma), 1% non-essential amino acids (Gibco)and 20ng/ml FGF-4 
(Gibco).  SHEF1-6 cells are grown with a sub-confluent layer of mouse embryonic 
fibroblasts (MEFs) derived from swiss-strain mice.  SHEF7 is  grown on human 
gonadal interstitial cell feeders.  MEFs are passaged to between passage 3-6 and 
inactivated by irradiation for 65 s, seeded at around 200,000 cells per flask.  hES cells 
are fed daily and passaged 1 in 3 once or twice weekly, depending on the growth rate 
of the line.  The cells are assessed by eye prior to passage using phase microscopy, 
the presence of differentiated colonies indicating the need to split the flask.  
Collagenase or trypsin is used to loosen the cells and 3mm glass beads to dissociate 
them from the flask.  There are approximately 200,000 ES cells per T25 prior to 
passage, as counted by FACS.  Kings College lines are grown in 60 mm dishes 
(Nunc) with ES media containing either FGF-2 or LIF.  Colonies are split by manual 
dissociation and transferred to new feeders. 
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2.4.1 hES cell differentiation 
Trophoblast differentiation of hES cells was carried out in Sheffield by Ramya 
Udayashankar.  hES colonies were disrupted using 2 ml collagenase incubated at 
37°C for 6 minutes, and removed from the flask surface using glass beads.  The cell 
mix was added to a non-adhering bacterial plate in embryoid body (EB) media 
containing 80% Knockout DMEM, 20% knockout serum replacement, 1 mM 
glutamine, 0.1mM β-mercaptoethenol and 1% non-essential amino acids.  Cells 
forming EBs were cultured in EB medium for five days, before transferral to adherent 
plates containing MEFs and cultured in trophoblast media consisting of RPMI 
(Sigma) supplemented with 20% fetal bovine serum (FBS), 1mM Sodium Pyruvate, 
100 μM β-mercaptoethenol, 2 mM LGlutamine and 50 µg/ml Pen/Strep.  The 
cytotrophoblast stem cell lines received from Sheffield were derived from the SHEF4 
line, and from the H7S14 sub-line, obtained from an H7 line gifted to the laboratory 
of Professor Peter Andrews by Dr J. Thomson.   
2.5 fMSC tissue culture 
Frozen fMSC stocks were thawed and seeded in 100mm polystyrene cell 
culture dishes (Corning, Hemel Hempstead, UK).  Cells were cultured in DMEM 
(Sigma-Aldrich®, Steinheim, Germany), supplemented with 10% FBS (Gibco), 2 mM 
L-glutamine, 500 U/ml penicillin and 50 g/ml streptomycin (PenStrep) (Gibco).  
Adherent cells were passaged before reaching confluency using 0.25% Trypsin-
EDTA (Gibco/Invitrogen, Paisley, UK) and the medium changed twice weekly.   
2.5.1 fMSC differentiation 
Differentiation of fMSCs was carried out by Dafni Moschidou at the Institute of 
Reproductive and Developmental Biology, Imperial College London.  fMSCs were 
seeded and grown to 70% confluency before beginning differentiation.  Adipogenic 
differentiation was carried out by incubation with DMEM with 10% FBS 
supplemented with 0.5 mM hydrocortisone, 0.5 mM isobutyl methylxanthine, and 60 
M indomethacin (Sigma-Aldrich) for four weeks as previously described 
(DiGirolamo et al., 1999).  Cells were stained with fresh Oil-red-O solution to assess 
lipid deposition (Sigma-Aldrich).   Osteogenic differentiation was carried out by 
incubating the cells with DMEM with 10% FBS supplemented with 10-8 M 
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dexamethasone, 0.2 mM ascorbic acid, and 10 mM b-glycerol phosphate (Sigma-
Aldrich) for four weeks, also previously described (DiGirolamo et al., 1999).  To 
assess mineralization, cultures were stained with silver nitrate (Sigma-Aldrich).   
2.6 Adult peripheral blood leukocyte collection 
Fifteen ml blood was extracted from each of 50 randomly selected  healthy 
adult volunteers employed at the Institute of Child Health, University College 
London.  The resulting male/female ratio was 1:1 and volunteers were of a mixed 
ethnicity, from an age range of 20-50 years.  Full consent was obtained from each 
person and the collection of blood for research purposes was approved by the joint 
Hammersmith Hospitals Trust and Imperial college Ethics committee (Reg No. 
2001/6029).   
2.6.1 Peripheral blood leukocyte purification 
Peripheral blood leukocytes (PBL) were isolated from whole blood using 
density gradient centrifugation as described previously (Ting and Morris, 1971).  
Briefly, whole blood was layered on top of a 1:1 solution of  ‘Lymphoprep™’ 
(Nycomed, Birmingham, UK) and phosphate buffered saline (PBS).  The 
blood/lymphoprep mixture was then spun at 800 g from 20 minutes and the resultant 
white cell layer isolated.  The cells were washed in PBS and snap frozen.    
2.6.2 Peripheral blood leukocyte separation 
For lineage-specific analysis, whole blood was separated into CD3, CD15 and 
CD19 positive cell fractions using an autoMACS™ Separator (Miltenyi Biotech, 
Surrey UK). CD19+ B-lymphocytes corresponded to 5% total cell count,  CD3+ T-
lymphocytes 25% and CD15+ myeloid cells between 50-70% of cells in a population 
of purified PBL.   
2.7 DNA extraction 
DNA extraction from PBL and cell pellets was performed using standard 
phenol/chloroform extraction.  Briefly, 100 µl 10% SDS and 50 µl proteinase K (20 
mg/ml) were added to the cell pellet and incubated overnight (O/N) at 55°C.  1 ml of 
phenol was added, mixed and centrifuged at 10,000 rpm for 10 mins at room 
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temperature (RT). The supernatant was collected and a second phenol extraction 
carried out if the sample contained many cells.  1 ml of chloroform was then added in 
the upper layer and centrifuged at 10,000 rpm for 5 mins at RT. This step was 
repeated once more. The supernatant was collected and precipitated in two volumes 
of 100% EtOH.  The DNA was removed using a glass pipette, added to 300-500 µl 
Tris EDTA (TE) buffer and resuspended O/N rotating at 37°C.  The absorption at 260 
nm (A260) was measured (Gene Quant II, Amersham Pharmacia Biotech) to assess the 
concentration of the DNA; [DNA] = A260 x 50ug/ml, and the ratio of A260/A280nm 
calculated to estimate purity.  Stocks were stored at 4°C. 
2.8 RNA extraction from cells and fetal tissues 
RNA was extracted directly from snap frozen cell and tissue samples using 
Trizol® (Invitrogen)  Fetal tissues were homogenised with a probe (Ultra Turrax, IKA 
laboratories, Germany)  in 1ml Trizol, whilst cells were homogenised in 500 µl-1 ml 
Trizol using a 27 gauge needle (Microlance™, Beckton Dickinson, Spain).  The 
trizol/sample solution was transferred to 1.5 ml eppendorf tubes, 200 µl chloroform 
added and vortexed thoroughly.  The sample was incubated at RT for 5 minutes and 
centrifuged at 13,000 g for 15 minutes at 4°C.  400ul of the aqueous phase was 
precipitated in 0.8 volumes (standardly 340ul) isopropanol, incubated for 10 minutes 
at RT and centrifuged as before.   
2.8.1 DNAse treatment (I) 
 
A solution of 180 ul DEPC water (Invitrogen), 12 µl TURBO DNase™ buffer 
and 8 µl TURBO DNase™ (Ambion) was used to resuspend the pellet, and the 
reaction incubated at 37C for 30 minutes.   A 1:1 solution of phenol chloroform was 
added (total 200 µl), mixed and the mix transferred to a 2 ml phase-lock eppendorf, 
before centrifugation at RT at 13,000 g for five minutes.  200ul chloroform was added 
to the tube and the mix centrifuged a second time.  The supernatant was again added 
to 0.8 volumes isopropanol (160 µl), mixed and spun at 4C  for 15 minutes.  The 
pellet was washed in 70% EtOH and centrifuged at 13,000 g at 4C for five minutes, 
the wash removed and the pellet allowed to partially dry.  RNA pellets were 
resuspended in 25 mM EDTA and stored at -80°C.     The absorption at 260 nm (A260) 
was measured as for DNA, [RNA] = A260 x 42 µg/ml. 
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2.8.2 cDNA synthesis and DNase treatment (II) 
One–two µg total RNA was treated with DNase1 (Promega) in a total reaction 
volume of 10 ul, for 30 minutes at 37C, followed by denaturation at 70C for 10 
minutes.  DNased RNA was then primed with random hexamers (Promega) and 
reverse transcribed with either M-MLV reverse transcriptase or a point mutant of the 
same (Promega).   
2.8.3 cDNA Synthesis Reaction: 
 
Component      Vol (µl) per reaction 
M-MLV RT buffer (5x)       4  
 dNTPs (10 mM)        2  
 MilliQ water         2  
 Random primers (500 µg/ml)       1  
 M-MLV reverse transcriptase (200 units/µl)  0.5  
 RNasin RNase inhibitor (40 units/µl)    0.25  
     Incubation at 42C for >1 hour 
     Denaturation 70C 10 minutes 
 
For every sample, a second reaction was carried out in parallel, with M-MLV 
omitted.  These samples are referred to as ‘RT +’ and ‘RT –’ denoting the respective 
presence and absence of reverse transcriptase in the reaction.  Several of the 
transcripts analysed did not possess introns in their genomic sequence, and in other 
cases, important SNPs were located in the middle of large exons.  As a result, 
genomic contamination in the RT-PCR was inevitable, and the parallel processing of 
RT- samples allowed quantification of this.   cDNA was stored at -20C 
2.9 Polymerase chain reaction (PCR)  
PCR selectively amplifies a specific target DNA sequence (Mullis et al., 1986). 
Oligonucleotide primers approximately 18-22 bp in length anneal to opposite strands 
flanking the target DNA.  Double stranded DNA is denatured by high temperatures 
and subsequent cooling allows the primers to anneal to the complementary sequences.  
New strands of DNA are extended from the primers by a thermostable DNA 
polymerase.  The new double stranded DNA is then denatured and the process 
repeated, giving rise to the exponential synthesis of the specific DNA fragment. 
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2.9.1 A standard Bioline PCR reaction: 
 
Component      Amt per reaction 
DNA or cDNA template    50 ng (1µl) 
Primers (forward & reverse)    100 ng (0.5ul) 
dNTPs       10 mM (0.5ul) 
NH4+2 buffer (10x)     5 µl  
MgCl2       1.5 mM (0.74ul) 
Betaine (5 M)      7.5 µl 
Taq polymerase     1 unit  (0.2ul) 
MilliQ water      adjust to 25 µl total vol 
 
2.9.2 Thermal cycling conditions: 
Initial denaturation 94 C, 5 minutes 
1. Cycle denaturation 94 C, 30 s 
2. Annealing (Tm; ~53-63°C), 30 s 
3. Extension 72 C, 30 s 
Cycling from 1 to 3 for 30 to 45 cycles 
Final extension at 72 C, 5 minutes. 
 
All reactions were carried out with a heated lid to prevent evaporation in a DNA 
engine DYAD Peltier Thermal Cycler (MJ Research, UK).  
2.10 Primer Design 
2.10.1 Genotyping PCR primers 
Genotyping primers were designed to have a G/C content of 50-60%.  A G or 
a C base at, or within five bases from, the 3’ end of the primer was included in the 
design to promote hybridisation.  Genotyping primers were designed to flank exonic 
SNPs with >70 but <300bp between at least one of the primers and the SNP, to allow 
detection by sequencing (See section 2.13).   
2.10.2 Non quantitative (Nq) reverse transcriptase PCR (RT-PCR) 
primers  
Nq RT PCR primers were designed similarly to genotyping primers but were 
either to cross intron exon barriers, or to include in their genomic amplification region 
a large intron, allowing specific amplification of cDNA.   
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2.10.3 Bisulphite primers  
Bisulphite primers were designed to be slightly longer (<30 bp) and to have at 
least 30% C or G, whilst containing no CpG islands.  This was to ensure no 
preferential amplification of methylated or unmethylated strands occurred.  The 
amplicons of bisulphite PCR were designed to contain a recognition site for one of 
the endonucleases which would allow distinction between methylated and 
unmethylated DNA (see section 2.15).   
2.10.4 Quantitative PCR (QPCR) primers 
QPCR or ‘Taqman’ primers were designed to be 18-22 bp , and to have a GC 
content of >50% to ensure optimal Tm between 58 and 60°C.  Where appropriate, 
they were also designed to have the same two bases (preferably CC or GG) at the end 
of each primer so that the synthesized oligonucleotides had the least chance of 
forming primer dimers.  Taqman PCR product size was kept to around 100 bp 
wherever possible.  For each set of primers an optimum Tm was determined by a 
temperature gradient profile.   An 8 µl aliquot of PCR product was visualized on an 
agarose gel to confirm the product size and quality.   
2.11 Agarose gel electrophoresis  
The size and integrity of PCR amplicons and restriction endonuclease 
digestions (see section 2.12) were analysed using size separation by agarose gel 
electrophoresis, visualised by staining with ethidium bromide (EtBr).  Agarose 
concentration was standardly 1.5% for PCR, 3% for restriction digests and 4% for 
CDKN1C genotyping.   1.5% gels  consisted of 1.5 g of agarose in 100 ml Tris acetate 
EDTA (TAE) buffer.  Gel solutions were microwaved in 1x TAE buffer to dissolve 
the agarose and 3 µl EtBr (10 mg/ml) per 100 ml was added when the solution had 
cooled enough to be held.  Gels were set in 20 + 20 well casts.  Samples were 
prepared for electrophoresis by adding 3ul bromophenol blue loading dye (Promega) 
diluted 1:4 in 80% glycerol, to 8 µl PCR product or 17 µl restriction digest.  5 μl 
100bp DNA marker (Promega) loaded in parallel allowed estimation of fragment size. 
Loaded gels were electrophoresed in 1x TAE buffer at 150 V for 30 mins-1 hr. The 
DNA/RNA fragments were visualised using a UV transilluminator and then 
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photographed or stored as a digital image (ImageMaster, Amersham Pharmacia 
Biotech).  
2.12 Restriction digestion  
PCR products amplified across polymorphic regions corresponding to 
recognition site of endonucleases were digested for genotyping and to analyse allelic 
expression.  The differential methylation of bisulphite PCR products was analysed 
using Combined Bisulphite and restriction analysis (COBRA) which utilises the 
presence or absence of Taqa1, Tai1, MboI or BstUI restriction sites in the DNA to 
ascertain methylation status. 
2.12.1 Restriction Digest reaction: 
 
Component      Vol (µl) per reaction 
PCR product      10 µl 
10x Buffer (provided by manufacturer)  2 µl    
Enzyme (Promega, NEB)     1 unit 
MilliQ water      Adjust to 20 µl total 
 
The digestions were incubated at 37, 60 or 65C for 2-4 hours based on 
manufacturer’s instructions (New England Biolabs).  
2.13 Sequencing 
The dideoxy chain terminating method was used to sequence PCR products 
(Sanger et al., 1977).  5ul PCR product was first purified and precipitated using 1 
volume of microCLEAN (Microzone, Cambio, UK)  and centrifuging for 40 minutes 
at 3000 g at RT.  The microCLEAN was removed and 10ul sequence mix then added 
to the precipitate containing 5.7 µl MilliQ water, 4 µl Big Dye Terminator 3 (Applied 
Biosystems) and 0.3ul 10mM primer. 
2.13.1 Sequencing reaction: 
 
96°C   1 min 
96°C   30 s 
53°C   15 s        29 cycles 
60°C   4 mins 
20°C   2 mins 
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Sequences were precipitated by mixing with 170 µl of ‘Sequence Wash’ – 5 ml 3M 
NaAc, 30 ml 100% EtOH, made up to 250 ml with MilliQ; and centrifuged at 3000  g 
for 40 minutes at RT.  The pellets were washed with 170 µl 70% EtOH and spun 
again for 10 minutes.  The wash was removed and the pellet allowed to partially dry, 
before being dissolved in 10 µl formamide.  The sequencing reaction was analysed on 
a 3730 DNA analyser (Applied Biosystems (ABI), CA) and the read-out visualised 
using Sequencher™ v4.6 (Gene Codes Corporation, MI) 
2.14 Real time RT-PCR 
Real time PCR measures the incorporation of fluorescent molecules (i.e. 
SYBR® Green dye) into the PCR product, enabling quantification of the exponential 
reaction such that relative, or exact, starting amounts can be determined.  cDNA to be 
added to the reaction was diluted 1:10 with DEPC water to minimise the impact of 
pipetting errors.  The real time RT PCR reaction was prepared, in triplicate in optical 
plates. 
2.14.1 Real Time RT -PCR reaction: 
 
Component      Vol (µl) per reaction 
SYBR Green Mastermix (Applied Biosystems)  12.5 
Forward Primer (10 mM)    0.6 
Reverse Primer (10 mM)    0.6 
DEPC H2O      1.5 
1:10 Template dilution     10 
 
The plate was spun briefly to pool the reaction mixture and remove air 
bubbles (3000 g) and run standardly for 40 cycles with a Tm of 60°C on the ABI 
Prism 7700 Sequence Detector 1.7 (Applied Biosystems).  Optimisation runs were 
carried out for each primer pair to ensure optimum amplification and allow 
assessment of primer dimer production (see Figure 2.1).  Data was analysed using 
Sequence Detector 1.7 software (Applied Biosystems). 
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Figure 2.1 Real time PCR optimisation curves   
(a) Amplification plot of fluorescence (proportional to the level of amplicon 
generated) against cycle number.  The amplification plot shows both the kinetics of 
the PCR, and also the accuracy, based on samples in triplicate and the blank (DEPC 
water only; the lighter blue line at the base).  The PCR was considered accurate 
enough to be included in analysis if two or more of the triplicates were within one 
cycle of one another during the linear phase.  Dissociation, or melt curves, (b) and (c), 
were generated during primer optimisation to test the integrity of the amplification.  
(b) shows a reaction containing only one product whereas (c) contains two; the first 
likely being primer dimers as the melting temperature is so low.  The presence of a 
second amplicon reduces the accuracy of this technique and primers were redesigned 
in such an instance. 
2.14.2 Relative Quantification 
Real time PCR, or ‘Taqman’ generates data based on the ΔCt of each reaction.  
The ΔCt is the difference (Δ) in the number of cycles (C) between the gene of interest 
and the control house keeping gene (e.g. GAPDH) take to reach a threshold (T) value 
of expression.  The threshold is set at 0.3 arbitrary units.  In order to calculate the 
exact amount of material, standard curves can be generated using known quantities of 
template.  The studies carried out in this thesis only required relative, and not 
absolute, quantification and so this was not done.  Amplification of GAPDH was 
carried out in parallel with the samples on every plate, and a control sample included 
on each to allow comparison across plates.  Relative expression data is presented in 
the form of  
either:      2-ΔCt  
Where each cycle is a doubling of the amount of starting material, and its inverse 
takes account of the relationship between cycle number and starting amount. 
Or:          Log102-ΔCt  
To better illustrate large differences between actual levels 
2.15 Combined bisulphite and Restriction Analysis 
(COBRA) 
DNA is methylated specifically on the cytosine base of the symmetric CpG 
dinucleotide, giving 5-methylcytosine.  Sodium bisulphite deaminates cytosine to 
uracil, but does not affect 5-methylcytosine.  When bisulphite-treated DNA is then 
amplified by PCR, the uracil is amplified as thymine and the methylated cytosines as 
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cytosine.  The use of bisulphite treatment combined with PCR allows the 
measurement of DNA methylation.   
Specific genomic regions can be analysed by PCR by designing primers 
which anneal specifically to bisulphite treated DNA.  The resulting amplicons can 
then be digested with restriction enzymes whose recognition site is affected by the 
conversion of Cs to Ts (COBRA), or cloned and sequenced. 
Figure 2.2 Illustration of the COBRA technique   
Examples of a methylated genomic region and an unmethylated one are shown, with 
their resultant PCR products following the COBRA assay.  In these examples the 
restriction enzyme specifically recognises a CpG sequence, so methylated DNA is 
represented by a digested product, and unmethylated DNA by an intact one.  
 
To verify the presence of a region of allelic differentially methylated DNA, bisulphite 
conversion was carried out on 2 ug phenol/chloroform purified genomic DNA from 
each sample.   Bisulphite conversion was carried out as follows in a themocycler: 
2.15.1 Bisulphite Conversion 
94C   10 minutes 
 53C    30 minutes 8 cycles 
 53C    6 minutes      
37C   30 minutes 
 
Bisulphite treated DNA was cleaned up using the EZ DNA Methylation-Gold Kit™ 
(Zymo, CA), before amplification using primers specific for each DMR.   Hotstar Taq 
polymerase (Qiagen, West Sussex, UK) was used for 45 PCR cycles and amplicons 
digested using either Taqα1 (-TCGA-), Tai1 (-ACGT-), MboI (-GATC-) or BstUI (-
CGCG-) restriction enzymes (New England Biolabs) depending on the presence of 
any of these recognition sites in the amplicon.  Digested products were resolved on 3-
4% agarose gels and stained with EtBr.  Differentially methylated alleles could be 
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identified by the presence of both digested and undigested product in the digest, as 
methylated DNA (e.g. the maternal allele, in the case of the KvDMR) would be 
recognised and digested, but unmethylated DNA (i.e. the paternal allele) would not 
(see Figure 2.2 and Figure 2.3) 
 
Figure 2.3 Cartoon of a COBRA gel   
Representation of a agarose gel electrophoresis assay of COBRA products, stained 
with ethidium bromide. Lane (i), a sample of the original PCR product which is not 
incubated with enzyme is run as a molecular weight control for the unmethylated 
DNA.  Lanes (ii) and (iii) represent samples containing only unmethylated DNA or 
only methylated DNA respectively.  Lane (iv) is what would be expected when the 
region amplified is a DMR, so both methylated and unmethylated DNA is present in 
the same sample, and intensity of the digestion products is equal to that of the 
undigested products – corresponding to equal representation of the parental alleles. 
2.16 Bisulphite cloning  
COBRA only allowed the analysis of about one, or at most three, CpG sites in 
any given region, so to gauge the level of methylation across the whole region of the 
amplified DNA, amplicons were cloned and sequenced, allowing analysis of each 
CpG dinucleotide.  1-3 µl PCR product was ligated into PGEM-T ® Vector (Promega) 
as per manufacturers instructions at room temperature for 4 hours, or O’N at 4C.  
Ligations were then incubated at 4C with JM109 competent bacterial cells 
(Promega) for 30 minutes, before heat shocking bacteria at 42C for 45 s, quenching 
on ice for 2 minutes and then growing up the cultures in 100 µl LB (no antibiotic) at 
37C for 30 minutes.  Cultures were plated onto LB-agar containing ampicillin, IPTG 
and X-gal and incubated in O/N at 37C. 
2.16.1 Blue White colony selection 
IPTG (Isopropyl β-D-1-thiogalactopyranoside) mimics allolactose to activate 
transcription of the bacterial lac operon, namely lacZ.  Beta-galactosidase is 
subsequently produced, and turned a blue colour by X-gal.  Inserts into the vector 
disrupt the lacZ gene, no Beta-galactosidase is produced and the colony remains 
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white.  White (transformed) colonies were selected (usually 20 per sample/plate) and 
transferred to 100ul LB broth using a pipette tip.  Individual colonies were 
resuspended in the broth and incubated at 37C for 1-2 hours, allowing them to grow.  
2 µl of each colony was then amplified using M13 primers, and the products run out 
on agarose with a size marker, to ensure the clones had amplified the desired insert. 
2.17 Bisulphite Sequencing 
M13 PCR amplicons were sequenced as in section 2.13 using the forward 
bisulphite primer.  Sequences were analysed using Sequencher™ and the presence of 
methylated or unmethylated CpGs within individual DNA strands noted down in a 
grid, giving an idea of methylation density across the whole region. 
 
Figure 2.4 Example CpG dot plots, to show bisulphite sequence data   
Each dot represents a single CpG.  Each line of dots represents an individual clone.  It 
is desirable to see small differences between each clone (due to low level-incomplete 
conversion), to ensure that they are in fact different clones.  Closed circles represent 
methylated CpGs, open circles represent unmethylated CpGs.  (a) depicts a region of 
intermediate methylation, where each clone has a mixture of methylated and 
unmethylated alleles.  (b) depicts a 50:50 ratio of methylated to unmethylated clones, 
indicating that some alleles within the region are completely methylated, and some 
completely unmethylated.  This is what would be found at a DMR.  (c) depicts a 
completely unmethylated region. 
 
 
(a)          (b)    (c) 
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Chapter 3                                            
Expression of placental-specific imprinted genes 
in a model of human preimplantation 
trophoblast 
 
3.1 Testing placental-specific imprinting in the human 
Previous evidence shows that genes which are imprinted in the placenta only 
in mice are no longer imprinted in the human.  This evidence is gathered from 
experiments from eight weeks of human gestation onwards.  As events early in 
gestation are more similar between species it is hypothesised that placental specific 
imprinting may be present in the human but earlier in gestation.  The availability of a 
new model of early human placentation, trophoblast stem cells, provides a means to 
test this. 
3.1.1 Introduction to KCNQ1 imprinting conservation 
 
Expression within the Kcnq1/KCNQ1 imprinting cluster on mouse chromosome 
7/human chromosome 11 is not conserved between humans and mice (Monk et al., 
2006a).  Whilst the central six transcripts, covering 400 kb, maintain monoallelic 
expression in both species, the eight flanking genes are maternally expressed only in 
the mouse and bovine placenta, extending the imprinted domain to 780 kb (Lewis et 
al., 2004; Umlauf et al., 2004; Arnold et al., 2006).  These flanking transcripts are 
biallelic in the human  (Monk et al., 2006a).   
 
Figure 3.1 Gene expression at the KCNQ1 region in humans and mice 
  102 
All gene annotations are human, FT = first trimester.  The UCSC genome track scales 
the genomic size and spatial relationship of each gene.  Allelic expression status in 
mouse embryo and placenta, and human first trimester fetus and placenta is shown 
(Miyamoto et al., 2002; Lewis et al., 2004; Umlauf et al., 2004; Monk et al., 2006a). 
  
The function of several of the genes in the cluster has been extensively 
characterised, corresponding with roles in embryonic and placental growth.  
ASCL2/Mash2 is essential for placental growth, whilst CDKN1C/Cdkn1c is a growth 
suppressor, whose absence causes neonatal lethality in the mouse (Guillemot et al., 
1995; Yan et al., 1997).  Mutations in CDKN1C result in Beckwith Wiedemann 
Syndrome (BWS) in the human (Hatada et al., 1996).  Human PHLDA2 expression 
levels have been shown to have an inverse relationship with birthweight (Apostolidou 
et al., 2007).  KCNQ1 is imprinted where it is expressed in the human, except in the 
heart, the site of the defect in long-QT syndrome, caused by mutations in KCNQ1 
(Wang et al., 1996; Lee et al., 1997). 
A DMR in intron 10 of KCNQ1 acts dually as the imprint control region (ICR) 
for the cluster, called KvDMR, and the promoter of antisense ncRNA KCNQ1OT1 
(Mitsuya et al., 1999; Fitzpatrick et al., 2002).  In the mouse, Kcnq1ot1 RNA has 
been shown to  recruit Eed-Ezh2 polycomb proteins to the paternal allele, resulting in 
H3K27Me3 and H3K9Me2 enrichment, a repressed chromatin conformation and 
allelic silencing (Umlauf et al., 2004).  In the absence of DNA methylation, histone 
modifications are able to maintain imprinting of placental specific genes but 
imprinting of the central six genes requires maintenance of the KvDMR (Lewis et al., 
2004; Umlauf et al., 2004; Green et al., 2007).  Murine Kcnq1ot1 RNA has been 
shown to establish a silencing compartment in the nucleus, to which the silenced 
genes are localised.  This compartment is larger in the murine placenta, accounting 
for the increased size of the repressed region in this tissue (Redrup et al., 2009).  
The lack of conservation of imprinting in this region, and others, has been 
suggested to be due to the marked differences between murine and human 
placentation and pregnancy.  Rodents have a labyrinthine interdigitation, whilst 
humans have a villous structure, allowing a longer gestation and possibly reducing 
demand from the fetus.  Laboratory mice typically carry 12 fetuses or more, and 
humans only one (Carter and Mess, 2007; Wildman et al., 2006).  
 Early placentation events are more similar between species than later 
development (Knox and Baker, 2008).  The gene expression profile of the placenta 
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goes through a transition from utilising evolutionarily ancient genes during 
developmental stages (E8.5 to E10.5), gradually transferring to newer genes during 
mid (E10.5 to E15) to late gestation (E15 to P0), by which point the expression 
profile of the murine placenta is enriched for rodent specific genes, and the human for 
primate specific genes (Knox and Baker, 2008). 
It is therefore possible that placental-specific imprinting seen in the mouse 
may be present in the human placenta, but at much earlier gestation than has so far 
been analysed.  In order to investigate this, human embryonic stem cells (hES), a 
model for early human development, were differentiated to trophoblast stem cells 
(hTS).  These cells are capable of forming all trophoblast lineages in vitro, and are 
currently the best available model for the earliest human cells from the placenta. 
3.1.2 Trophoblast stem cells 
Models of human trophoblast historically take the form of primary tissue 
samples or choriocarcinoma cells (King et al., 2000).  In terms of the study of 
placentation and very early trophoblast lineages, however, these samples are limited 
as they are already committed to a specific lineage, and choriocarcinoma cells have a 
malignant phenotype, making them very different from normal trophoblast.  In the 
mouse it is possible to derive trophoblast stem (TS) cells, with multilineage 
differentiation and in vitro proliferation capacity, directly from the trophectoderm of 
blastocysts.  This has also been achieved in the rhesus monkey (Vandevoort et al., 
2007), but attempts to derive equivalent human TS cells in this way have been 
unsuccessful (Douglas et al., 2009).  A new model has been developed, where human 
trophoblast and cytotrophoblast stem (hTS) cells have been differentiated from 
embryonic stem cells.  hES cells are aggregated to form embryoid bodies, and 
individual cells were isolated by clonal dilution, selecting and enriching cells based 
on their hCG secretion (Harun et al., 2006; Schulz et al., 2008).  These cells remain 
undifferentiated with frequent passage and are able to proliferate over a prolonged 
period in culture.  They express markers characteristic of villous and extravillous 
trophoblast (EVT), including CDX2, HLA-G, CD9 and cytokeratin 7 (CK7), are able 
to differentiate to both lineages and form syncytium, reminiscent of early 
trophectoderm differentiation and implantation (Red-Horse et al., 2004).  These 
qualities indicate that hTS cells are a close relative of the trophectoderm and early 
trophoblast.  Similar, but ontogenically older, cells derived from the first trimester 
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placenta do not proliferate in culture, and spontaneously form EVT. The hTS cells are 
also able to migrate and invade cell culture matrices such as Matrigel® or 
endometrial stroma co-culture.  Allowing the cells to reach high density results in 
terminal differentiation to endovascular cytotrophoblast (Schulz et al., 2008; Harun et 
al., 2006). 
3.1.3 Genotyping of cell lines  
Two hES cell lines, H7 (Wisconsin cell line) and SHEF4 were used for 
trophoblast differentiation, so were genotyped alongside other control hES and fMSC 
lines.  At least one SNP was analysed for each of the genes in the KCNQ1 region, 
inclusive of both the central ubiquitously imprinted genes, and the flanking placental 
specific genes, plus a control gene outside of this cluster, IGF2.  Exonic SNPs were 
chosen based on their validation from the UCSC Genome Browser dbSNP build 129 
(http://genome.ucsc.edu/cgi-bin/hgGateway) and PCR amplicons sequenced (Figure 
3.2).   
 
Figure 3.2 Genotyping of cell lines for KCNQ1 region SNPs 
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Sequencher sequence traces from genotypes of the two hES cell lines analysed.  
fMSC lines were also genotyped, as was the gene TSSC4 (data not shown).  
Polymorphic bases are boxed in orange.  Representatives from both the ubiquitously 
expressed genes, and the flanking placental-specific genes were found to be 
informative in at least one line, summarised in  
Table 3.1. 
 
Gene OSBPL5 NAP1l4 SLC22A18 KCNQ1OT1 LTRPC5 CD81 TSSC4 PHEMX IGF2 
hES 
(TS) 
H7 H7 
SHEF4 
H7 H7 0 0 0 0 SHEF 4 
hES 2 4 5 2 0 0 0 0 2 
fMSC 2 6 4 1 0 1 0 0 ND 
 
Table 3.1 Genotyping summary of KCNQ1 for hES cell and fMSC lines 
‘hES (TS)’ represents the two hES cell lines which were differentiated to trophoblast 
stem (TS) cells, H7 and SHEF4.  The cell lines which were heterozygous for the 
polymorphic base(s), and therefore informative for allelic expression analysis, are 
listed under each gene.  ‘hES’ represents the other, undifferentiated, hES lines from 
both Sheffield and KCL which were analysed alongside the TS cells.  fMSC lines 
were also genotyped to act as undifferentiated and non-ES controls.  Numbers 
indicate the number of informative cell lines.  ND=not done 
 
Expression levels of each of the genes was analysed, to ensure that allele 
specificity could be analysed during the log-linear phase of the PCR reaction.  Non-
quantitative RT-PCR for 40 cycles was carried out on informative samples, for fMSC, 
undifferentiated hES cells (not H7) and H7 and SHEF4 TS cell derivatives.  Where 
possible, PCR primers crossed introns, preventing amplification of contaminating 
genomic DNA.  hTS cell RNA had been isolated from a number of different passages 
and freeze-thaw cycles, each of which were analysed independently (see Figure 3.3).  
Amplicons were digested with restriction endonucleases where appropriate, and 
results confirmed by sequencing. 
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Figure 3.3 RT-PCR and sequencing of informative hTS and hES cell samples 
Central ubiquitously expressed genes are monoallelic in hTS and hES cells, whilst 
flanking “murine placental-specific” genes are biallelic. IGF2 was also 
monoallelically expressed in hES and hTS.  B=Biallelic expression, M=monoallelic 
expression.  Passage annotation: e.g. P8+2 indicates eight passages, followed by 
cryopreservation and another two passages.  The number of fMSC and 
undifferentiated hES cell lines available is indicated, as well as the number found to 
be informative for each gene (n = 2, for example).  For the hTS cells, the number of 
genes which could be analysed was limited by informativity as only two genetically 
different lines were available.  Samples which were freeze-thawed between passages 
and those at later passages without freezing, were also analysed simultaneously.  No 
differences were detected between the different samples.  SNPs: OSBPL5 rs2289998 
and rs935431, NAP1L4 rs8505, SLC22A18 rs1048047, KCNQ1 rs1057128 
KCNQ1OT1 rs231357, CD81 rs1049390 and IGF2 rs680. 
3.1.4 Methylation of the KvDMR in hTS cells 
Maternal expression of genes in this domain is set up by the paternal 
expression of the long ncRNA KCNQ1OT1, which in turn is controlled by allelic 
DNA methylation (Fitzpatrick et al., 2002).  The germline KvDMR is methylated on 
the maternal allele, and located in intron 10 of the KCNQ1 gene, see Figure 3.4  
(Yatsuki et al., 2002).  KvDMR is within a CpG island which acts as the promoter for 
KCNQ1OT1, and knockout studies in mice have confirmed its status as the ICR 
(Mancini-DiNardo et al., 2003).  A LOI of KCNQ1OT1 has two possible outcomes, 
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biallelic expression or silencing.  Its biallelic expression would result in silencing of 
all flanking genes.  Complete KCNQ1OT1 silencing would result in reactivation of 
both alleles and biallelic expression of surrounding transcripts.  It is possible that a 
subset of cells have gained methylation at the KvDMR, accounting for the biallelic 
expression of some genes.  To study this question, methylation of the KvDMR was 
analysed using bisulphite sequencing. 
 
 
Figure 3.4 Methylation analysis of the KvDMR in hTS cells 
Bisulphite treated DNA was amplified over 32 CpGs within the KvDMR.  H7 and 
SHEF4 TS were analysed alongside a sample of human term placenta.  The UCSC 
genome track (NCBI Build 36.1) location of the KvDMR and CpG island with 
reference to KCNQ1 is indicated.  Each panel is representative of forty clonal strands 
anlaysed for each sample.  Each dot represents a single CpG island. Filled in dots are 
methylated, clear dots are un-methylated. 
 
The results indicate that allelic methylation is maintained at the KvDMR.  
Unfortunately no informative SNPs were available to allocate strands to alternate 
alleles, however, the presence of either completely unmethylated or completely 
methylated individual strands is strongly suggestive of a DMR.  There is a bias 
towards methylated strands, however, as this is also present in the term placenta 
sample, and has been noted frequently in other bisulphite sequencing assays (own 
observations)  it is thought to be an artefact of a cloning bias.   
Using the hTS cell model, which at present is one of the best available for 
human preimplantation development, the results show that no placental-specific 
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imprinting exists in this cluster in the human.  The monoallelic expression of central 
KCNQ1 and KCNQ1OT1 genes correlates with their imprinted expression in the 
human fetus, in hES cells, and is consistent with the maintenance of differential 
methylation at the KvDMR.  The murine ubiquitously imprinted gene SLC22A18 was 
biallelically expressed in all cell lines examined, and seems to be a cell culture 
induced loss of imprinting.   
A lack of placental specific imprinting in hTS cells suggests that this 
phenomenon does not exist in the human.  The presence of apparent cell-culture 
induced changes to imprinting from the in vivo state, however, indicates that hTS 
cells require further characterisation and may not be an appropriate model. The 
differentiation of hTS cells from hES cells means they are one step removed from 
direct derivation from the blastocyst.  Although they are phenotypically very similar 
to cytotrophoblast, and so to some extent have been epigenetically reprogrammed by 
the cell culture milieu used to differentiate them, reprogramming may not be 
complete.  As such, although they are a useful model for preimplantation trophoblast, 
the best model to look at would either be trophectoderm itself, or even cell lines 
derived from the trophectoderm. It is possible that in vivo placental specific 
imprinting does exist in the human, but improved models or analysis techniques are 
required to test this. 
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Chapter 4                                            
Expression of pluripotency associated 
transcription factors in fetal mesenchymal and 
human embryonic stem cells 
 
4.1 The potential of human fetal mesenchymal stem cells 
Human fetal mesenchymal stem cells (fMSC) have the potential to be used in 
regenerative medicine because they can differentiate to bone, muscle, fat and 
cartilage.  Evidence suggests they may also differentiate to neurons.  The capacity for 
multi-germ layer differentiation would mean that fMSC may have more wide 
reaching applications in the clinic.  Potential to differentiate is associated with 
specific transcriptional networks, and that of the pluripotent embryonic stem cell is 
widely characterised.  It is hypothesised that this network exists to some extent in 
fMSC, conferring an increased potential for differentiation than is currently 
recognised.  hES cells express key transcription factors to high levels and comparable 
levels of expression of these markers in fMSC would be indicative of an active 
network, promoting pluripotentiality in these cells.  
4.1.1 The stem cell maintenance gene network 
Embryonic stem cells express a unique set of transcription factors which work in 
concert to maintain their stem cell state, namely the POU domain, class 5, 
transcription factor 1 (POU5F1),  the homeobox transcription factor NANOG and the 
sex-determining region Y-box 2 (SOX2) (Boyer et al., 2005; Loh et al., 2006; Wang 
et al., 2006).  Removal of any of these factors or, conversely, introduction of them 
into a non-pluripotent cell type, is sufficient to respectively repress or promote the 
stem cell phenotype respectively (Niwa et al., 2000; Okita et al., 2007; Takahashi and 
Yamanaka, 2006; Wernig et al., 2007).  
POU5F1, formerly known as OCT4, encodes a transcription factor which plays 
a pivotal role in early human development, and is expressed in the early embryo, 
embryonic carcinoma (EC) and embryonic stem (ES) cells, where it is strongly 
implicated in the maintenance of pluripotentiality and self renewal (Nichols et al., 
1998).  It is thought to act in a positive feedback network with NANOG and SOX2 
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(Wang et al., 2006). NANOG is a direct downstream target of POU5F1, and closely 
associated with pluripotency both in vivo and in vitro. For example, Nanog-null mice 
have no epiblast and Nanog-null mES cells spontaneously differentiate (Chambers et 
al., 2007; Mitsui et al., 2003).   
 In addition to pluripotency and self renewal, the replicative lifespan of stem 
cells in culture is an important aspect to their use in therapy, which invariably 
requires extensive population expansion.  Telomerase (TERT) adds telomere repeats 
to chromosome ends, protecting the loss of coding DNA during replication.  
Telomere length correlates positively with cellular life-span, and the shortening of 
telomeres is thought to be closely linked with cellular senescence, and the ‘Hayflick’ 
replication limit of primary cells in culture.  The expression of telomerase is unique to 
gametes, embryonic tissues and ES cells, and confers immortality to these cell types 
(Hayflick and Moorhead, 1961; Thomson et al., 1998). 
 One of the earliest and most important facets of differentiation is the universal 
down-regulation of POU5F1, followed by SOX2 and NANOG (Niwa et al., 2005).  
Following embryogenesis, therefore, POU5F1 is thought only to be expressed in 
primordial germ cells.  There have been several reports of POU5F1 being expressed 
at significant levels in non-ES cell types, including adult peripheral blood leukocytes 
(PBL), multipotent adult progenitor cells (MAPCs) and in both adult and fetal 
mesenchymal stem cells (a/f MSC) (Jiang et al., 2002; Guillot et al., 2006a; Zangrossi 
et al., 2007).  The expression of these characteristic factors in cells other than hES 
cells is of great interest to the stem cell community because of their association with 
primitivity, pluripotentiality and immortality. 
4.1.2 Expression of stem cell markers in fetal mesenchymal stem cells  
The presence of a transcript in a cell, or in fact the real-time transcription of 
that gene, does not necessarily correspond to it having a function, especially when 
that expression is very low (Chelly et al., 1989).  POU5F1, NANOG and TERT 
expression in hES cells are known to have a physiological outcome, so comparing 
expression of these genes in hES to that in other cell types would give an indication 
as to whether the expression level in the other cell types is functionally relevant.   
To estimate the significance of previous reports of POU5F1, NANOG and 
TERT expression in fMSC and fMSC-like cells, the expression of these genes was 
measured in a selection of fMSC and hES lines (see Table 5.2 for full description of 
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cell lines) using quantitative RT-PCR.  The analysis of these undifferentiated, 
subconfluent fMSC and undifferentiated hES cells was carried out in parallel with 
differentiated derivatives of both cell types: fMSC differentiated to bone (‘fMSC 
BONE’), and hES cells differentiated to embryoid bodies, (‘hEB’).  Should 
expression of any of the factors be functional in fMSC in the same manner as in hES 
cells, further differentiation would then be expected to correspond with a reduction in 
expression levels.  Additionally, fMSC grown to confluence (‘fMSC CONF’) have 
less growth and differentiation potential than counterparts maintained in a 
subconfluent state, and so would also be expected to express less POU5F1, NANOG 
and TERT than subconfluent cells (Guillot et al., 2006a).  Primary fibroblasts were 
used as a negative control, and an adult peripheral blood leukocyte (‘PBL’) sample 
was also analysed.  Both panels (i) and (ii) of each of Figure 4.1 to Figure 4.3 show 
the 2^-dCT plotted against the cell type, where 2^-dCT is directly proportional to the 
amount of transcript present, based upon the difference (d) in qPCR cycle number 
(CT) required to meet a threshold (0.2) between the gene of interest and GAPDH. 
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(i) 
 
(ii) 
 
Figure 4.1. POU5F1 expression in fMSC and hES cells 
Panel (i) shows the expression of POU5F1 in two hES cell lines, hEBs, three fMSC 
lines, plus one CONF sample and one sample differentiated to bone.  Mean hES cell 
expression is 18 fold higher (0.082/0.005) than that of hEBs, and 410 fold higher 
(0.082/0.0002) than the most highly expressing fMSC line (fBM12+4).  Panel (ii) 
excludes hES cells from the graph to show more clearly the expression patterns in 
other cells.  POU5F1 expression in fMSC is highly variable, not significantly 
decreased in either fMSC grown to confluence of differentiated to bone, and actually 
less than in primary fibroblasts, a terminally differentiated cell type. 
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(i) 
 
(ii) 
 
 
Figure 4.2 NANOG expression in fMSC and hES cells   
Panel (i) shows the expression of NANOG in two hES cell lines, hEBs, three fMSC 
lines, plus one CONF sample and one sample differentiated to bone.  Mean hES cell 
expression is five fold higher (0.043/0.0083) than that of hEBs and 81 fold higher 
(0.043/0.00053) than the most highly expressing fMSC line (AF MSC).  Panel (ii) 
excludes hES cells from the graph to show more clearly the expression patterns in 
other cells.  NANOG expression in fMSC is not as variable as POU5F1 expression, 
where although AFMSC is almost five fold higher than the other fMSC lines, the 
other three measured are very similar.  The difference in expression of NANOG 
between hES and these three lines is similar to that of POU5F1, at 390 fold 
(0.043/0.00011).  Expression in these three lower expressing lines, fBL12+4, 
fLiv10+4 and fBl8+3 is the same as that found in fibroblasts and in fMSC grown to 
confluence, and much lower (five fold) than that found in cells differentiated to bone 
and in adult PBL. 
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(i) 
 
(ii) 
 
 
Figure 4.3 TERT expression in fMSC and hES cells   
Panel (i) shows the expression of TERT in two hES cell lines, hEBs, three fMSC 
lines, plus one CONF sample and one sample differentiated to bone.  Mean hES cell 
expression is 6.6 fold higher (0.0019/0.00028) than that of hEBs and 45 fold higher 
(0.0019/0.000042) than the most highly expressing fMSC line (fBM12+4).  Panel (ii) 
excludes hES cells from the graph to show more clearly the expression patterns in 
other cells.  TERT expression in fMSC is again very variable between fMSC, as for 
POU5F1, and no pattern exists to distinguish fMSC lines from either their 
differentiated derivatives or primary fibroblasts.   
 
From these results it can be concluded that the expression of pluripotency 
markers POU5F1, NANOG and TERT in fMSC is firstly very low and secondly non-
functional, at least for the functions considered canonical for these transcripts 
(Thomson et al., 1998; Chambers et al., 2003; Loh et al., 2006).  There are vast 
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differences between the expression of each of these genes between undifferentiated 
hES cells and undifferentiated fMSC.  The expression of each marker is shown to 
directly correspond with, and contribute to, the novel pluripotentiality and division 
potential of hES cells, and so expression at a level so vastly decreased from this is not 
indicative of parallel transcript functionality in the other cell types (Brehm et al., 
1997; Chambers et al., 2003; Niwa et al., 2005).  Additionally, the magnitude of these 
expression differences is greater than that between hES and hES differentiated to 
hEBs, the latter of which are characterised by their down-regulation of these markers.   
Differentiation of fMSC, or their growth to confluency, does not cause a 
reduction in transcript levels of any of the genes, and in the cases of TERT and 
NANOG, the level of transcript was increased in the cells differentiated to bone 
compared to every fMSC sample.  The variability of expression levels of TERT, 
NANOG and POU5F1 between the different fMSC cell lines, and the absence of any 
trend linking their expression to cells with different differentiation or growth potential 
(i.e. fMSC compared to fibroblasts) is further indication that the actual level of 
transcript is so low that it can be considered spurious. The lack of expression of so-
called pluripotency markers does not detract from the importance and value of fMSC 
for the treatment of mesodermal diseases such as osteogenesis imperfecta and 
muscular dystrophy, or of injury trauma (Chan et al., 2006; Guillot et al., 2008).   
The transcriptional network active in hES cells to promote a pluripotent, 
immortal phenotype is not active in fMSC.  If fMSC have the capacity to differentiate 
between germ layers, this is facilitated by a separate transcriptional pathway.  The 
differentiation capacity of fMSC should be characterised by appropriate experiments, 
using clonal dilution of the cells.  This is an important experiment, as they are a 
useful and easily grown source of cells.   
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Chapter 5                                            
Comparison of genomic imprinting in fMSC 
and hES cells  
 
 
5.1 The effect of deriving stem cells at different points in 
development 
Both human and mouse embryonic stem cells have been shown to lack normal 
imprinted expression of some genes, expressing certain transcripts biallelically. ES 
cells, like all other cell lines, are grown in artificial culture systems, in carefully 
optimised but imperfect media, resulting in changes in the cells from their phenotype 
in vivo.  ES cells have two additional attributes which may mean they are at an 
increased risk of divergence from an in vivo norm; they are formed through assisted 
reproductive technologies, specifically, high levels of steroid hormone cause 
accelerated maturation of oocytes which are then fertilised.  Secondly, the actual 
point of derivation of an ES cell is during the genome wide reprogramming that 
occurs in embryogenesis and disruption of this process may be detrimental.  The use 
of a different type of cell line, derived from normal conceptions, and later in 
development, enables the distinction of each variable, and may identify whether 
derivation or cell culture is causing aberrant imprinted gene expression.  Fetal 
mesenchymal stem cells are derived later in gestation and from natural conceptions 
and it is hypothesized that these cells harbour a more stable imprinting control than 
hES cells.  Changing the culture medium to unduce differentiation, freeze thawing 
and passaging cells are all part of stem cell culture are likely to have specific effects 
on cell phenotype.   
5.1.1 A comparison of two stem cell types 
Maintaining cells in culture alters their phenotype, changing them them from 
the population from which they were derived in vivo.  In order, to use cultured cells as 
a representative biological model, or in clinical therapy, it is important to know the 
extent and consequences of in vitro adaptation.  The epigenetic status of stem cells, or 
indeed any cells, including their genomic methylation level, chromatin accessibility 
and gene expression profile may be used as phenotypic markers.  Additionally, 
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specialised gene expression pathways, ultimately controlled by chromatin 
accessiblilty and DNA methylation,  reflect a cell’s differentiation capacity, ability to 
self-renew and susceptibility to undergo transformation.   
Genomic imprinting is an epigenetic mechanism which results in parent-of-
origin monoallelic expression of certain genes.  Depending on the gene, it can be 
transient, tissue dependent, polymorphic within a population, or preferential, where 
both alleles are expressed, but one at a significantly higher level.  The mechansims 
controlling imprinted expression are specific to each imprinted gene cluster and 
include a wide range of epigenetic modifyers.  A large number of the imprinted genes 
have been analysed extensively in vivo in both human and mouse tissues, through a 
range of ontological stages.  Parallel analysis of cells grown in vitro can demonstrate 
the extent to which they maintain imprinting, and may also be indicative of their 
overall epigenetic stability.  Disrupted imprinting is also implicated in cell cycle 
defects and tumorigenesis (Hernandez et al., 2003). 
Studies on imprinting in stem cells in the literature to date focus on human 
embryonic stem (hES) cells and find imprinting deregulation to be universal amongst 
cell lines, but in a very gene specific manner.  Some genes, e.g. SNRPN, seem to be 
constitutively monoallelic, others, e.g. SLC22A18 almost always biallelic, whereas 
imprinting of genes such as H19 are susceptible to specific culture conditions and 
passage number (Rugg-Gunn et al., 2005; Kim et al., 2007b; Adewumi et al., 2007).  
hES cells are derived from the blastocyst at a time of genome-wide epigenetic 
remodelling (see Figure 5.1).  It is possible that cell line derivation during this 
sensitive period may render them epigenetically unstable, manifesting, for example, 
in loss of imprinting.  In addition, the variation in the reprogramming stage at which 
the cells were derived is likely to introduce inter-line variation.  To examine these 
questions, the imprinting status of hES cells was analysed alongside another type of 
stem cell, fetal mesenchymal stem cells (fMSC) which are derived much later in 
gestation. 
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Figure 5.1 hES cell derivation during genome remodelling 
hES cells are derived during blastocyst expansion.  This is a point of development 
where the genome is being rapidly remethylated, completing the reprogramming of 
the embryo.  Reprogramming is required to reset the gametic genomes, affording the 
zygote the ability to undergo lineage specification in order to produce a new 
individual.  Cells beginning culture at this point may be prone to epigenetic 
instability.  In contrast, fMSC are derived from the fetus at 7 weeks of gestation, from 
tissues in which lineage specification and genome-wide epigenetic remodelling is 
complete. 
5.1.2 Expression analysis of fMSC and hES cells 
In order to analyse genomic imprinting in the two cell types, it was important 
to first assess whether any of the known imprinted genes were expressed or not.  
Expression was measured semi-quantitatively using RT-PCR, and ‘detectable’ 
expression denoted as the ability to visualise a band stained with ethidium bromide on 
agarose following RT-PCR in the log-linear phase of the PCR (Ferre, 1992).  
Expression in fMSC and hES cells was compared to that of adult peripheral blood 
leukocytes (PBL) and a mix of fetal tissues including placenta, liver and brain.  The 
fetal tissue sample was used as a positive control.  Results for each gene are in 
Appendix I, but examples and summary are shown below (Figure 5.2 and Table 5.1)  
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Figure 5.2 Example of two RT-PCR expression profiles: hChr20, imprinted 
genes GNAS and NESP 
L=100bp Promega molecular weight ladder; BL=no template in PCR; RT-=cDNA 
template prepared with reverse transcriptase omitted; 25-50 = Number of PCR cycles.  
PCRs were carried out in parallel, with both BL and RT- for 50 cycles.  Amplicons 
were visualised on 1.5% agarose gels stained with ethidium bromide.  Imagemaster 
Quant software was used to generate cycle profiles of each reaction, based on the 
intensity of the band (arbitrary units).  Linear part of the reaction is indicated with 
black arrows.  GNAS (NM_000516, 213bp) is universally highly expressed, highest in 
hES cells, then in the mixed fetus.  The lowest expression, although still easily 
detectable at 35 cycles, was in fMSC.  NESP (NM_016592, 288bp) was most 
expressed again in hES cells, albeit at a much lower magnitude, but is barely 
detectable in fetal tissues or fMSC and completely absent in adult PBL. 
 
Following expression analysis genes could be categorised depending on 
whether they were expressed in fMSC, hES or both.  Expression here is denoted as 
the ability to detect amplicons using RT-PCR and sequencing, as these techniques 
were used to measure allelic expression. 
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Gene fMSC cycle hES cycle Gene fMSC cycle hES cycle 
NAP1L5 42 44 KCNQ1OT1 35 40 
ZAC1 42  KCNQ1  43 
CPA4 33 44 IGF2 35 32 
GRB10 37 40 H19 40 33 
PEG10 42 44 GTL2 31  
MEST Iso1 40 45 DLK1  36 
MEST Iso 2 40 33 DIO3   
MESTIT1 45  SNRPN 40 40 
KLF14 43  NDN 30 30 
INPP5F_V2 33 33 ATP10C 33  
PHLDA2 35 40 PEG3  40 
SLC22A18 38 45 NESP  44 
SLC22A1LS 40 40 GNAS 1A 42 42 
CDKN1C 45 41 GNAS 33 37 
Table 5.1 Imprinted gene expression in fMSC and hES cells 
Genes analysed are listed alongside the optimum cycle number for RT-PCR based on 
non-quantitative RT-PCR expression profiles.  Samples of fMSC and hES cells 
consisted of mixes of a selection of each set of cell lines.  Blue boxes in the table 
indicate a lack of detectable expression (i.e. not until 50 cycles or more).  ZAC1 is the 
imprinted isoform. 
5.1.3 Validation of technique to assess imprinted gene expression 
In order to verify that the imprinted expression of genes in stem cells could be 
compared with that in the fetus, imprinting analysis of SLC22A18 was first carried out 
in samples of fetal tissues from first trimester terminations.  In addition, although no 
parental samples were available from any of the stem cell lines, it was important to 
show that the techniques used were capable of identifying parent-of-origin 
monoallelic expression where it was present, so trios of term placental DNA and 
RNA, plus parental DNA were analysed for imprinting of the IGF2 gene. 
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Figure 5.3 Imprinted expression of SLC22A18 in first trimester placenta and 
paternal expression of IGF2 in term placenta 
F in fetal tissue cohort = fetus number.  P in placental cohort = placenta, M= mother, 
F = father.  SLC22A18 expression was analysed in first trimester placenta.  Three 
informative samples are shown, with heterozygous SNPs (A/G) in their DNA, and 
monoallelic expression products.  F289 was informative for both SLC22A18 SNPs.  
All three samples expressed SLC22A18 monoallelically.  IGF2 is expressed 
monoallelically in term placenta, three example trios are shown which were doubley 
informative, firstly for the SNP (T/C) and secondly for parental origin allocation, 
where either the mother (P13, P109), father, or both parents (P53) were homozygous 
for the SNP.  In all samples analysed IGF2 was expressed monoallelically from the 
paternal allele. 
 
 
 
 
 
 
 
 
 
 
 
  122 
5.1.4 fMSC and hES genotyping 
Imperial College London (IC) 
fMSC lines 
Passage 
/Sex 
Kings College London (KCL) 
hES cell lines 
Passage 
/Sex 
Wild type (WT) 3 
WT4 
Cystic fibrosis 
transmembrane conductance 
regulator mutation ΔF508 
(CF) 1 
P41    XY 
P42    XY 
 
 
 
P23    XY 
Sheffield University hES cell 
lines 
 
 
Fetal bone marrow (fBM) 9+4 
(gestational age of nine weeks 
and four days) 
fBM10+4 
fBM12+4 
Fetal blood (fBl) 8+3 
fBl9+1 
fBl11+1 
Fetal liver (fLiv)10+4 
fLiv11+5 
Amniotic Fluid (AF)10 8+4 
Fibroblasts 
 
 
P9       XY 
P11     XX  
P9       ND 
P8       XX 
P4       XY 
P8       XX 
P6       XX 
P12     XY 
P8       ND 
P16     XY                   
SHEF1 
SHEF2 
SHEF4 
SHEF5 
SHEF6 
SHEF7 
P60     XY 
P46     XX 
P43     XY 
P36     XX 
P58     XX 
P56     XY 
Table 5.2 Origin of the cell lines used for imprinting analysis 
ND = Not Done.  fMSC from IC had been dervied from eight terminations, all in the 
first trimester, and were from bone marrow, peripheral blood and liver of fetuses.  All 
were cultured under identical conditions.  KCL hES lines were derived from three 
individuals, and were cultured using manual passage (Pickering et al., 2005).  
Sheffield SHEF lines were available from six individuals, and were cultured on a 
large scale using enzymatic passage.  Sexing was carried out using genomic primers 
specific for the SRY gene, found on the Y chromosome.   
 
Regions of genomic DNA, each including an exonic SNP, were amplified by 
PCR.  DNA from the cell lines was analysed at each of 30 SNPs, summarised in  
Figure 5.4 and Figure 5.5; full genotype analysis can be found in Appendix II.  
Amplicons were either sequenced or digested and run on a gel if the SNP 
corresponded with a restriction endonuclease recognition site.   
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Figure 5.4 Cell line informativity 
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Heterozygous samples carried a different base on each allele at one of the 
polymorphic sites analysed.  They are referred to as informative, based on the 
distinction of mono- and biallelic expression possible following RT-PCR.  There 
were 30 SNPs in total, and the total number of SNPs is plotted against cell line. Mean 
informativity = 9.4 SNPs, mode = 8, median = 9, minimum = 5, maximum = 15. 
 
Each cell line is derived from a different human individual, amongst which 
there is genetic variability.  This is revealed here as variation in informativity, which 
positively correlates with parental genetic disparity.  Some lines, e.g. fBM10+4, 
fLiv10+4 and SHEF4 are particularly informative, whereas others, e.g. SHEF5 and 
SHEF7 are not.   
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Figure 5.5 Informativity according to gene 
No. of cell lines which were informative for the SNP(s) chosen for each gene is 
plotted against the gene.  V2 = INPP5F_V2; A18 (1) = SLC22A18 rs1048046, A18 
(2) = SLC22A18 rs1048047, A1LS = SLC22A1LS, LIT1 = KCNQ1OT1 (rs231357 or 
Msp1), rs7121 = universal GNAS transcript SNP, exonic for GNAS, GNAS EXON 1A 
and GNAS XL.  All imprinted transcripts, except NESPAS, were informative in at least 
one cell line but the genes showed quite a wide variation in informativity, resulting in 
their unequal representation in expression analyses.  Mean = 6 SNPs, mode = 7 and 8,  
max = 12, min = 0  
 
Except the NESPAS transcript on hChr20, exonic SNPs were found to be 
informative in at least one cell line for each of the 27 genes of interest chosen in this 
study.  The differences in informativity between the SNPs in each gene meant that 
data on some of the genes was more comprehensive than others.  Each gene was 
included  nonetheless, but the number of informative samples was taken into account 
when analysing the data. 
5.1.5 Allelic expression analysis in fMSC and hES cells 
Genes which were informative in at least one cell type, and where this 
corresponded with expression, were then analysed using non-quantitative RT-PCR on 
cDNA templates derived from each cell line.  RNA was extracted from fMSC which 
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were undifferentiated and had been maintained at or below 70% confluency and from 
hES cells which were undifferentiated and karyotypically normal.  Amplicons were 
sequenced or digested as for the genotyping.  Results are summarised in Figure 5.6 
and Figure 5.7 but complete analysis of each gene and cell line is included in 
Appendix II. 
5.1.5.1 Allelic expression in fMSC 
(i) 
 
 
(ii) 
 
Figure 5.6. Allelic expression analysis: fMSC 
       = monoallelically expressed          = biallelically expressed.   
(i) No. of genes analysed against cell line.  Each fMSC line displays both mono- and 
biallelic expression of some imprinted genes.  Adult human fibroblast cells are used 
as a control, and show a similar pattern of both mono- and biallelic expression. (ii) 
No. of cell lines analysed against gene, genes are ordered according to their genomic 
sequence, running from NAP1L5 on hChr4 to GNAS EXON1A on hChr20.  ZAC1 is 
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the imprinted P1 isoform, V2 = INPP5F_V2; A18 = SLC22A18, both SNPs are 
pooled*, A1LS = SLC22A1LS, LIT1 = KCNQ1OT1, rs231357 (Msp1) and rs231359 
(Sac1) SNPs are pooled*.  Certain genes are invariably either monoallelic or biallelic 
in fMSC.   A subset show variable expression between cell lines.  The overall ratio of 
biallelic to monoallelic SNPs is 3:4 respectively.  *Except where informative samples 
overlapped. 
 
According to the gene, variation in expression shows a specific pattern.  Some 
genes are universally monoallelic, others always biallelic, the remainder show 
variable expression between mono- and biallelic depending on the cell line.  More 
imprinted genes are monoallelically expressed in the fMSC lines than are biallelic, 
with a total count of 38 monoallelic SNPs and 31 biallelic SNPs, a ratio of almost 3:4.  
There is inter-cell line variation but it is minor and not indicative of certain cell lines 
being more susceptible to biallelic expression of imprinted genes.  Primary fibroblasts 
showed the same gene-specific pattern of expression as the fMSC.  The minor inter-
cell line variation is a result of the allelic expression character of the genes which 
happened to be informative in each cell line (see Table 5.3 below).  In effect, these 
observations indicate that if all cell lines analysed were informative for the same 
genes, their overall expression profile would be identical. 
An example comparison of two fMSC lines both derived from liver 
Cell line fLiv10+4 fLiv11+5   
Overall status of gene 
expression (Mono:Bi) 
Predominately monoallelic 
(6:2) 
Predominately biallelic 
(4:7) 
Genes informative and expressed 
Always Biallelic SLC22A18 SLC22A18, CPA4, 
GRB10, IGF2, GNAS 
Biallelic where variable NAP1L5 MEST Iso2, SLC22A1LS 
Monoallelic where variabl MEST Iso1, SLC22A1LS MEST Iso 1 
Always monoallelic INPP5F_V2, KCNQ1, 
H19, NDN 
KLF14, CDKN1C, 
EXON1A,  
Table 5.3 Comparison between fMSC line expression status 
fMSC line fLiv11+5 displays predominately biallelic expression of imprinted genes, 
at a ratio of four monoallelic genes to seven biallelic genes.  This is due to the high 
number of genes which happen to be informative in fLiv11+5 which are always found 
to be biallelic.  This is in contrast to fLiv10+4, which exhibits a majority of 
monoallelic expression, at a ratio of six monoallelic genes to two biallelic ones.  
fLiv10+4 is only informative for one of the genes which are always biallelic 
(SLC22A18), but is informative for four of the genes which are always monoallelic.  
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Perhaps the most interesting comparisons are between the lines for genes which 
exhibit variable expression (see section 5.1.7). 
 
The analysis of imprinting in fetal tissues of an equivalent ontological age to 
fMSC has been previously characterised within our lab (Bentley et al., 2003; Monk et 
al., 2006a; Monk et al., 2006b).  It is important to note that several of the genes which 
are expressed biallelically in fMSC have a tissue-specific pattern of imprinting, i.e. 
GNAS is only imprinted in kidney and GRB10 only in brain, so are likely to already 
be biallelic in bone marrow blood or liver before fMSC derivation.  
5.1.5.2 Allelic expression in hES cells 
(i) 
 
(ii) 
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Figure 5.7. Allelic expression analysis: hES cells 
       = monoallelically expressed          = biallelically expressed.   
(i)No. of informative genes analysed against cell line.  Similarly to the fMSC, most 
hES cell lines display both mono- and biallelic expression of some imprinted genes.  
(ii) No of cell lines analysed against gene, ordered by genomic sequence.  ZAC1 is the 
imprinted P1 isoform, V2 = INPP5F_V2; A18 = SLC22A18, both polys are pooled, 
A1LS = SLC22A1LS, LIT1 = KCNQ1OT1, rs231357 (Msp1) and rs231359 (Sac1) 
SNPs are pooled.  Certain genes are invariably either monoallelic or bialleic in hES 
cells.   A subset show variable expression between cell lines.  The overall ratio of 
biallelic to monoallelic SNPs is 1:2 
 
 
The trend seen in the fMSC of variation in expression between genes but not 
between cell lines is mirrored in the hES cells.  Table 5.4 below outlines the contrast 
between the genes informative in WT4, which appears to maintain monoallelic 
expression, and SHEF5, which is always biallelic.     
Cell line WT4 SHEF5   
Status of gene expression  Monoallelic Biallelic 
Genes informative and expressed 
Biallelic where variable  DLK1, GNAS 
Monoallelic where variable MEST Iso2  
Always monoallelic INPP5F_V2, CDKN1C  
Table 5.4 Comparison between hES line expression status 
The two genes informative in SHEF5 were variable, but for WT4, two of the 
informative genes were universally monoallelically expressed, with just one being 
monoallelic where variable. 
5.1.6 Comparison of allelic expression between fMSC and hES cells 
The patterns of allelic expression in fMSC and hES cells were very similar.  
Whether a gene was monoallelic or biallelic depended in almost all cases on the gene 
not the cell line.  The only exception was IGF2 expression, which was preferential, 
but biallelic in fMSC, and monoallelic in hES cells. 
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Figure 5.8 Allelic expression of IGF2 in fMSC and hES cells 
Sequence traces from genotyping and RT-PCR products in cell lines informative for 
the IGF2 rs680 polymorphism.  Products were sequenced in both forward and reverse 
with the same result (data from only the reverse sequence shown).  Amplicons from 
fMSC samples were also digested with the ApaII restriction endonuclease.  IGF2 
expression was monoallelic in hES cells, but consistently showed low level 
expression from the second allele in fMSC lines, using both sequencing and digest 
analyses.   
 
There is a subtle difference between the allelic expression of IGF2 in fMSC 
and hES cells.  There were a total of four informative samples available, so it is 
difficult to ascertain whether this difference is due to polymorphic imprinting, known 
to result in biallelic IGF2 in 10 % of the white European population, or to differences 
inherent between fMSC and hES cells (Sakatani et al., 2001).  Expression of H19 
was, conversely, variable in hES cells, where one sample was found to be biallelic 
(CF1), but always monoallelic in fMSC.  There were no other distinctions in allelic 
expression for any gene in hES cells and fMSC, indicating that the integrity of their 
imprinted gene expression is not dramatically different.  Comparing the total number 
of biallelic to monoallelic SNPs for each cell type gave ratios of 3:4 and 1:2 for fMSC 
and hES cells respectively, indicating a slightly increased ration of biallelic 
expression in the fMSC compared to the hES cells.  This trend is attenuated by the 
increased proportion of  always-biallelic SNPs informative in the fMSC.   
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Variation of allelic expression between hES cell lines was less than between 
fMSC lines, where the standard deviation of the difference in monoallelic to biallelic 
expression between the lines was 2±0 for the hES cells but 2±1.7 for fMSC.  fMSC 
lines were from several different gestational ages, and three different tissues and as 
such may each represent slightly different populations.  Their use as a comparision 
for derivation from a point during ontogeny where no epigenetic remodelling is 
occuring still stands.  The data therefore indicate that the impact of derivation at 
different points during preimplantation genome remodelling on the epigenetic 
comparability of hES cells is low, as the variation between lines is not any more than 
for fMSC, all derived after remodelling is complete. 
The analysis was limited by availability of informative samples, and so 
distinctions may exist that were below the limits of detection.  Epigenetic 
dysregulation was present in both cell lines, and the common profile exhibited by the 
two indicates that a lack of imprint integrity is not due to the fact that hES cells are 
derived from a blastocyst undergoing epigenetic remodelling, but entirely due to in 
vitro cell culture. 
5.1.7 Analysis of variably expressed genes 
There is a variation in the susceptibility of the imprinted genes analysed in 
their ability to maintain monoallelic expression.  Three classes of genes have been 
revealed:   
 Always monoallelic  
 Always biallelic  
 Variable between lines 
The genes which are always monoallelic may be said to be stable in an in vitro 
environment, maintaining their monoallelic status.  Genes which are always biallelic 
are most susceptible to in vitro culture, and as their status is invariant amongst the 
lines tested, it is likely they become biallelic upon derivation.  Genes which vary 
between cell lines are intermediately sensitive to cell culture, and may reveal interline 
variation in epigenetic stabililty.   
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Figure 5.9 Allelic expression per gene, combining fMSC and hES cell data 
       =Monoallelically expressed           = Biallelically expressed.  The distribution of 
genes displaying always monoallelic, variable and always biallelic gene expression is 
approximately 3:2:1. The ratio of total biallelic to monoallelic SNPs is approximately 
2:3 (43:63), but the increased level of informativity in several of the biallelic and 
variable genes (e.g. A1LS, GNAS and A18) results in their over-representation. 
Approximately one-third of the analysed imprinted genes displayed variable 
expression which was dependent on the cell line.  This was in contrast to the majority 
of allelic expression analysed, which varied according to the gene.  Expression data 
from both categories of genes is summarised in Table 5.5, combining the results from 
both fMSC and hES cells.   
Monoallelic  (informative samples)  Biallelic  (informative samples) 
    
ZAC1    (2)   CPA4   (4) 
INPP5F_V2  (8)   GRB10  (4) 
PEG10  (4)   SLC22A18  (9) 
MESTIT1  (1)   ATP10C  (2) 
KLF14   (3)   PHLDA2  (1) 
GTL2   (1) 
CDKN1C  (4)   Variable      (Mono+Bi)        
KCNQ1OT1  (4)    
KCNQ1  (3)   NAP1L5  (1+3) 
SNRPN  (4))   MEST Isoform 1 (3+1) 
NDN   (7)   MEST Isoform 2 (1+2) 
PEG3   (1)   SLC22A1LS  (4+5) 
GNAS EXON1A (4)   IGF2   (2+2)  
      H19   (5+1) 
      DLK1   (1+3) 
      GNAS   (1+7) 
Table 5.5 Summary of allelic expression in the combined cell lines  
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Data from both fMSC and hES are combined, and shown graphically in Figure 5.9.  
The majority of imprinted genes (approximately 2/3) are monoallelically expressed in 
fMSC and hES cells.  Three genes are uniformly biallelic in all cell lines investigated.  
The remaining 1/3 exhibit a variable expression, where in some cell lines they are 
monoallelic, but in others biallelic. 
To detect differences between cell lines in expression of the genes which were 
variable, genes which where invariably monoallelic or biallelic were excluded from 
the next set of analyses.  Genes which were variable were categorised according to 
the cell lines analysed, and whether expression in the cell line was monoallelic or 
biallelic.  
BM9+4 BM10+4 BM12+4 Bl8+3 Bl11+1 Liv10+4 Liv11+5 
NAP1L5 
SLC22A1LS 
 MEST Iso1 
MEST Iso2 
H19  H19 
MEST Iso1 
SLC22A1LS 
MEST Iso1 
 MEST Iso1 
MEST Iso2 
SLC22A1LS 
GNAS 
SLC22A1LS 
NAP1l5 
A1LS 
IGF2 
NAP1L5 NAP1L5 GNAS 
MEST Iso2 
SLC22A1LS 
IGF2 
CF1 SHEF1 SHEF2 SHEF4 SHEF5 SHEF6 Fibro 
DLK1 
SLC22A1LS 
GNAS 
H19 H19    SLC22A1LS 
H19 GNAS DLK1 
GNAS 
DLK1 
SLC22A1LS 
DLK1 
GNAS 
GNAS GNAS 
Table 5.6 Comparison of allelic expression of variable genes 
        = Monoallelically expressed         = biallelically expressed.  Genes which did not 
vary in allelic expression status between lines were excluded from this analysis.  Each 
line was analysed compared regarding their allelic expression of the variable genes.  
Two fMSC lines (BM10+4 and Bl11+1), and three hES lines, SHEF4, SHEF45 and 
SHEF6 were biallelic in all cases, and just one line fBM9+4, was always monoallelic.  
Cells derived from all three fMSC tissues were a mix of expression patterns and could 
be either always monoallelic, always biallelic or a mix of the two.  There was no 
trend according to gestational age of the fetus.  For the hES cells, no difference was 
detected between cells grown in Sheffield and those from KCL. 
 
Aside from differences in allelic IGF2 expression (Figure 5.8), there were no 
other specific trends distinguishing fMSC from hES cells.  NAP1L5 and MEST 
Isoforms 1 and 2 were not expressed in hES cells, whereas DLK1 was not expressed 
in fMSC.  There was no bias for monoallelic or biallelic expression according to the 
fMSC tissue of origin, i.e. fBM9+4 was always monoallelic, fBM10+4 always 
biallelic and fBM12+4 a 50:50 mix of the two.  There was also no pattern according 
to gestational age of the fetus from which the lines were derived, with a mix of 
biallelic and monoallelic expression seen across the range of 8 weeks up to 12.  The 
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hES cells were from two different laboratories, Kings College London and Sheffield 
University, each growing and deriving cells under slightly different conditions.  No 
difference was observed between the lines from the different laboratories.  
Allelic expression of DLK1 and GNAS appeared to be linked, i.e. allelic 
expression of each was mirrored by the other where commonly informative.  
Expression of DLK1 also mirrored that of SLC22A1LS, but SLC22A1LS expression 
varied from that of GNAS.  In the two samples where SLC22A1LS and IGF2 were 
informative, they also appeared to be linked.  Surprisingly, where both H19 and IGF2 
are informative (for fBl8+3) H19 is monoallelic but IGF2 biallelic.  No other patterns 
of allelic gene expression between genes were observed.    
5.1.8 Epigenetic variation within cell lines 
So far in this study, analyses have been limited to undifferentiated sub-
confluent fMSC and undifferentiated, karyotypically normal hES cells.  In some 
cases, cells were available from different stages during their growth in vitro.  RNA 
was extracted additionally from fMSC which had been left to reach confluency and 
then cultured at this density without passage for four weeks, denoted fMSC CONF.  
This treatment vastly reduces the cells’ potential, both for differentiation and self 
renewal (Guillot et al., 2006a).  hES RNA was available from the KCL lines from 
cells which had been differentiated to embryoid bodies, denoted hES EB, which 
consist of cells from all the three germ layers and are no longer pluripotent.  SHEF 
cell lines were available from a large range of different passages, which when high 
was accompanied by karyotypic alterations, denoted SHEF high passage (HP): 
SHEF4, passage (P)104 16% trisomy 17; SHEF1, P121 10% trisomy 3, 90% del 2(q). 
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Figure 5.10 Comparison of informative mono- and biallelic transcript expression 
between normal and confluent fMSC lines 
        = Monoallelic expression           = biallelic expression.  A selection of fMSC line 
cultures were grown to confluency, and are denoted as fMSC CONF.  As only some 
of the genes informative in each cell line were analysed in the CONF samples, only 
those measured in both samples were compared.  The proportion of monoallelic and 
biallelic transcripts as a percentage of the total number of SNPs (e.g. N=3) analysed is 
plotted, with the cell line on the x-axis. i.e. for fLiv10+4, a total of 3 SNPs were 
analysed in both the sub-confluent and the confluent samples.  In both samples two of 
the three SNPs (i.e. transcripts) were monoallelic, and the other biallelic.  No 
differences were observed in any of the lines between expression in undifferentiated, 
sub-confluent fMSC compared to their confluent counterparts. 
 
 
Figure 5.11 Comparison of informative mono- and biallelic transcript expression 
between undifferentiated hES cells and EBs 
       = Monoallelically expressed         = biallelically expressed.  A selection of hES 
cells differentiated to embryoid bodies (EB) were available.  The proportion of 
monoallelic and biallelic transcripts as a percentage of the total number of SNPs (e.g. 
N=6) analysed is plotted, with the cell line on the x-axis. i.e. for CF1, 6 SNPs were 
analysed in both the undifferentiated cells and EB samples.  In both samples there are 
three SNPs (i.e. transcripts) expressed monoallelically, and three biallelically. One 
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gene, GNAS, becomes biallelic upon differentiation to embryoid bodies.  No 
differences were observed in the WT4 hES line. 
 
Figure 5.12 Comparison of allelic expression between low and high passage hES 
cells 
Monoallelic expression: SHEF1; SHEF2; SHEF4; Biallelic expression.  There are no 
allelic expression differences between low passage and high passage cells in these 
three cell lines.  The difference between SHEF2 lines is only 13 passages however 
SHEF1 and SHEF4 are  both compared with cells around 100 passages on, in both 
cases of which harbour karyotypic abnormalities.   
 
Overall the different conditions in which the cells were cultured, of high 
passage number, differentiation and growth under sub-optimal (confluent) conditions, 
has not altered the allelic expression profiles of these cells.    The purturbation of 
allelic expression of some genes seems inherent in cultured cells.  In the same way 
that some genes are robust and others variable according to cell line, it is likely that 
certain genes may be sensitive to culture conditions.  Certain variations in culture 
environment have been shown to have profound effects on hES cell gene expression 
patterns (Allegrucci et al., 2007).  Genes which have been found here to be robustly 
monoallelic, or variable, may become biallelic if subjected to specific insults, for 
example H19 has been shown to become biallelic at high passage (Rugg-Gunn et al., 
2005).   
5.2 Differentiation of fMSC 
 
Before stem cells may be used in therapy, they are standardly differentiated to 
the cell type required.  fMSC readily differentiate into osteoblasts, adipocytes, 
chondrocytes and myocytes.  They are potentially a valuable cell resource for 
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regenerative therapy in disease or injury involving the mesoderm.  Genomic 
imprinting is known to be highly tissue specific in certain genes, and to change 
dynamically during ontogeny.  Tissue specific imprinted expression may be 
represented by either 
 
 Expression which is always monoallelic but restricted to certain tissues 
 Expression which may be monoallelic or biallelic, depending on the 
tissue/cell lineage, but consistent within that tissue/cell lineage 
 
To further investigate the lack of imprinting of some genes found in fMSC, 
the cells were differentiated to bone and fat, and expression and imprinting of certain 
imprinted transcripts analysed.  Samples of each differentiation culture were stained 
to detect deposits of minerals in bone differentiation and lipid droplets in the fat 
cultures. 
 
Figure 5.13 Differentiation of fMSC to bone and fat 
Each cell line underwent differentiation to varying extents, but all showed evidence 
of lipid deposition during adipogenic culture, and calcium deposition during 
osteogenic culture.  Von Kossa staining (silver nitrate) was used to stain calcium 
deposits, seen above as dark brown or black staining and Oil red ‘O’ to stain lipid 
droplets red.  fMSC differentiation was carried out by Dafni Moschidou at the 
Institute of Reproductive and Developmental Biology, Imperial College London. 
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 The four imprinted genes chosen for analysis in differentiated derivatives of 
fMSC were PEG10, KCNQ1OT1, SLC22A18 and DLK1.  PEG10 is expressed early 
in adipogenesis, during the accumulation of lipid by  preadipocytes (Hishida et al., 
2007).  It is required to modulate expression of the adipogenic CCAAT/enhancer-
binding protein α, (C/EBPα)  and clonal expansion of the differentiating cells 
(Hishida et al., 2007).  The mechanism of PEG10 upregulation during adipogenesis is 
unknown, and may be related to loss of allelic expression.  PEG10 was found to be 
robustly monoallelically expressed in undifferentiated fMSC, so its expression in 
differentiated cells was analysed.  KCNQ1OT1 was also found to be universally 
monoallelic in the cell lines, but expressed biallelically in a population of 
differentiated cells - adult peripheral blood leukocytes.  It was therefore interesting to 
analyse allelic expression of KCNQ1OT1 in other differentiated tissues.  SLC22A18 
was universally biallelic in cultured cells and its expression status in osteoblasts and 
adipocytes is unknown.   
DLK1 regulates differentiation of adult MSC, and is widely expressed during 
fetal development.  Human uniparental disomy 14, resulting in DLK1 deficiency, is 
associated with obesity, hypotonia, and short stature (Berends et al., 1999).  Mice 
harboring DLK1 mutations exhibit growth retardation, obesity, skeletal malfomations 
and abnormal haematopoiesis (Moon et al., 2002).  These mesodermal pathological 
phenotypes are each consistent with a role for DLK1 in the formation of bone and fat.  
DLK1 expression maintains MSC in an undifferentiated state, and is down regulated 
upon differentiation to bone or fat (Abdallah et al., 2004; Abdallah et al., 2007).  
DLK1 was not detected in the fMSC used for expression analyses, however, 
the samples used for differentiaton were at an earlier passage, which has been shown 
to positively correlate with potential, and thus may express more DLK1 (Bonab et al., 
2006).  The expression of DLK1 was measured in a mix of early passage 
undifferentiated cells and compared to derivatives differentiated to the osteoblast and 
adipocyte lineages;  a sample of mixed fetal tissues was used as a positive control. 
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Figure 5.14 Expression profile of DLK1 in differentiated fMSC 
L = 100bp molecular weight ladder, BL = no template control, RT- = parallel cDNA 
sample produced without reverse transcriptase, 35, 40 and 45 denote the cycle 
number at which the PCR reaction was stopped.  DLK1 is expressed in mixed fetal 
tissues, and easily detectable from PCR cycle 35.  It is not expressed in 
undifferentiated fMSC or fMSC differentiated to adipocytes.   A very faint band is 
visible at 40 and 45 cycles in fMSC differentiated to osteoblasts.   
 
DLK1 was not detected in low passage undifferentiated fMSC, although a 
faint product was visible in the reaction using cDNA from fMSC differentiated to 
osteoblasts.  This indicates that there was a slight increase in the DLK1 transcript 
levels upon differentiation to osteoblasts, however the expression was not sufficient 
to allow further analysis. KCNQ1OT1, PEG10 and SLC22A18 are expressed in 
undifferentiated fMSC, so each line was genotyped for exonic SNPs in these three 
genes. 
 
 
 
Genotyping 
SLC22A18 
Sample Passage 
PEG10 
rs1048046 rs1048047 
KCNQ1OT1 
Tissue Diff. 
period 
(days) 
RNA 
ug/ul 
UND   
FAT #1 39 1.0 
fBM10+4 P5  
HET 
 
G 
 
HET 
 
A 
FAT #2 39 0.4 
UND   
BONE 43 1.3 
fBl8+3 P6  
HET 
 
HET 
 
A 
 
G 
FAT 36 1.2 
UND   
BONE 43 0.8 
fBl9+1 P4  
C 
 
G 
 
A 
 
HET 
FAT 43 1.0 
UND   
BONE 36 1.4 
fBl9+4 P5  
HET 
 
G 
 
HET 
 
A 
FAT 36 1.4 
UND   
BONE 39 1.7 
fBl11+1 P5  
T 
 
G 
 
HET 
 
HET 
FAT 39 1.5 
UND   
BONE 43 1.0 
fLiv11+5 P6  
T 
 
G 
 
HET 
 
A 
FAT 43 1.2 
Table 5.7 Genotyping of fMSC lines differentiated to bone and fat 
Six lines were available for differentiation to bone and fat and were genotyped with 
respect to PEG10, SLC22A18 and KCNQ1OT1.  Each line was informative for at 
least one of the three genes, and each gene was informative in at least two lines.  
Differentiation was carried out over approximately 40 days and RNA extracted from 
differentiated cultures 
 
 Allelic expression from each of the differentiated cell lines was analysed and 
compared to that from the undifferentiated cell lines.  The expression of each of the 
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three analysed genes was maintained through differentiation.  RT-PCR amplicons 
from informative samples were sequenced and monoallelic or biallelic expression 
designated according to the peaks visible at the polymorphic site in the sequence trace 
(data not shown). 
Gene Cell line Undifferentiated Fat Bone 
fBL9+4 M M M 
fBM10+4 M M ND 
PEG10 
 
fBL8+3 M M NOT EXP 
fBM10+4 B B (#1 and 2) ND 
fBL8+3 B B B 
fBL11+1 B B B 
SLC22A18 
fBL11+5 B B B 
fBL9+1 M M M KCNQ1OT1 
fBL11+1 M M M 
Table 5.8 Allelic expression analysis of differentiated fMSC 
M=monoallelic, B=biallelic, ND=Not Done, NOT EXP, expression of PEG10 in two 
of three bone differentiated samples could not be detected.  Allelic expression of 
PEG10, SLC22A18 and KCNQ1OT1 was not altered by differentiation of informative 
fMSC lines to bone and fat.   
 
The biallelic expression of certain imprinted transcripts has been shown in 
undifferentiated fMSC from a range of fetal origins, and seems to be inherent.  
Differentiation of fMSC to the mesodermal lineages of osteoblasts and adipocytes is 
likely to be an important step in their development for use in regenerative therapy.   
These results show that in vitro differentiation of fMSC to either cell type does not 
result in a change of allelic expression of three imprinted genes.  This further 
confirms that loss of imprinted expression of certain imprinted genes is an inherent 
feature of cultured cells.  Importantly, differentiation culture, which puts additional 
selective pressures on the cells, does not seem to result in additional dysregulation of 
imprinting.  The execution of ‘normal’ tissue-specific imprinting in cells 
differentiated in-vitro is likely to be one of the challenges of differentiation culture. 
 
The comparison of imprinting in fMSC and hES cells has shown that as far as 
could be analysed here, aberrant imprinted expression was found in both types of cell 
and was not more prolific in one cell type than the other.  This means that the 
derivation of hES cells from ART embryos at a sensitive time point does not increase 
the prevalence of biallelic expression of imprinted genes.  The number of cell lines 
analysed here is relatively few, and it will be important to extend this study to include 
more hES cell lines and non-hES cell lines to test the hypothesis absolutely.  
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Imprinted expression was not altered after differentiation of fMSC or by culturing 
hES cells over a longer passage or through freeze-thaw cycles, although a more 
extensive analysis may induce changes in the cells   
 
 
5.2.1 Summary 
 
 Culturing human fetal mesenchymal stem cells and hES cells disrupts their 
imprinted gene expression. 
 
 The extent and pattern of imprinting disruption is not increased by the 
derivation of stem cell lines during pre-implantation epigenetic reprogramming 
i.e. of hES cells from blastocysts. 
 
 Differentiating human fetal mesenchymal stem cells to bone and fat does not 
change the pattern of imprint disruption. 
 
 The regions subject to disruption by cell culture do not share common parental 
origin of expression, parental origin of methylation, common expression 
profile, imprint control mechanism (i.e. histone modification, ncRNA 
expression) or genomic location. 
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Chapter 6                                            
Methylation at imprinting control regions in 
fMSC and hES cells  
 
6.1 Imprinted gene expression is controlled by allelic DNA 
methylation 
Given that aberrant imprinted genes expression was observed the the fMSC and hES 
cell models, there must be a transcriptional effector which is adversely influenced by 
the cell culture environment.  As imprinted expression is controlled by allelic DNA 
methylation, it is likely that biallelic expression is caused by either a loss of DNA 
methylation, or a gain of methylation on both alleles – depending on the locus in 
question. 
6.1.1 Imprinting and methylation 
The control of genomic imprinting is intricately linked with DNA methylation 
(Li et al., 1993).  Germline methylation at specific loci set up regulatory networks for 
the monoallelic expression of imprinted genes.  The methyltransferases DNMT3a and 
DNMT3L work in concert to establish these methylation patterns, and the removal of 
either from mouse embryos results in the abolition of imprinting in these animals 
(Bourc'his et al., 2001; Kaneda et al., 2004).   
Differentially methylated regions (DMRs) are methylated on one allele but not 
the other.  The presence of DNA methylation usually corresponds with a lack of 
transcription from that region due to the recruitment of chromatin condensation 
complexes by methyl binding proteins (Jones et al., 1998; Nan et al., 1998).  The 
regulation of imprinted clusters is often quite complex, and methylation does not 
necessarily correspond with suppression.  Where a DMR corresponds with a promoter 
of one of the cluster transcripts, that gene will be repressed on the methylated allele.  
At some imprinted domains, however, such as the KCNQ1 region on hChr11, the 
expression of a ncRNA molecule from the unmethylated allele results in repression of 
other genes in cis, so in fact the majority of imprinted transcripts from that cluster are 
expressed from the methylated allele (Fitzpatrick et al., 2002).  As previously 
decribed (Table 1.3 in Chapter 1, Introduction) The creation of transgenic mice 
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lacking known DMRs has identified several of them as ‘imprint control regions’ 
(ICRs). 
In the human, the disruption of allelic ICR methylation, which may involve 
either a loss or a gain of overall methylation, can result in several different imprinting 
syndromes.  Ten percent of the fetal overgrowth disorder, Beckwith Wiedemann 
Syndrome (BWS) cases are caused by methylation changes at IGF2/H19 (ICR1), and 
40-50 % by loss of methylation at the KvDMR (ICR2) (Elliott and Maher, 1994).  As 
many as half of all Silver Russell syndrome (SRS) cases are due to methylation 
defects at ICR1 (Abu-Amero et al., 2008).  Mutation of the ICR sequence can result 
in the inappropriate setting of methylation during gametogenesis.  Two percent of 
Prader-Willi syndrome (PWS) and 8 % Angelman syndrome (AS) cases are caused 
by mutation of the paternal (unmethylated) and maternal (methylated) ICRs 
respectively (Buiting et al., 1995; Saitoh et al., 1996).  The genome-wide disruption 
of methylation during cancer development often results in the biallelic expression, or 
repression, of imprinted genes notably IGF2, a potent growth enhancer  (Cui et al., 
2003).  Children affected by BWS caused by loss of methylation at IGF2/H19 are 
also highly likely to develop Wilm’s tumour (Rump et al., 2005; Weksberg et al., 
2001) 
Cells growing in culture often display changes from the cell population from 
which they were derived, commonly involving methylation (Bibikova et al., 2006).  
Prolonged culture growth, and stress put on the cells during cryopreservation or 
passaging can result in the accumulation of induced methylation changes (Maitra et 
al., 2005).  Where methylation changes correspond with ICR methylation, concurrent 
loss of imprinting can occur.  Murine ES cells display widespread loss of imprinting, 
which is correlated with a loss of appropriate allelic methylation (Dean et al., 1998; 
Humpherys et al., 2001).  Changes in methylation are often locus specific, indicating 
that there are regions prone to disruption, but others which are more robust.  
Disruption of imprinting of IGF2/H19 of primate ES cells was found to correlate with 
hypermethylation of the CTCF binding site, whereas maintained imprinting of 
SNRPN was consistent with the maintenance of the DMR (Mitalipov et al., 2007).   
Data on human ES cells reveals one set of genes whose allelic expression can 
be correlated with ICR methylation status, and a second for which both expression 
and methylation vary between different cell lines independently (Kim et al., 2007b).  
Methylation status of  KvDMR, PEG3, NESP55 and SNRPN (PWS/AS-IC) DMRs 
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correlated with allelic expression in hES cell lines, whereas status of the MEST DMR 
and IGF2 DMR2 did not (Kim et al., 2007b).  In another study, biallelic expression of 
H19 was observed following prolonged passage, but was associated with DMD 
hypermethylation, the opposite of what would be expected normally (Rugg-Gunn et 
al., 2005). 
In the present study, a gene specific loss of imprinting has been observed.  
This loss of imprinting could be due to changes in methylation at differentially 
methylated ICRs.  To investigate whether this was the case, methylation at DMRs of 
the MEST, PEG10, IGF2, KCNQ1, SNRPN, PEG3, and GNAS imprinted gene 
clusters was analysed.  Combined bisulphite and restriction analyses (COBRA) were 
used to quantify allelic methylation, followed by bisulphite sequencing to measure 
bisulphite conversion and the methylation status of each CpG in the region analysed. 
 
Figure 6.1 Combined bisulphite and restriction analysis (COBRA) 
Combined bisulphite and restriction analysis (COBRA) uses bisulphite treatment and 
endonuclease recognition to distinguish methylated and unmethylated DNA.  
Genomic DNA is incubated with sodium bisulphite, resulting in the conversion of 
unmethylated cytosines to thymines, and then amplified using bisulphite-specific 
primers for the region of interest.  The inclusion of a CpG dinucleotide containing-
restriction enzyme recognition site (e.g. TCGA) into the amplicon, allows the semi-
quantitative resolution of methylated and unmethylated alleles by size following 
digestion by the restriction enzyme. (i) PCR product prior to incubation with enzyme, 
then (ii), (iii) and (iv) after incubation: (ii) completely unmethylated region; (iii) fully 
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methylated region; (iv) region containing equal amounts of methylated and 
unmethylated DNA – a candidate DMR. 
 
The COBRA technique allows estimation of the ratio of methylated to 
unmethylated alleles (Xiong and Laird, 1997).  It only allows analysis of one or two 
CpG dinucleotides per assay, however, so to measure the extent of methylation 
throughout the whole region, the PCR amplicon may be cloned and sequenced.  
Bisulphite sequencing additionally permits estimation of the efficiency of bisulphite 
conversion.  However, bias during ligation and colony growth for PCR products 
representing methylated or unmethylated DNA cannot be controlled for, so 
sequencing does not necessarily give an accurate ratio of each type of DNA.   
6.1.2 The MEST region DMR 
The genes of the MEST cluster analysed were CPA4, KLF14, MESTIT1 and 
both MEST isoforms and they displayed a mixed pattern of allelic expression.  
MESTIT1 and KLF14 were monoallelic in all cell lines analysed.  CPA4 was 
uniformly biallelic but the MEST isoforms displayed a polymorphic pattern of 
imprinting, see Table 6.1. 
 
CPA4 Allelic expression MEST ISOFORM 1 Allelic expression 
fBl9+1 Biallelic fBM10+4 Biallelic 
fLiv11+5 Biallelic fBM12+4 Monoallelic 
CF1 Biallelic fLiv10+4 Monoallelic 
SHEF1 Biallelic fLiv11+5 Monoallelic 
    
MESTIT1  MEST ISOFORM 2  
fBM12+4 Monoallelic fBM10+4 Biallelic 
  fBM12+4 Monoallelic 
KLF14  fLiv11+5 Biallelic 
fBM12+4 Monoallelic   
fLiv11+5 Monoallelic   
Table 6.1Results of allelic expression analysis of the MEST cluster 
Results of allelic expression analysis (Chapter 2) indicating whether expression of 
each of the transcripts analysed was biallelic or monoallelic in informative cell lines.  
CPA4 was universally biallelically expressed, whereas MESTIT1 and KLF14 were 
monoallelic.  MEST Isoform 1 was mostly monoallelic but was biallelic in one fMSC 
sample, whereas MEST isoform 2 was biallelic in two samples and monoallelic in 
one. 
 
The MEST DMR is a germline, maternally methylated CpG island located 
within the MEST promoter (Lefebvre et al., 1997).  MEST Isoform1, 2, MESTIT1 and 
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KLF14 are expressed from the paternal, unmethylated allele, and a loss of 
methylation may be expected to result in biallelic expression of these genes.  CPA4 is 
maternally expressed, and methylation on both alleles could be expected to result in 
biallelic expression. 
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Figure 6.2 Analysis of methylation at the MEST DMR 
(i) COBRA analysis of the MEST DMR, visualised on ethidium bromide stained 
agarose.  MEST DMR bisulphite PCR product 227 bp, full digestion with Taqα1 
restriction enzyme (methylated DNA) results in fragments of 98 bp, 101 bp and 21 
bp.  Each cell line appears to have maintained differential methylation at the MEST 
DMR (ii) Quantitation of (i) using ImageMaster 1D Prime software V.2.01.  Black = 
methylated, Grey = unmethylated.  The 98 and 101 bp fragments overlaid each other 
on the gel, and the 21 bp band was not detected, so ratios of the approx 100 bp 
(methylated) and 227 bp (unmethylated) bands were measured. The ratio of 
methylated to unmethylated alleles was uniformly approximately 1:1.  (iii) Bisulphite 
sequence analysis of the same PCR products, showing individual CpG dinucleotides 
represented by circles. Open circles represent unmethylated CpGs; filled circles, 
methylated CpG.  The number of clones analysed is shown in brackets, at a ratio of 
unmethylated to methylated strands.  Both unmethylated and methylated alleles are 
present in each of the three cell lines analysed.  C to T conversion rate was high, 
between 96 and 99 %.  Of the 18 CpGs in the sequence, in any given strand almost all 
are either unmethylated or methylated.  Human term placenta is used as a control.  
There is a slight bias towards methylated alleles using this technique.  
 
 Each cell line appears to have maintained differential methylation of the 
MEST DMR.  The polymorphic imprinting of MEST and biallelic expression of CPA4 
is therefore not explained by methylation defects.  Notably, the fMSC line fBM10+4, 
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which expressed both MEST isoforms biallelically, shows no aberrant methylation by 
either COBRA or sequencing, indicating that the loss of imprinting seen in this cell 
line is due to a loss of other control mechanisms, such as allelic histone methylation. 
6.1.3 The IGF2/H19 region DMRs 
 
Analysis of allelic expression of IGF2 found it to be monoallelic in hES cells 
(informative lines SHEF1 and SHEF4) but to be biallelic, albeit highly preferential, in 
fMSC (informative lines fBl8+3 and fLiv11+5).  IGF2 expression is controlled by 
differential methylation at the H19 DMD (Leighton et al., 1995a).  Paternal 
methylation at the DMD results in maternal H19 expression, blocking activation of 
maternal enhancers through CTCF and silencing the maternal IGF2 allele.  
Differential methylation of the H19 DMD spreads post-fertilisation to the H19 
promoter, which becomes differentially methylated during fetal development, and is 
indicative of methylation status of the H19 DMD.  H19 was always monoallelic in 
fMSC, but the CF1 hES cell line expressed H19 biallelically.  The methylation status 
of the H19 promoter and H19 DMD differentially methylated regions were analysed 
to determine the role of methylation in the difference between the cell lines, and in 
the loss of differential expression. 
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Figure 6.3 COBRA analysis of the H19 Promoter region 
(i) COBRA analysis of the somatic DMR at the H19 promoter, visualised on agarose.  
Full length bisulphite amplicon is 371 bp, and digestion (methylated DNA) with 
Taqα1 enzyme gives products of 196 and 176 bp.  Most lines are differentially 
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methylated, but WT3, WT4 and CF1 are completely methylated (ii) Quantification of 
the COBRA gel, showing that the fMSC and SHEF hES cell samples appear to be 
differentially methylated, although there is a bias towards methylated alleles.  WT3, 
WT4 and CF1 samples display complete hypermethylation by COBRA. 
 
Methylation of the H19 promoter remains differential in the fBl8+3 and 
fLiv11+5 lines, shown to express IGF2 biallelically, so this anomaly is not explained 
by hypermethylation at the H19 promoter.  The complete hypermethylation of hES 
cell lines WT3, WT4 and CF1, is unexpected as CF1 expresses H19 biallelically, so 
hypomethylation would be predicted.  The bisulphite conversion was repeated, and 
COBRA carried out again on WT3, WT4 and CF1, plus two control samples.  The 
PCRs were then sequenced, to check that the hypermethylation was not a technical 
artefact, or due to incomplete bisulphite conversion.  
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Figure 6.4 Repeat analysis of H19 promoter methylation 
Repetition of the COBRA assay, (i) and (ii), found that there were unmethylated 
alleles present in the three KCL hES lines, indicative of differential methylation, but 
there was again a bias towards methylated alleles.  (iii) Bisulphite conversion was 
between 86 to 91% explaining the bias towards methylated alleles by COBRA.  22 
CpG dinucleotides were present in the PCR product, and along any given strand 
almost all were either methylated or unmethylated.  Methylated alleles were more 
abundant than unmethylated ones, at a ratio of 1:9 for the three KCL samples and 2:8 
for the SHEF1 line. 
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The ratio of methylated to unmethylated alleles was still higher for WT3 and 
CF1, which may indicate a polymorphic pattern of methylation amongst the cells 
analysed.  Methylation at the H19 promoter is indicative of methylation at the H19 
DMD.  The aberrant methylation does not seem to be linked to loss of imprinting, as 
biallelic methylation, which may be occurring in some cells, would result in H19 
silencing.  The reactivation of the maternal IGF2 allele, which is seen to a small 
extent in fMSC lines, could feasibly be caused through biallelic methylation, and 
there is a small bias towards methylated alleles, although this is true of hES cell lines 
as well.  There have been reports of a decoupling of differential methylation status at 
the H19 promoter and H19 DMD, so methylation analysis at the DMD region was 
also carried out (Ito et al., 2008). 
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Figure 6.5 H19 DMD methylation analysis 
(i) COBRA analysis of methylation at the H19 DMD, visualised on agarose.  
Bisulphite PCR product 233 bp.  BstUI digestion products of 148 and 85 bp.  fMSC 
samples and SHEF hES cells are differentially methylated in a ratio of approx 1:1, but 
WT3, 4 and CF1 are predominately methylated.  (ii) Quantification of COBRA gel, 
showing the ratio of methylation of WT3 and CF1 to be 1.7 to 0.3 and WT4 1.5 to 0.5 
methylated to unmethylated alleles respectively.  (iii) Bisulphite sequencing analysis 
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of samples from (i) and (ii), 14 CpG dinucleotides in PCR product.  fMSC, SHEF1 
and control term placenta samples show a methylated to unmethylated allele ratio of 
1:1 but the two hES samples found to be hypermethylated by COBRA were found to 
be uniformly methylated using this technique. 
 
Differential methylation at the H19 DMD is maintained in all the cell lines 
analysed.  Again, there is a bias towards methylated alleles in the WT3, WT4 and 
CF1 hES cell lines, which may be due to a subset of cells displaying methylation on 
both alleles.  The loss of imprinting of H19, and to a lesser extent, IGF2, in hES cells 
and fMSC respectively, does not seem to be linked to methylation at the H19 DMD, 
which is normal. 
6.1.4 The KvDMR 
The KvDMR is the ICR for the KCNQ1 region on hChr11p15, which includes 
six imprinted transcripts in the human.  The KvDMR is maternally methylated during 
oogenesis, resulting in paternal expression of the ncRNA KCNQ1OT1.  Expression of 
this transcript acts to recruit polycomb complex PRC2, resulting in formation of 
repressive chromatin domain on the paternal allele, including enrichment of histone 
H3K27 tri-methylation (Umlauf et al., 2004).  The remainder of the genes in the 
human cluster, PHLDA2, SLC22A18, SLC22A1LS, CDKN1C and KCNQ1, are 
expressed from the maternal allele only (Monk et al., 2006a). 
 KCNQ1OT1 was always monoallelic in the fMSC and hES cells analysed, so 
it would be expected that the other transcripts would also be monoallelic.  KCNQ1 
and CDKN1C were monoallelic in all cell lines for which they were informative.  
SLC22A18 was biallelic in every sample, including those whose informativity 
overlapped with cell lines showing monoallelic KCNQ1OT1, although this 
observation is consistent with other reports of cultured cells (Kim et al., 2007b; 
Adewumi et al., 2007).  SLC22A1LS was polymorphically imprinted, where both 
fMSC and hES cells showed both monoallelic and biallelic expression depending on 
the line, see Table 6.2 below.  Hypermethylation in a subset of cells may result in the 
detection of biallelic expression of these transcripts, which were more highly 
expressed than KCNQ1 and CDKN1C in fMSC and hES cells (see Appendix I) so 
methylation at the KvDMR was analysed. 
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Monoallelic SLC22A1LS Biallelic SLC22A1LS 
fBM9+4, fLiv10+4, Fibroblasts, CF1 fBM10+4, fBM12+4, fBl8+3, fLiv11+5, SHEF4 
Table 6.2 Expression patterns of SLC22A1LS in fMSC and hES cells 
Showing which of the cell lines informative for SLC22A1LS expressed the transcript 
biallelically, and which expressed it monoallelically 
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Figure 6.6 KvDMR methylation analysis 
(i) COBRA gel of KvDMR methylation analysis.  KvDMR bisulphite PCR 372bp, 
Taqα1 digest of 152 + 116 + 85 + 16 bp fragments.  All samples appear differentially 
methylated.  (ii) Quantitation of COBRA gel shows that all samples have a ratio of 
methylated to unmethylated alleles of 1:1.  (iii) Bisulphite sequencing of COBRA 
samples (30 CpG dinucleotides) confirms COBRA result of differential methylation 
in fMSC and hES at the KvDMR, where CpGs recognised by restriction digest are 
representative of the entire strand. 
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The maintenance of differential methylation of the KvDMR in all the cell 
lines analysed is consistent with the monoallelic expression of KCNQ1OT1.  The 
biallelic expression of SLC22A1LS and SLC22A18, which are the genes furthest from 
the KvDMR in this cluster, does not appear to be linked to any changes in 
methylation, but may be caused by defects in the maintenance of histone 
modifications, shown to be important for differential expression at this locus (Lewis 
et al., 2004; Monk et al., 2006a; Umlauf et al., 2004).   
6.1.5 The DLK1/GTL2 DMR region 
The germline intergenic DMR (IG-DMR) situated between the DLK1 and 
GTL2 genes on hChr14 has been shown in the mouse to be the ICR for this imprinting 
cluster  (Lin et al., 2003).  It is methylated on the paternal allele, resulting in maternal 
expression of the ncRNA GTL2, and paternal expression of DLK1 and DIO3.  In the 
human, the IG-DMR is conserved and methylated in the male germline, but has been 
shown to relax differential methylation in a polymorphic way during fetal 
development (Geuns et al., 2007).  In hES cells, the IG-DMR has been shown to 
maintain differential methylation (Plaia et al., 2006). 
DIO3 could not be analysed in any of the cell lines as it was not expressed, 
and DLK1 and GTL2 were not co-expressed in either cell line, commonly observed in 
analyses of  fetal tissues (da Rocha et al., 2007).  GTL2 was expressed in fMSC and 
found to be monoallelic in the fBM10+4 cell line.  DLK1 was monoallelic in hES cell 
line CF1, but biallelic in SHEF2, SHEF4 and SHEF5.   
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Figure 6.7 Analysis of methylation at the DLK1-GTL2 IG DMR 
(i) COBRA amplicons on agarose, stained with ethidium bromide.  IG-DMR 
bisulphite PCR product 219 bp, digest with Taqα1 restriction enzyme gives 128 + 
101bp products.  fMSC look differentially methylated with an even distribution of 
methylated and unmethylated alleles.  hES cells are highly varied, with several 
appearing completely methylated.  fBl11+1 and SHEF5 appear to be slightly 
hypomethylated.  (ii) Quantification of COBRA gel, showing almost complete 
methylation of SHEF1, SHEF4, SHEF7, WT3 and WT4, approx ratio 9:1 methylated 
to unmethylated  (iii) Bisulphite sequence analysis of COBRA PCR, confirming the 
retention of differential methylation in fMSC and some hES cell lines, but complete 
methylation of hES cell samples SHEF1, SHEF4, WT3 and WT4.   
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The methylation status of the IG-DMR correlates with allelic expression in 
certain cell lines.  fBM10+4 and CF1 express GTL2 and DLK1 monoallelically, and 
display differential allelic methylation, with a ratio of methylated to unmethylated 
alleles of 1:1.  SHEF4 expresses DLK1 biallelically, and is hypermethylated, 
consistent with the role of the IG-DMR, and the phenotype of mice mutant for the 
maternal, unmethylated, IG region (Lin et al., 2003).  hES lines SHEF2 and SHEF5, 
however, also express DLK1 biallelically, but do not show any hypermethylation at 
the IG-DMR, and were differentially methylated.  Interestingly, the IG-DMR retained 
differential methylation in all fMSC lines, but was variable in hES cells.   
In summary, in some cases methylation at the IG-DMR is disrupted by cell 
culture, specifically in hES cells, causing changes in allelic expression of imprinted 
genes.  Allelic expression may also be disrupted in the absence of methylation 
defects, however, due to other regulatory anomalies, such as CTCF binding for 
example, postulated to play a role in this region (Rosa et al., 2005).  
6.1.6 The SNURF/SNRPN (PWS/AS-IC) DMR region  
 
Imprinting at the SNURF/SNRPN region on hChr15 is controlled by 
differential methylation at the PWS/AS-IC, or SNRPN DMR (Horsthemke and 
Wagstaff, 2008).  This imprinting cluster includes paternally expressed NDN, 
SNRPN, IPW and ATP10C, expressed preferentially from the maternal chromosome 
in human brain and fibroblasts (Herzing et al., 2001; Meguro et al., 2001). 
Both SNRPN and NDN were monoallelically expressed in all cell lines 
analysed, consistent with data in other studies of hES cells (Kim et al., 2007b).  
ATP10C, however, was biallelic in both fBM9+4 and fBl11+1.  Methylation at the 
PWS/AS-IC was analysed in each cell line to assess whether expression status was 
consistent with DMR methylation. 
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Figure 6.8 Methylation analysis of the PWS/AS-IC DMR 
(i) COBRA analysis of PWS/AS-IC DMR on agarose stained with ethidium bromide.  
Full size PWS/AS-IC DMR bisulphite PCR product 408bp.  Full digestion with Tai1 
restriction enzyme gives fragments of 178 + 115 + 116 bp (115 + 116 bp not 
separated on this gel).  A lack of digestion at the first Tai1 site alone gives an 
additional fragment of 230 bp, or at the second site 294 bp.  All cell lines have an 
undigested band, indicating that they all maintain this DMR.  Additionally, they vary 
in the number of bands present (i.e. the 230 and 294 bands), showing that the 
methylation of certain bases varies between samples (ii) Quantification of the 
COBRA gel.   fBl11+1, Liv11+5, WT3, and SHEF1 are all differentially methylated 
with a ratio of 1:1 methylated to unmethylated alleles.  CF1 is biased towards 
unmethylated alleles.  All other samples appear to be predominately methylated.  (iii) 
Bisulphite sequencing of the COBRA PCRs.  The PCR product contained 22 CpGs, 
and for some samples there was mixed methylation within individual strands, as 
indicated by the presence of alternate Tai1 digest products in the COBRA gel.  
Sequence analysis shows that these events were overall a rare occurrence and most 
strands were predominately either methylated or unmethylated.  fBM10+4 seems 
completely methylated by sequencing.  The presence of apparently unmethylated 
strands in the fBM10+4 COBRA analysis may be explained by unmethylated CpG 
dinucleotides corresponding to both Tai1 digestion sites within a methylated strand. 
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 There is a large variation in methylation levels between each cell line, 
although they all seem to maintain differential methylation.   The PWS/AS-IC DMR 
has been shown to maintain differential methylation at another hES cell line (Plaia et 
al., 2006).  The variation in methylation is present in both fMSC and hES cell lines, 
but does not correlate with loss of imprinting, as all samples expressed both SNRPN 
and NDN monoallelically.  In addition, the biallelic expression of ATP10C occurred 
in two of the only lines displaying a 1:1 ratio of methylated to unmethylated alleles, 
so does not appear to be the result of disrupted methylation, and may be due to tissue 
specificity. 
6.1.7 The PEG3 DMR  
Monoallelic expression of PEG3 is controlled by a maternally methylated 
germline DMR in the promoter of the gene. Expression analysis of PEG3 was only 
possible in one cell line, SHEF4, where it was found to be monoallelic.   
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Figure 6.9 Methylation analysis of the PEG3 DMR 
(i) COBRA analysis of the PEG3 DMR, shown on agarose stained with ethidium 
bromide.  PEG3 bisulphite PCR product 303bp, Tai1 restriction digest gives 
fragments of 156 and 147 bp, not resolved on this gel.  All cell lines have undigested 
bands present, indicating that they are differentially methylated.  (ii) Quantification of 
COBRA gel shows that all fMSC lines are differentially methylated at a ratio of 1:1, 
but the hES cell lines are predominately methylated, with a ratio of approx 1:5.  (iii) 
Bisulphite sequencing of COBRA PCR products, including 13 CpG dinucleotides.  
fMSC are found to be methylated in a ratio of 1:1 using this technique, also, whereas 
hES cells appeared to be uniformly methylated. 
 
 SHEF4 DNA was hypermethylated at the PEG3 DMR, despite maintaining 
monoallelic expression, indicating that the methylation status is not affecting 
expression in this line at this locus.  Overall, fMSC methylation remained differential, 
and at a 1:1 ratio.  Methylation of hES cells was uniformly bias towards being 
hypermethylated, indicating that this locus is prone to changes in methylation 
specifically in hES cells. 
 
6.1.8 The GNAS region DMRs 
 
GNAS is a complex locus, containing two germline DMRs and a somatic 
DMR.  Germline NESPAS/XL is the principle DMR, controlling differential 
methylation at somatic NESP55 and germline EXON 1A DMRs, and subsequent 
allelic expression of each transcript, including paternally expressed GNASXL and 
NESPAS.  (Coombes et al., 2003).  GNAS expression is predominately biallelic, but 
tissue-specific maternal expression is controlled by the germline EXON 1A DMR, 
which also executes maternal expression of the EXON1A transcript.  The NESP55 
DMR formed during embryonic development, controls maternal NESP expression 
(Coombes 2003).   
Only GNAS and EXON1A could be analysed, due to lack of NESP and XL 
expression, and no available informative samples for the NESPAS polymorphism.  
GNAS was biallelic in all samples except for hES cell lines CF1 and EXON1A was 
always monoallelic. 
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Figure 6.10 Analysis of methylation at the NESPAS/ XL DMR 
(i) COBRA analysis of NESPAS/XL DMR visualised on agarose stained with 
ethidium bromide.  XL bisulphite PCR product 239bp, Taqα1 digest gives 149 bp + 
90 bp.  fMSC and hES cells display both methylated and unmethylated bands, 
indicating that they are all differentially methylated, except for WT3 and WT4 which 
have only methylated bands present.  COBRA was repeated with a different DNA 
prep, which gave the same result.  (ii) Quantification of the COBRA indicates that the 
ratio of methylated to unmethylated alleles is approx 5:6.  (iii) Bisulphite sequencing 
of COBRA PCRs, including 15 CpGs.  This technique shows that the results from 
COBRA represent the whole DNA strand.  Example fBM9+4 is differentially 
methylated at a ratio of 1:1, whereas WT3 and WT4 are hypermethylated. 
 
  158 
(i) 
 
(ii) 
 
0
0 .5
1
1 .5
2
fB
M
9+
4
fB
M
10
+4
fB
l8
+3
fB
l9
+1
fB
l1
1+
1
fL
iv
10
+4
fL
iv
11
+5
W
T4
C
F1
S
H
E
F1
S
H
E
F2
S
H
E
F4
S
H
E
F5
S
H
E
F6
S
H
E
F7
 
(iii) 
 
Figure 6.11 Analysis of methylation at the NESP55 DMR 
(i) COBRA analysis of the NESP55 DMR visualised on agarose stained with 
ethidium bromide.  NESP55 bisulphite PCR is 225 bp in length, complete digestion 
with Tai1 restriction enzyme gives 157 + 68 bp products.  All samples except for 
WT4 appear to retain differential methylation at this locus, i.e. 225, 157 and 68 bp 
products are visible in each lane.  WT4 hES cell line appears to be completely 
unmethylated.  There is an overall bias towards digested (methylated) PCR products 
in all the other samples, notable in hES lines SHEF1 and SHEF5.  (ii) Quantitation of 
the COBRA gel, showing that the ratio of methylated to unmethylated DNA is approx 
1:1 for all samples except WT4 (completely unmethylated) and SHEF1 and 5, whose 
ratios are 1:3 and 1:3 unmethylated:methylated alleles respectively.  (iii) Bisulphite 
sequencing of COBRA products, encompassing 12 CpG dinucleotides.  Bisulphite 
conversion efficiency may account for the trend towards methylated alleles.  WT4 
was found to be completely unmethylated using this technique as well, showing that 
this result was not due to incomplete restriction digestion.  SHEF1 has a similar ratio 
of methylated to unmethylated alleles using this technique. 
 
The methylation status of the NESPAS/XL DMR reflects that of the somatic 
NESP55 DMR in most but not all cell lines.  Notably, WT4 was hypermethylated at 
NESPAS/XL, and hypomethylated at the NESP55 DMR.  Monoallelic expression of 
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GNAS in the CF1 hES line does not correlate with any changes in methylation.   As 
GNAS is only monoallelically expressed in certain tissues, the biallelic expression of 
this gene in fMSC and hES cells is likely to be due to this tissue specificity, rather 
than a loss of imprinting due to cell culture.  Overall, at this locus the maintenance of 
differential methylation at both DMRs reflects the appropriate allelic expression of 
the transcripts analysed.  The methylation of hES lines WT3 and WT4 is disrupted, 
perhaps due to a particular sensitivity of these cells, but unfortunately allelic 
expression could not be analysed in these lines as they were not informative for any 
of the expressed genes. 
6.1.9 Summary 
 
In most fMSC and hES cell lines differential methylation at ICRs was 
maintained at all of the loci analysed.  In a minority of lines, which were always hES 
cell lines, some loss of differential methylation was seen.  This involved both hypo- 
and hypermethylation.  Where this was observed, allelic expression status was not 
correlated with losses in differential methylation.  In some cases methylation changes 
were seen which did not correlate with loss of imprinting, and in other cases, loss of 
imprinting was observed where methylation remained normal, such as for biallelic 
expression of SLC22A18 coincident with differential methylation at the KvDMR.  
This is consistent with other data for hES cell lines, and the trend is present in fMSC 
lines as well, indicating that this pattern is not specific to hES cells (Kim et al., 
2007b).  There were cell line specific variations in methylation at certain loci, 
normally involving hypermethylation.  Notably, in several cases such as the PEG3 
DMR and DLK1 IG-DMR, disrupted methylation was confined to hES cell lines, 
indicating that differential methylation at these loci is more stable in fMSC lines.  
Consistent with alack of correlation for aberrant methylation in hES cells with 
biallelic gne expression, the biallelic expression in fMSC could not be correlated with 
methylation as in all samples the ICRs were normally methylated.  The findings of 
aberrant methylation at ICRs in hES cells but not fMSC show that ICR methylation 
may be altered either by superovulation or hES derivation. 
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Chapter 7                                                 
Imprinting in adult human peripheral blood 
leukocytes 
 
7.1 Imprinting in the human in vivo  
 
To analyse imprinting in humans, blood is a useful tissue because it is easily 
available.  It has been shown that imprinting in blood can be polymorphic, but also 
can become biallelic when an individual has a tumour in an unrelated tissue.  This 
means biallelic expression of imprinted genes may be used as a biomarker for cancer 
and possibly other diseases.  As polymorphic imprinting was found for one imprinted 
gene, it might also be present in the population for other genes, which would limit the 
use of a lack of imprinting as a biomarker.  
 
7.1.1 Analysis of human transcription  
Transcriptional profiles vary between different tissues, and so in the study of a 
mechanism controlling transcriptional levels such as genomic imprinting, which is 
frequently tissue specific, many tissues must be analysed to draw valid conclusions  
(De Pagter-Holthuizen et al., 1987; Arnaud et al., 2003; Plagge and Kelsey, 2006; 
Valleley et al., 2007).  The diagnosis of imprinting disorders, and the potential use of 
loss of imprinting (LOI) as a marker for cancer susceptibility or disease state, requires 
an accurate picture of imprinting in the normal, healthy human (Cui et al., 2003). 
In vivo analysis of human physiology and molecular biology is inherently 
limited by sample availability.  The research community is restricted to ex-vivo tissue 
culture, pathological samples and the products of pregnancy termination and only 
after ethical approval and consent is obtained by the patients or the families.  
However, the most readily available tissue is samples of adult peripheral blood and 
buccal epithelium. Collection of these tissue sources is minimally invasive, fast, and 
most people are willing to donate.  Routine genetic testing is primarily carried out on 
peripheral blood and for analysis of genomic DNA this is an invaluable resource.  
For the reasons outlined in the previous paragraph, peripheral blood cells are 
also frequently used as a normal control tissue in imprinting studies.  A loss of 
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imprinting in peripheral blood of the paternally expressed IGF2 gene was found to be 
significantly increased in patients who went on to develop colon cancer, and LOI of 
this gene has been shown to promote tumorigenesis in mice (Cui et al., 2003; 
Sakatani et al., 2005).  Subsequently, loss of imprinting as a general process has been 
suggested as a potential marker for cancer development (Feinberg et al., 2006).  The 
fact is, the status of imprinted gene expression in peripheral blood has not been 
characterised to safely allow LOI in this tissue as a marker for disease. 
7.1.2 Introduction to haematopoiesis 
 
Haematopoiesis in the very early stages of life, from E7.5 to E10.5 in the 
mouse, occurs to produce erythrocytes and endothelial cells, sequentially found in the 
ventral mesoderm, yolk sac, mesonephros and placenta.  Definitive haematopoiesis, 
involving differentiation of haematopoietic stem cells to myeloid and lymphoid 
lineages, occurs in the liver before birth, moving to the bone marrow post-natally (see 
Figure 7.1) (Orkin and Zon, 2008). 
 
Figure 7.1 Definitive haematopoiesis 
Haematopoietic stem cells (HSC), populating the pre-natal liver, and later the bone 
marrow, are a self-renewing stem cell population which provides precursors for each 
blood lineage.  Differentiation occurs in sequential stages, with cells at each stage 
becoming less primitive and more differentiated.  The HSC first differentiate into 
myeloid and lymphoid precursors.  Myeloid precursors differentiate to 
megakaryocytes, erythrocytes, basophils, neutrophils and eosinophils, macrophages 
and osteoclasts.  The lymphoid lineages consists of B and T-lymphocytes, and natural 
killer cells (Orkin and Zon, 2008). 
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 Whilst B lymphocytes acquire immunocompetence in the fetal liver and bone 
marrow, T lymphocyte precursors migrate to the thymus to mature.  The thymus 
establishes a long-lasting T lymphocyte pool during early life, and the organ becomes 
increasingly obsolete towards middle age, gradually involuting during ontogeny 
(Roitt and Delves, 2001).  Mature cells of the blood are released directly from the 
bone marrow (and thymus) into the circulation.  The anucleated, haemoglobin 
containing erythrocyte, or red blood cell population predominates, at 45 % blood 
volume.  Granulocytes, lymphocytes and monocytes make up the so-called white 
blood cells, and are collectively referred to as peripheral blood leucocytes, 
contributing a total of 1 % blood volume (see Table 7.1 for detail of blood 
composition) (Roitt and Delves, 2001; Alberts et al., 1994)  
 
Table 7.1 Leukocyte populations in adult peripheral blood 
Erythrocytes are the predominant population in blood.  White blood cells make up 1 
% of blood volume, amongst which neutrophils are the most abundant, followed by B 
and then T lymphocytes (Alberts et al., 1994).   
7.1.3 Bone marrow stem cells 
Erythrocytes are terminally differentiated, and in the human the life span of 
each cell is 120 days, whereby 1011 erythrocytes are removed from circulation, and 
must be replaced, each day.  Granulocytes last for a far shorter time, perhaps only a 
few days (Alberts et al., 1994).  The replenishment of these cell populations is 
achieved by haematopoietic stem cells (HSC).  This highly regenerative stem cell 
population resides in the bone marrow, and they are multipotent, providing a stem 
cell pool for each blood cell type (see Figure 7.1).  HSC are able to repopulate the 
immune system of immunocompromised mice and are a important resource for 
regenerative therapy in the clinic (Osawa et al., 1996; Larochelle et al., 1996).  
Cohabiting in the stem cell niche of HSC are mesenchymal stem cells (MSC), which 
have been discussed at length previously (in Chapter 3).  MSC do not differentiate to 
Cell type [Adult median] cells per ml total blood 
Erythrocytes 5 x 109 
Neutrophils 5 x 106 
Eosinophils 2 x 105 
Basophils 4 x 104 
T lymphocytes  1 x 106 
B lymphocytes 2 x 106 
Monocytes 4 x 105 
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any of the blood cell lineages but provide progenitors for bone, fat and cartilage 
(Bruder et al., 1997). They reside with HSC at sites of definitive haematopoiesis 
throughout ontogeny, providing structural and biochemical support to these cells.  
Having characterised imprinted gene expression in MSC, it was both important and 
interesting to compare the imprinted status of peripheral blood leucocytes, as an in 
vivo cell population originating from an identical tissue niche. 
7.1.4 Expression of imprinted genes in peripheral blood leucocytes 
 
Forty imprinted transcripts were chosen for analysis, encompassing genes 
from each imprinting cluster characterised in the human, plus the majority of isolated 
imprinted genes found to-date http://igc.otago.ac.nz/IGC/.   
Gene/cluster 
name 
Locus Genes in 
cluster 
Parent of 
origin 
Reference human imprinting 
DIRAS3 1p31  PAT (Yu et al., 1999) 
TP73 1p36  MAT (Martinez-Delgado et al., 2002; Mai et 
al., 1998; Cai et al., 2000) 
NAP1L5 4q22  PAT (Wood et al., 2007) 
Iso 1 PAT (Kamiya et al., 2000) ZAC1 6q24 
Iso 2 BIAL (Valleley et al., 2007) 
IGF2R 7  MAT (Monk et al., 2006a) 
GRB10 7p11  MAT (Arnaud et al., 2003) 
PEG10 7q21 PEG10 PAT (Ono et al., 2001) 
  SGCE PAT (Grabowski et al., 2003) 
CPA4 MAT (Bentley et al., 2003) 
MESTIT1 PAT (Nakabayashi et al., 2002) 
MEST Iso 1 PAT (Kobayashi et al., 1997) 
MEST  7q32 
MEST Iso 2 PAT (McMinn et al., 2006; Nakabayashi et 
al., 2002) 
INPP5F_V2 10q26  PAT (Wood et al., 2007) 
WT1 11p13  PAT (Malik et al., 2000) 
WT1-AS    (Dallosso et al., 2004) 
PHLDA2 MAT 
SLC22A18 MAT 
SLC22A1LS MAT 
CDKN1C MAT 
KCNQ1OT1 PAT 
(Monk et al., 2006a) KCNQ1  11p15 
KCNQ1 MAT (Lee et al., 1997) 
H19 MAT IGF2/H19 11p15 
IGF2 PAT 
(Rainier et al., 1993a) 
HTRA2 13q14  MAT (Bunzel et al., 1998) 
GTL2 MAT (Miyoshi et al., 2000) 
DLK1 PAT (Kobayashi et al., 2000) 
DLK1/DIO3 14q32 
DIO3 PAT  
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NDN PAT (MacDonald and Wevrick, 1997) 
SNRPN PAT 
IPW PAT 
(Nicholls and Knepper, 2001) 
SNURF/ 
SNRPN 
15q11 
ATP10C MAT (Meguro et al., 2001) 
PEG3 19q13  PAT (Murphy et al., 2001) 
MCTS2 20q11  PAT (Wood et al., 2007) 
NNAT    (Evans et al., 2001; Schulz et al., 2009) 
NESPAS PAT 
NESP MAT 
GNAS MAT 
Exon 1A PAT 
GNAS  20q13 
GNAS XL PAT  
(Hayward et al., 1998b; Hayward et 
al., 1998a; Hayward et al., 2001; Liu et 
al., 2000) 
Table 7.2 List of the 38 human imprinted genes chosen for analysis in PBL 
In order to analyse the allelic expression status of imprinted genes in 
peripheral blood leucocytes (PBL), it was important to establish that expression in 
this tissue could be detected.  Expression levels were quantified using real-time RT-
PCR in two healthy adults. 
 
Figure 7.2 Expression of imprinted genes in peripheral blood leucocytes 
Quantitative expression levels and allelic status of imprinted genes in the PBL of two 
individuals PBL A       and PBL B     . . Log(10) 2-ΔCt is plotted on the y axis where ΔCt 
is the cycle number at which transcript level reached threshold, corrected to an 
endogenous control.  ΔCts for triplicates of each transcript were calculated using 
GAPDH as the control, so that log(10) 2-ΔCt of GAPDH = 1. (i) The outline of the 
position of each gene within the human genome is shown, demonstrating the extent of 
each imprinting cluster.  Expression levels in PBL varied widely, with many 
transcripts expressed at a very low level.  NAP1L5, IGF2R, SNRPN, KCNQ1OT1, 
KCNQ1 and GNAS were the most highly expressing genes in PBL.  Variation 
between the two samples was small.  
 
Three genes were expressed at notably high levels: GNAS, SNRPN and 
IGF2R.  Other genes, KCNQ1, KCNQ1OT1, NAP1L5, IPW, GNAS EXON 1A, 
SLC22A18, CDKN1C, MEST ISOFORM 2 and PEG10 were expressed at a level 
decreased by approximately ten fold relative to the three highly expressed genes, and 
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the remaining 24 by at least 100 fold.  Gene expression between the two samples PBL 
A and PBL B showed a high level of consistency, with 26/32 (81%) detectable ΔCts 
being within two cycles, and of these 16 (50%), being within one cycle of one another 
(See Appendix III). 
Allelic expression analysis was carried out using non-quantitative PCR 
followed by Sanger sequencing.  Using non-quantitative (nq) PCR cycle profiles 
(Appendix III) it was found that sufficient amplicon could be reliably generated for 
sequencing within the linear phase of nq-PCR where the corresponding dCt generated 
by quantitative PCR was 9 or below (2-dCt of 0.0015).  The exception, where a 
transcript could not be detected using nq-PCR despite a dCt lower than 9 was 
CDKN1C, whose dCts were 6.9 and 8.0 for PBLA and PBLB respectively.   
Of 40 imprinted transcripts analysed, expression was at a high enough level to 
obtain allelic expression data from 16 (40 %).  Peripheral blood was taken 
anticubitally from 50 consenting healthy adult staff at the Institute of Child Health, 
London.  DNA from each sample was used to genotype each individual for exonic 
single nucleotide polymorphisms (or a polymorphic proline-alanine repeat in the case 
of CDKN1C) in each of the 16 genes.  cDNA was generated from each sample and 
allelic expression ascertained for informative individuals.  As no parental DNA was 
available, parental origin could not be assigned, so imprinting is only inferred from 
monoallelic expression. 
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Figure 7.3 RT-PCR gel electrophoresis and sequence chromatograms of three 
example genes 
Agarose gel electrophoresis of non-quantitative PCR amplicons from SLC22A18, 
KCNQ1OT1 and KCNQ1 imprinted genes on hChr11p15.5.  Gels are stained with 
ethidium bromide and amplicons (+) are run next to RT negative samples (-), BL = no 
template control.  Sequence chromatograms of an example genotyping PCR, and 
chromatograms of expressed transcripts for each informative sample are shown.  Each 
of SLC22A18, KCNQ1OT1 and KCNQ1 were expressed biallelically in all PBL 
samples analysed. 
 
Allelic analysis of the expressed transcripts revealed three groups of genes: (i) 
ZAC1/PLAGL1 Isoform 2, IGF2R, MEST Isoform 2 (polymorphic) and GNAS were 
expressed biallelically.  Each of these genes are widely expressed but imprinted only 
in certain tissues, so a lack of imprinted expression in peripheral blood was not 
unexpected; (ii) PEG10, IGF2, SNRPN, NDN, IPW and GNAS EXON 1A were 
expressed monoallelically, as expected; and finally (iii) NAP1L5, INPP5F_V2 
(polymorphic), SLC22A18, KCNQ1 and KCNQ1OT1 which were expressed 
biallelically.  This was unexpected given the monoallelic status of these genes in the 
human fetus wherever they are expressed (Monk et al., 2006a; Wood et al., 2007) (see 
Table 7.3). 
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Cluster Locus Transcripts UCSC SNP P
O 
QdCt 
mean 
nqC Allelic 
Expression  
NAP1L5 4q22  rs710834 P 5.61 33 9/9 Bi 
ZAC1 6q24 Isoform 2 rs9373409 B 12.64 45 3/3 Bi 
IGF2R 6q25  rs614754 M 2.26 35 1/1 Bi 
PEG10 7q21 PEG10  rs13073 P 9.10 36 4/4 Mo 
MEST  7q32 MEST Iso 2  P 7.58 35 8/9Bi;1/9Mo 
INPP5F_V2 10q26  rs3188055 P 15.99 40 8/11 Mo; 3/11 Bi 
KCNQ1 11p15 SLC22A18  rs1048046/7 M 8.18 40 6/6 Bi 
  CDKN1C PAPA RPT M 7.46 U U 
  KCNQ1OT1  rs231357/9 P 5.38 32 6/6 Bi 
  KCNQ1 rs1057128 M 4.97 38 4/4 Bi 
IGF2/H19 11p15 IGF2  rs680 P 11.84 40 20/20 Mo 
SNURF/ 
SNRPN 
15q11 NDN  rs2192206 P 13.57 40 3/3 Mo 
  SNRPN  rs705 P 2.42 40 3/3 Mo 
  IPW  rs691 P 6.18 35 5/5 Mo 
GNAS  20q13 GNAS  rs7121 M 0.28 33 13/13 Bi 
Exon 1A   P 6.65 40 7/7 Mo 
Table 7.3 Allelic expression in imprinted genes expressed in PBL  
M, maternal allele expressed*; P, paternal allele expressed*; *for reference only - 
based on previous findings in the literature; PAPA RPT, the CDKN1C polymorphism 
used was a proline and alanine repeat of variable length; QdCt mean, the average dCt 
of PBL samples A and B, dCt generated by quantitative PCR (to 2 decimal places); 
nqC, non-quantitative PCR cycle number used; U, undetectable by sequencing 
following nq-PCR; Numbers indicate how many individuals were analysed; Mo, 
monoallelic expression; Bi, biallelic expression.  Of the 15 transcripts which could be 
detected by nq-PCR, six, from four clusters, were expressed completely 
monoallelically (40%), two (13%) displayed a polymorphic pattern of imprinting, 
expressed monoallelically in some individuals but biallelically in others.  The 
remaining seven (47%) were expressed biallelically in all informative individuals.  In 
grey are the genes which were not monoallelic. 
 
 To estimate the functional relevance of the levels of transcript that had been 
detected, the expression of imprinted transcripts in PBL was compared to that of 
normal first trimester human placenta, liver and brain.  As three of the most important 
fetal organs for growth and development, these tissues express key imprinted genes at 
high levels (Apostolidou et al., 2007; Wilkinson et al., 2007) and are also 
representative as sites of tissue-specific expression (Choi et al., 2005; Qian et al., 
1997). 
Fetal placenta, liver and brain expression levels were higher both in 
magnitude and in representative coverage than PBL for 28 of the 36 analysed 
transcripts, indicating that overall imprinted genes are not highly expressed in this 
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tissue (Appendix III).  A total of eight genes were expressed more highly in PBL 
compared to other the fetal tissues and, interestingly, of these all except SNRPN were 
biallelic (see Figure 7.4, Figure 7.5 and Table 7.3).  PBL are a circulating cell 
population, and are therefore not in contact with a static cell niche.  To evaluate 
changes in gene expression from the time of cell release into the circulation, a sample 
of adult human bone marrow, as the origin of the predominant myeloid cell 
population in peripheral blood was also analysed.  Although displaying the same 
pattern of expression where GNAS, SNRPN and IGF2R are most highly expressed, 
bone marrow has a lower level of expression compared to PBL (see Figure 7.4, 
Figure 7.5 and Appendix III). 
 
Figure 7.4 Fetal tissue expression of genes expressed monoallelically in PBL 
Quantitative expression of imprinted genes found to be monoallelically expressed 
PBL is measured in adult peripheral blood leukocyte samples A and B (PBLA/B in 
red) and compared to that in adult bone marrow (AdBM), fetal brain (fBRN), fetal 
liver (fLIV), fetal placenta (fPLA).  Expression levels are represented by 2-ΔCt where 
Ct is the number of cycles to reach a threshold (0.3), and the delta indicates correction 
to GAPDH.  This calculation makes the expression level of GAPDH equal to 1, 
indicated in blue where appropriate.  PEG10 and GNAS EXON1A are most highly 
expressed in fetal placenta, INPP5F_V2 and IPW in fetal brain, and IGF2 in fetal 
liver and placenta.  SNRPN is expressed most highly in PBL and fetal brain. 
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Figure 7.5 Fetal tissue expression of genes expressed monoallelically in PBL 
Quantitative expression of imprinted genes found to be biallelically expressed PBL is 
measured in adult peripheral blood leukocyte samples A and B (PBLA/B in red) and 
compared to that in adult bone marrow (AdBM), fetal brain (fBRN), fetal liver 
(fLIV), fetal placenta (fPLA).  Expression levels are represented by 2-ΔCt as before.  
MEST Isoform 2 is most highly expressed in brain.  For all other biallelic genes; 
NAP1L5, ZAC Isoform 2, IGF2R, SLC22A18, KCNQ1, KCNQ1OT1 and GNAS,  PBL 
is the most highly expressing tissue.   
Both imprinted and non-imprinted monoallelic expression can be cell-type 
specific within certain organs (Constancia et al., 2002; Gimelbrant et al., 2007).  PBL 
are a mixed cell population, containing granulocytes, lymphocytes and monocytes 
(see Table 7.1).  The patterns of allelic expression observed may have been due to 
biallelic expression in an individual subpopulation, masking monoallelic expression 
in other cell types.  To investigate this, the three predominant cell types found in the 
PBL population, CD19+ B-lymphocytes (5%), CD3+ T-lymphocytes (25%) and 
CD15+ myeloid cells (50-70%) were isolated.  PBL samples from three individuals 
with wide coverage of informativity at SNPs were analysed with respect to the allelic 
expression of NAPIL5, ZAC1 Isoform 1, ZAC1 Isoform 2, MEST Isoform 2, 
KCNQ1OT1, SLC22A18, IGF2, SNRPN and NDN in the three cell sub-populations.   
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Figure 7.6 Sequence results for expression analysis in immuno-separated blood 
Blood from informative individuals was separated into myeloid cells, T and B 
lymphocytes.  Sequencing data from PBL was compared to that from the three 
lineages.  Patterns of allelic expression did not change between PBL and the 
separated components of whole blood.  Examples shown are NAP1L5, which was 
biallelic both in PBL and separated components, and SNRPN which was always 
found to be monoallelic. 
 
The biallelic/monoallelic expression pattern of the genes analysed was 
identical for each cell type (summarised in Table 7.4).  This demonstrates that the 
biallelic expression of imprinted genes is found throughout peripheral blood, at least 
as far as could be investigated. 
Gene n Whole PBL Myeloid Cells T-Lymphocytes B-Lymphocytes 
NAP1L5 1 B B B B 
ZAC1 Iso2 1 B B B B 
MEST Iso2 1 B B NE B 
KCNQ1OT1 2 B B B B 
SLC22A18 2 B B B B 
IGF2 1 Mono NE Mono NE 
SNRPN 1 Mono Mono Mono Mono 
NDN 2 Mono Mono Mono Mono 
Table 7.4 Allelic analysis of expression in separated PBL components 
Analysis of expression and allele specificity in myeloid, T and B lymphocyte 
fractions.  M, monoallelic; B, biallelic; NE, not expressed.  Three informative 
individuals were selected, and n numbers are based on the number informative for 
SNP in each respective gene.   Expression levels varied slightly, and could not be 
detected in certain cell types.  Allele specificity, where analysed, was identical 
between sub-populations. 
These results demonstrate that many imprinted genes are not highly expressed 
in blood, and those that are functionally expressed are mostly biallelic.  Lack of 
imprinting in adult human blood is both common, normal and in most cases unlikely 
to provide a useful marker for disease. 
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7.2 Summary of Conclusions 
 
The KCNQ1 region in hTS cells 
 Early human trophoblast does not exhibit tissue specific imprinting of the 
KCNQ1 region in vitro. 
 Placental specific imprinting is not conserved in the human preimplantation 
embryo when compared with the mouse. 
(Frost et al., Lack of placental-specific imprinting of the KCNQ1 region in human 
trophoblast stem cells) 
 
Imprinting in human fMSC and ES cells 
 Human fetal mesenchymal stem cells do not express functional levels of 
markers of pluripotency POU5F1, NANOG and TERT. 
 Culturing human fetal mesenchymal stem cells and hES cells disrupts their 
imprinted gene expression. 
 The extent and pattern of imprinting disruption is not increased by the 
derivation of stem cell lines during pre-implantation epigenetic reprogramming 
i.e. of hES cells from blastocysts. 
 Differentiating human fetal mesenchymal stem cells to bone and fat does not 
change the pattern of imprint disruption. 
 The regions subject to disruption by cell culture do not share common parental 
origin of expression, parental origin of methylation, common expression 
profile, imprint control mechanism (i.e. histone modification, ncRNA 
expression) or genomic location. 
 
Methylation at imprinting control DMRs in fMSC and hES cells 
 Culturing cells causes loci-specific changes in methylation at imprint control 
regions. 
 The imprinted genes disrupted by culture do not correlate with the control 
regions where methylation is disrupted. 
 The disruption of genomic imprinting by cell culture does not seem to be 
caused by changes in methylation. 
(Frost et al., A comparison of the effects of culture on genomic imprinting profiles in 
human embryonic and fetal mesenchymal stem cells) 
 
Imprinting in human peripheral blood leukocytes 
 Human peripheral blood leukocytes do not express the majority of imprinted 
genes 
 Imprinted genes which are expressed in peripheral blood leucocytes tend to be 
biallelic 
(Frost et al., Lack of imprinting in the blood of healthy adults precludes its use as a 
cancer biomarker) 
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Chapter 8 – Discussion 
 
8.1 Imprinting in hTS cells 
Placental-specific imprinting has been identified in the mouse at several loci, 
including Slc22a2 and Slc22a3 on mChr17, Tfpi2/TFPI2 on mChr7, Gatm on mChr2, 
Dcn on mChr10  and genes of the Kcnq1 cluster on mChr7 (Monk et al., 2008; Lewis 
et al., 2004; Umlauf et al., 2004; Zwart et al., 2001; Sandell et al., 2003; Mizuno et 
al., 2002).  Analysis of these genes in the human placenta have shown a lack of 
placental specific imprinting in the human, with the only exception of TFPI2 (Monk 
et al., 2006a). The earliest placental samples obtained for the above studies were from 
8 weeks gestation at the termination of pregnancy.    
Early placentation events are more similar between species than late ones 
(Knox and Baker, 2008).  In the mouse, the placenta utilises evolutionarily ancient 
genes, such as those involved in metabolism, the cell cycle and RNA processing 
during developmental stages (E8.5 to E10.5).  During mid (E10.5 to E15) to late 
gestation a transition occurs where expression profiles become enriched for genes 
which evolved since the divergence of rodents from primates.  From E15 to P0 genes 
specific to the rodent placenta are expressed, such as the prolactin-like protein family, 
carcinoembryonic antigen-related cell adhesion molecules, pregnancy-specific 
glycoprotein (PSG) family, and the cathepsin family (Knox and Baker, 2008).  In the 
human placenta, a similar transition occurs, and later in gestation primate specific 
genes including pregnancy-specific beta-1-glycoproteins, adrenomedullin, 
corticotropin releasing hormone, and chorionic gonadotropin beta polypeptides are all 
enriched compared to the mouse (Knox and Baker, 2008). 
Using human trophoblast stem (hTS). cells as a model, imprinting of the 
KCNQ1 region, which displays placental specific imprinting in the mouse, was 
analysed.  No placental specific imprinting was found in hTS cells, and the allelic 
expression in this cell type mirrored that of undifferentiated hES cells.  These results 
show that, as far as can be investigated, placental specific imprinting at the KCNQ1 
cluster does not exist in the human. 
In the mouse, imprinting of the central, ubiquitously imprinted genes of the 
KCNQ1 domain is executed by the blastocyst stage (Umlauf et al., 2004).  Placental-
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specific imprinting is established later, during differentiation of the trophoblast 
lineages, between E4.5 and E7.5 (Lewis et al., 2006).  Mouse TS cells express Osbpl5 
and Tssc4 biallelically, whilst Cd81 showed a maternal bias of 3.5:1, compared to 1:1 
in mES cells.  Paternal expression of Kcnq1ot1 throughout this stage only influences 
the ubiquitously expressed genes, although enrichment of H3K27me3 is found on the 
paternal allele at Cd81, but not Osbpl5 or Tssc4.  Terminal differentiation of mTS to 
trophoblast giant cells does not alter their expression status.  These results suggest 
that mTS cells do not behave like trophectoderm in vitro, although imprinting has not 
specifically been examined in giant cells (Lewis et al., 2006). 
 Murine TS cells are not derived from mES cells, but directly from the 
trophectoderm of pre- or post-implantation blastocysts (Tanaka et al., 1998; Huynh 
and Lee, 2003).  As such they are a different cell type from the human trophoblast 
cells studied here, representing early human placenta.  The mouse TS cells may 
therefore be more or less susceptible to the rigors of cell culture than human TS cells.  
The observations by Lewis and collegues using mTS cells, showing that they do not 
mirror the in vivo environment, therefore do not preclude the the value of hTS cells as 
a model for imprinting in the human trophoblast.  In order to evaluate this question 
more fully, however, it would be interesting to measure allelic expression of the 
genes SLC22A2, SLC22A3, and TFPI2 in hTS and mTS, shown to be either 
polymorphically or completely imprinted in both human and mouse placenta, but not 
the fetus (Monk et al., 2006a; Monk et al., 2008). In addition it would be interesting 
to analyse other murine placental-specific transcripts, such as DCN on hChr12 and 
GATM on hChr15 in both these cells, and to increase the number of individual lines 
examined in order to detect polymorphic imprinting.  An increase in the number of 
hTS and hES cell lines from genetically diverse individuals is required for these 
studies.  The exciting possibility of imprinted XCI occurring very early on in the 
human placenta may also be investigated in hTS cells.  
 The presence of placental-specific imprinting in this region has also been 
assessed in sheep and in cattle, where species-specific imprinting profiles are 
observed.  Post-implantation, the flanking, murine placental-specific gene Mash2 is 
specifically expressed in the placenta of mice, cattle (MASH2) and humans (ASCL2) 
(Tanaka et al., 1999; Miyamoto et al., 2002; Arnold et al., 2006).  In the sheep, 
however, the Mash2 homologue, SASH2, is expressed both in the embryo and the 
placenta but not imprinted, in contrast with CDKN1C which is maternally expressed 
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(Thurston et al., 2008).  In cattle, MASH2 expression is biallelic in the placenta during 
early gestation, becoming maternal later on, from around day 40 d.p.c. (Arnold et al., 
2006).  
 
Figure 8.1 Summary of imprinting at the KCNQ1 region in human and mouse 
The UCSC genome browser (NCBI build 36.1) is shown in black with gene names.  
Below this is the status of imprinting in each of the genes represented by coloured 
bars, where red is maternal expression, blue paternal expression and white/grey is 
biallelic expression.  The allelic expression status of hTS cells reflects that found in 
human first trimester placenta, rather than that of the mouse, where only the central 
six genes are monoallelically expressed. 
 
The murine ubiquitously imprinted gene SLC22A18 was biallelically 
expressed in the two human trophoblast stem cell lines examined and also in two 
undifferentiated hES cell lines.  This gene is imprinted in human fetal tissues and in 
placenta from 8 weeks gestation (Monk et al., 2006a).  Biallelic expression in hES 
cells, as representatives of the embryo proper, could be an artefact of cell culture.  It 
is clear that early in vitro trophoblast differentiation does not either establish or 
maintain imprinting of this gene.  
The maintenance of imprinting of the placental specific genes is independent 
of DNA methylation, and correlates with allelic histone modification  (Lewis et al., 
2004; Monk et al., 2006a; Umlauf et al., 2004).  DNA methylation was maintained in 
this region in hES and hTS cells, but in order to complete analysis of hTS cells at this 
stage, it would be useful to analyse the presence of allelic histone modifications at the 
distal ends of the cluster.  The lack of monoallelic expression is highly suggestive of a 
lack of allelic histone modification, consistent with the situation in the placenta later 
in gestation (Monk et al., 2006a). Such a study, involving chromatin 
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immunoprecipitation (ChIP), would require large amount of tissue, at least 10 million 
cells are needed in order to perform sequential ChIP and confirm allelic enrichment.  
Alternatively, native ChIP could be performed, requiring fewer cells but to assign 
alleles the presence of SNPs, such as single stranded conformation polymorphisms 
(SSCP), which may then be visualised on polyacrylamide gels, are required and so 
more individuals and parental DNA would be needed for this data. 
The loss of human placental-specific imprinting compared to the mouse is in 
contrast to the maintenance of tissue-specific imprinting in the human in the brain, the 
other main organ where this is found (Arnaud et al., 2003; Wood et al., 2007).  The 
difference between the placental-specific imprinting between mice and human may be 
due to disparities in gestational length and fetal load which are likely to reduce 
conflict at the placenta in the human compared to the mouse (Carter and Mess, 2007; 
Wildman et al., 2006).   Conversely, parental conflict-related evolutionary pressures 
in the developing human brain, affecting both future maturation and sexual 
behaviour, may be increased for the human in comparison to the mouse. 
 
8.2 Comparisons between fetal mesenchymal stem cells and 
embryonic stem cells 
8.2.1 Stem cell markers 
Pluripotent cells, including the early embryo, hES cells and human embryonic 
carcinoma (hEC) cells are characterised by their high expression of the transcription 
factors POU5F1, SOX2 and NANOG.  These transcripts are linked intricately with 
pluripotency and immortality (Boyer et al., 2005).  Findings of their expression in 
other cell types has raised hopes that these particular cells may exhibit the potential 
previously thought reserved for primitive embryonic cells.  fMSC are one of these 
cell types, and the detection of transcripts such as POU5F1  would be an important 
and exciting marker to find and may indicate the possible increased potential of these 
cells (Guillot et al., 2006a).   
fMSC are derived from fetuses from a gestational age of a minimum of seven 
weeks.  They can survive without changes in morphology or growth kinetics for up to 
70 population doublings, or 30 passages in culture, as described by Nick Fisk and 
colleagues, and perhaps for over 100 passages (Dr Jerry Chan, personal 
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communication).  There is no evidence to support suggestions of immortality, 
however, as exhibited by embryonic stem cells (Campagnoli et al., 2001).  
Additionally, they differentiate readily to bone, fat, cartilage, and even muscle, but 
reports of wider differentiation strategies do not provide the definitive proof of clonal 
assays (Campagnoli et al., 2001; Lee et al., 2004).  The ability to draw definitive 
conclusions from such data is confounded by the complexity of differentiation 
strategies required by an individual cell population.  Cellular potential is likely 
limited by inefficiencies in cell culture methodology.   
If a cell type such as fMSC were truly pluripotent one might expect the 
expression of POU5F1, NANOG and TERT to be high as in hES cells. However, the 
present study shows that fMSC exhibit very low expression of all three markers.  The 
expression levels in each line analysed were comparable to that of fMSC which had 
been left to reach confluency and then cultured at this density, without passage for 
four weeks.  This treatment is shown to vastly reduce potential of the cells for 
differentiation and self renewal (Guillot et al., 2006a).  There was no difference in 
pluripotency marker expression between undifferentiated fMSC and their 
differentiated derivatives.  Additionally, there was no distinction between expression 
levels of POU5F1, TERT and NANOG between fMSC and human adult peripheral 
blood leukocytes or adult fibroblasts.  The levels of expression of these markers in 
fMSC can thus be attributed to background.  Given the commitment of fMSC to the 
mesoderm, and the relatively mature ontology of the cells, compared to a hES cell, 
this observation was perhaps not a surprising one.  
The detection of pseudogenes for POU5F1 and an alternatively spliced second 
isoform (POU5F1_iB, NM_203289), which has identical C-terminal domain to the 
embryo-specific POU5F1_iA isoform (NM_002701), but is not able to bind DNA or 
act as a transactivator of transcription, has complicated the available literature 
regarding POU5F1 expression (Cauffman et al., 2006; Lee et al., 2006a).  It is 
important that misleading data describing POU5F1 expression in non-embryonic 
cells, which actually represents comparatively low expression, or does not distinguish 
between POU5F1_iA and _iB, is not permitted to cloud the reputation of cells such as 
fMSC as a valuable resource (Liedtke et al., 2007; Lengner et al., 2007; Berg and 
Goodell, 2007).  The lack of expression of POU5F1, NANOG and TERT does not 
reflect the ability of fMSC to differentiate into tissues within the mesoderm germ 
layer, particularly bone, fat and cartilage.  Whilst current research continues to 
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attempt to reprogram fully differentiated cells into pluripotent ones, with some 
success, fMSC are available now for the treatment of diseases of the mesoderm 
(Hanna et al., 2008; Okita et al., 2007).  fMSC are a highly expandable cell source, 
potentially very valuable for the treatment of diseases such as osteogenesis imperfecta 
and muscular dystrophy, or of injury trauma (Chan et al., 2006; Guillot et al., 2008).  
In addition to their properties of expansion and multilineage differentiation, fMSC 
display certain immune privileges, potentiating their use in non-autologous cell 
therapy and making them an important addition to the resources currently available to 
treat degenerative disease (Gotherstrom, 2007). 
8.2.2 Imprinting in fMSC and hES cells 
The use of human stem cells in the clinic requires an in-depth characterisation 
of their potential and safety, particularly regarding any possible potential neoplastic 
transformation.  Karyotypic changes have been shown to occur in human embryonic 
stem (hES) cells following extended passage, and alterations to epigenetic profiles, 
including genomic imprinting, have also been shown to be common (Draper et al., 
2004; Kim et al., 2007b).  Both karyotypic instability and loss of imprinting have 
been implicated in cancerous tumour tissue, so it is crucial to evaluate whether the 
changes associated with in vitro cell culture do promote the transformation of stem 
cells (Hernandez et al., 2003; Holm et al., 2005).   
Whilst hES cells have certain characteristics associated with neoplasm, such 
as immortality, they also carry ethical issues, such as the destruction of a potential 
human life being required for their derivation (Thomson et al., 1998; Vogel, 2008).  
Other stem cell sources are currently under investigation, with the long-term plan that 
the need for embryos may be replaced by these alternative cells (Hanna et al., 2008; 
Gurdon and Melton, 2008).  One poignant example is the recent creation of induced 
pluripotent cells from fully differentiated fibroblasts, although the potential of these 
cells has not yet been fully characterised (Takahashi and Yamanaka, 2006; Wernig et 
al., 2007).  Adult and fetal stem cell sources also have much promise, and although 
they tend to differentiate to lineages confined to their germ layer of origin, they are 
still very valuable as potential treatments for degenerative disease (De Coppi et al., 
2007; McGuckin et al., 2008).  Once such cell type is the human fetal mesenchymal 
stem cell, shown to differentiate to bone, fat, cartilage and muscle, and to have 
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increased potential compared to counterpart adult mesenchymal stem cells 
(Campagnoli et al., 2001; Chan et al., 2006; Zhang et al., 2008).   
In order to further characterise these cells it was important to analyse their 
epigenetic status.  To this end, and also to act as an interesting comparison to hES 
cells, a collection of nine fMSC lines and nine hES cell lines were analysed using 
imprinted gene expression as an index for stability.  As no parental DNA was 
available for any of the lines, imprinting was inferred from findings of monoallelic 
expression.  A gene-specific pattern of allelic expression was found across both cell 
types, where some genes where always monoallelic, and others always biallelic (see 
Table 8.2).   There was an apparent reactivation of the minor (i.e. maternal)  IGF2 
allele specifically in fMSC samples, and not hES cells.  Culture conditions associated 
specifically with fMSC e.g. trypsinisation; continual growth at subconfluency; and 
the absence of feeder cell media conditioning; may all have caused reactivation of the 
repressed (maternal) allele.  Alternatively the requirement for IGF2 imprinting may 
be less stringent in the bone marrow tissue, as has been demonstrated in the adult 
liver (Davies, 1994).  There were a total of only four informative lines, two hES and 
two fMSC, which could be analysed for IGF2 gene.  It is therefore possible but 
statistically unlikely that polymorphic imprinting present in the normal population is 
being detected, which serendipitously corresponds with the two different sample 
types (Sakatani et al., 2001).  Analysis of other informative samples would allow 
further conclusions to be drawn.     
No other differences were found between allelic expression patterns in fMSC 
or hES cells.  hES cells are derived ontologically during a period of genome-wide 
epigenetic remodelling, including remethylation of a completely demethylated 
genome.  It has been postulated that this may cause susceptibility in hES cells for 
epigenetic instability, or inherent irregularities in methylation profiles, including 
differentially methylated imprint control regions (Reik et al., 2001b).  As the 
epigenetic status of imprinted genes was the same between fMSC and hES cells, it 
seems that this is not the case.  Instead, growing cells in vitro seems to universally 
cause de-regulation amongst a subset of imprinted genes.   
The analysis of imprinting in fMSC and hES cells revealed a group of genes 
whose expression pattern varied according to individual cell lines, rather than in a 
gene-specific manner.  Table 8.1 shows allelic expression of each of the varying 
genes according to cell line. 
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BM9+4 BM10+4 BM12+4 Bl8+3 Bl11+1 Liv10+4 Liv11+5 
NAP1L5 
SLC22A1LS 
 MEST Iso1 
MEST Iso2 
H19  H19 
MEST Iso1 
SLC22A1LS 
MEST Iso1 
 MEST Iso1 
MEST Iso2 
SLC22A1LS 
GNAS 
SLC22A1LS 
NAP1l5 
SLC22A1LS 
IGF2 
NAP1L5 NAP1L5 GNAS 
MEST Iso2 
SLC22A1LS 
IGF2 
CF1 SHEF1 SHEF2 SHEF4 SHEF5 SHEF6 Fibro 
DLK1 
SLC22A1LS 
GNAS 
H19 H19    SLC22A1LS 
H19 GNAS DLK1 
GNAS 
DLK1 
SLC22A1LS 
DLK1 
GNAS 
GNAS GNAS 
Table 8.1 Comparison of allelic expression of variable genes 
        = Monoallelically expressed         = biallelically expressed.  Two fMSC lines, 
fetal bone marrow (fBM)10+4 and fetal blood (Bl)11+1, and three hES lines, SHEF4, 
SHEF45 and SHEF6 were biallelic in all cases, and just one line fBM9+4, was always 
monoallelic.  Cells derived from all three fMSC tissues were a mix of expression 
patterns and could be either always monoallelic, always biallelic or a mix of the two.  
DLK1, GNAS, SLC22A1LS and IGF2 shared allelic expression patterns (__), except in 
fibroblasts (__). 
 
fMSC may be derived from the fetal liver, bone marrow, and peripheral blood 
circulation.  Liver-derived fMSC are thought to be present to support fetal 
haematopoiesis.  The fMSC found in peripheral blood are thought to be travelling 
from the liver to the bone marrow, and like liver-fMSC are absent post-natally 
(Campagnoli et al., 2001).  Although essentially the same type of cell, it is possible 
that each population may display different attributes, on account of their varied 
environment.  No differences between fMSC for the genes which were variable were 
found which correlated to tissue of origin, i.e. fBM9+4 was always monoallelic, 
fBM10+4 always biallelic and fBM12+4 a 50:50 mix of the two.  There was also no 
pattern according to gestational age of the fetus, with a mix of biallelic and 
monoallelic expression seen across the range of eight weeks up to 12.   
The hES cells were sourced from two different laboratories, each with varied 
derivation and culture protocols.  Kings College London (KCL) hES cells were 
passaged manually, whereas the Sheffield University derived SHEF lines were 
passaged using either trypsin or collagenase, and glass beads.  There is evidence that 
passaging cells causes chromosomal instabilities, and that high passage number may 
affect imprinting of genes such as H19 (Draper et al., 2004; Rugg-Gunn et al., 2005).  
Passaging cells by manual dissection, without the use of enzymes, may reduce the 
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stress on the cells and seems to prevent karyotypic abnormalities (Mitalipova et al., 
2005; Buzzard et al., 2004).  No obvious differences based on the genes analysed 
were observed during this study between hES cells from the two different centres.  
Allelic expression of DLK1 and GNAS appeared to be in disequibrium, i.e. 
allelic expression of each was mirrored by the other where commonly informative.  
Expression of DLK1 also mirrored that of SLC22A1LS, but SLC22A1LS expression 
varied from that of GNAS.  In the two samples where SLC22A1LS and IGF2 were 
informative, they also appeared to be in disequilibrium.  Surprisingly, where both 
H19 and IGF2 are informative (for fBl8+3) H19 is monoallelic but IGF2 biallelic.  
DLK1 and GNAS also show opposing allelic patterns to H19, and as their expression 
pattern is mirrored by IGF2 they may be indicative of opposing allelic expression of 
H19 and IGF2 in other samples.   
The biallelic IGF2 expression referred to here is highly preferential.  Such 
patterns may be due to a low level of reactivation of the minor (maternal) allele 
throughout the cell population.  Alternately, a subpopulation of cells may express 
IGF2 biallelically with no allelic preference, which is detected as a minor reactivation 
due to the majority of cells expressing IGF2 monoallelically.  The fMSC analysed are 
not a clonal population, and contain subpopulations of cells with differences in 
potential, notably the propensity to differentiate to bone or to fat (Pittenger et al., 
1999).  Cultures of fMSC differentiated to bone or fat are likely to contain more 
uniform cell populations in this respect, however the allelic expression of PEG10, 
KCNQ1OT1 and SLC22A18 was identical between populations of bone, fat and 
undifferentiated fMSC.  No other patterns of allelic gene expression between genes 
were observed.    
8.2.3 Comparisons with current literature 
Two other similar studies on hES cells have been carried out recently: the 
International Stem Cell Initiative (ISCI) analysed 59 hES cell lines, including three of 
those analysed in the present ICH study, SHEF1, SHEF2 and CF1, although it 
incorrectly lists the latter as a female line (Adewumi et al 2007).  Lorraine Young and 
colleagues at the Wolfson Centre for Stem cells, Tissue Engineering and Modelling 
(STEM) and Institute of Genetics at the University of Nottingham analysed 22 hES 
cell lines, including the 16 lines derived by Chad Cowan in 2004 (Cowan et al., 
2004), plus an embryonal carcinoma line from Sheffield University. 
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In addition to assigning mono- or biallelic status to imprinted gene expression, 
both the STEM and ISCI studies assigned preferential status to expressed SNPs where 
the minor allele was less than 30% of that of the major allele.  Notably, ISCI 
measured the contribution of minor alleles by calculating the area under cDNA 
sequence chromatograms.  Such ‘partial imprinting’ was not distinguished in the ICH 
study.  This was because in several cases the area under the cDNA sequence 
chromatogram varied depending on the direction of the sequence, due to the increased 
detection levels of certain dyes, and therefore was deemed unreliable.  Instead, 
biallelic expression was assigned wherever the presence of the minor allele was 
observed, no matter how small.  To account for this here, ISCI ‘partial imprinting’ 
data, and STEM ‘preferential’ samples are added to the ‘biallelic’ data in Table 8.2 to 
ease comparison of the two data sets with the present study.  Any loss of repression, 
compared to that observed in the fetus in vivo, (Monk et al 2006 and own 
observations) was deemed important for the analysis of imprinting in cell lines as it 
may reflect a reduction in the stringency of imprinting.  Functionally meaningful 
allele specific expression, whether it is complete or preferential, is a definitive 
measure of imprinting, however the functional relevance of such a loss of repression 
was beyond the scope of this study. 
Gene Imprinting Status – n (n as % of total samples) 
Monoallelic Biallelic Pat 
ISCI STEM ICH ISCI STEM ICH 
PEG10  3 (75) 4 (100)  1 (25) 0 
MEST Iso 1 9 (24) 10 (83) 3 (75) 29 (73) 2 (17) 1 (25) 
MEST Iso 2  2 (17) 1 (33)  10 (83) 2 (66) 
MESTIT1  9 (75) 1 (100)  3 (25) 0 
KCNQ1OT1 54 (100) 12 (100) 4 (100) 0 0 0 
IGF2 37  (71) 0 2 (50) 15 (30) 10 (100) 2 (50) 
GTL2 9 (75) 8 (80) 1 (100) 3 (25) 2 (20) 0 
SNRPN 66 (100) 12 (100) 4 (100) 0 0 0 
NDN  7 (100) 7 (100)  0 0 
PEG3 8 (100) 5 (100) 1 (100) 0 0 0 
H19 53 (98) 11 (85) 5 (83) 1 (2) 2 (15) 1 (17) 
SLC22A18 1 (4) 0 0 22 (96) 7 (100) 9 (100) 
PHLDA2  10 (62) 0  6 (48) 1(100) 
CDKN1C  3 (100) 4 (100)  0 0 
KCNQ1  8 (100) 3 (100)  0 0 
ATP10C  2 (17) 0  10 (83) 2 (100) 
TOTAL 237 (77) 102 (66) 40 (69) 
 
70 (23) 53 (34) 18 (31) 
Table 8.2 Comparison of hES imprinting to ISCI study (Adewumi et al 2007). 
Mat 
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Number of samples is shown with percentages in parentheses.  Included in ISCI data 
are the same samples at different time points.  ICH data (the present study), and data 
from Nottingham University (STEM) include individual line data only.  Maternally 
expressed genes, paternally expressed genes, not analysed.  The overall patterns of 
allelic expression between the three studies is very similar, except for MEST, where 
the bias of biallelic to monoallelic expression is opposite between ISCI and the 
STEM and ICH studies. 
 
The overall results of the ISCI, STEM and Sun et al studies, comparing the 
total number of monoallelic and biallelic genes across all the lines analysed are 
consistent with the findings here, as is shown in the last row of Table 8.2  (Adewumi 
et al., 2007; Kim et al., 2007b; Sun et al., 2006).  Analysis of individual genes also 
gives similar results across all four studies, and the following genes - SNRPN, NDN, 
KCNQ1OT1, KCNQ1, CDKN1C and PEG3; are always monoallelic in hES cells 
(Adewumi et al 2007; Sun et al 2005, Kim et al 2007).  The present study shows this 
to additionally be true of fMSC.   
SLC22A18 is found to be biallelically expressed in all samples analysed in the 
present (ICH) study, and by Kim et al, (STEM study) although Adewumi and 
colleagues (ISCI study) find one monoallelic sample.  PEG10 was found to be 
monoallelic in the ICH study and by Sun et al, but variable by the STEM study.  For 
the other genes analysed, IGF2, MEST Isoform 1 and 2, GTL2 and H19, a mixed 
expression pattern was found in both ISCI and ICH studies, with a predominant 
monoallelic expression pattern for H19, consistent with that seen in the study by Sun 
et al.  Results from allelic expression data from the STEM and ICH studies closely 
mirror one another. There are minor differences, i.e. ATP10C, GTL2 MESTIT1 and 
PEG10 display a mixed expression pattern according to the STEM study, but not in 
the ICH study.  The allelic expression bias for these genes is the same for both data 
sets, and the small variations observed are likely due to the inter-individual 
differences between cell lines, whereby the analysis of further samples in each case 
would likely dilute any difference.  As such, many more samples will have to be 
analysed to fully understand the reasons behind variation in allelic expression of these 
genes. As the ICH study included fewer informative samples for each, it is likely that 
analysis of more samples would reveal a pattern identical to the STEM data.   
More differences were apparent between the ISCI and ICH/STEM studies.  
IGF2 expression was predominately biallelic in hES cells in the STEM data, in fMSC 
in the ICH data, but mostly monoallelic in the ISCI hES cells.  As previously 
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mentioned, a variation in the designation of expression bias between the three studies, 
where the ISCI study allowed inclusion of samples with a minor allele input of up to 
14 % in their ‘monoallelic’ category, may account for the difference.  The other main 
variation was in the expression of the MEST isoforms, which were also predominately 
biallelic in the ISCI study.  The manuscript did not elaborate on which isoform was 
analysed, and non-isoform specific PCR would result in apparent biallelic expression 
of these transcripts. 
8.2.4 Variations in passage and differentiation state 
In some cases in the ISCI study expression varied within lines, dependent on 
the particular sample.  In such a case polymorphic imprinting within the population 
may be ruled out, and changes in expression assigned to cell culture.  Such 
differences between samples of the same line were not observed in the ICH study, but 
the samples analysed were fewer and so changes may have been below detection.  
Allelic expression patterns of imprinted genes in the ICH study were the same 
between hES cells derived from two different labs, and those with variations in 
passage.  hES RNA was available from the KCL lines from cells which had been 
differentiated to embryoid bodies, denoted hES EB, which consist of cells from all 
the three germ layers and are no longer pluripotent  (Doetschman et al., 1985).  SHEF 
cell lines were available from a large range of different passages, which when high 
was accompanied by karyotypic alterations, 16 % of the SHEF4 line at passage (P) 
104 was trisomy 17, and SHEF1 at P121 had 10 % of cells with trisomy 3, and 90% 
with a deletion on the long arm of chromosome 2.  These samples allowed an 
interesting extension to this analysis and showed that such differentiation and passage 
did not appear to alter the imprinted gene status for that specific line. 
The biallelic expression of certain imprinted transcripts has been shown here 
in undifferentiated fMSC from a range of fetal origins, and seems to be inherent.  
Differentiation of fMSC to the mesodermal lineages of osteoblasts and adipocytes is 
likely to be an important step in their development for use in regenerative therapy 
(O'Donoghue and Fisk, 2004).   The results show that in vitro differentiation of fMSC 
to either cell type does not result in a change of allelic expression of three imprinted 
genes.  This further confirms that loss of imprinted expression of certain imprinted 
genes is an inherent feature of cultured cells.  Importantly, differentiation culture, 
which puts additional selective pressures on the cells, does not seem to result in 
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additional de-regulation of imprinting.  The execution of ‘normal’ tissue-specific 
imprinting, or just allelic expression alone in cells differentiated in-vitro is likely to 
be one of the challenges of differentiation culture, particularly for culture which is 
aimed at therapeutics.  
8.2.5 Imprint cluster regulation 
The regulation of genomic imprinting is carried out through several tiers of 
epigenetic regulation.  There are several features common to each imprinting cluster, 
i.e. a high concentration of tandem repeats and a CpG rich region, which generally 
harbours allelic differential methylation of DNA.  There are other features which are 
common, but not necessarily universal, such as the presence of binding sites for 
CTCF and YY1, transcriptional units containing long, non coding (nc) RNA 
molecules, and the allelic enrichment of histone proteins, resulting in permissive or 
restrictive chromatin conformation.  Characterisation of imprint clusters is still in 
progress, and it is possible that inconsistencies between clusters are due to technical 
limitations in their analysis.  At present, however, each imprinting cluster maintains 
apparent unique aspects to the way monoallelic expression is executed.   
The present study has shown a lack of correlation between the universal 
imprint control feature, differential ICR methylation, and loss of appropriate allelic 
expression.  As each cluster has additional mechanisms which are used to carry out 
monoallelic expression, it is possible that one particular feature may be susceptible to 
the rigors of in vitro culture.   
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Figure 8.2 Allelic expression of genes grouped according to epigenetic regulators 
Genes are shown grouped according to epigenetic regulatory mechanisms with which 
they have been linked.  Each regulator is represented by a coloured circle, and the 
inclusion of a gene within such circle indicates that their expression is influenced by 
that factor.  Genes positioned where circles are overlapping indicates where two or 
more regulators are implicated.  Genes are coloured according to their allelic 
expression as observed in hES cells and fMSC, where BLACK = monoallelic 
expression and ORANGE = biallelic or mixed expression.  There is no apparent 
correlation between any of the epigenetic regulatory factors; alternative promoter 
useage, CTCF binding, somatic DMRs, YY1 binding, ncRNA expression and histone 
modification; and allelic expression.   
 
Figure 8.2, above, shows a summary of the genes which were expressed 
biallelically, or in a mixed pattern, in the stem cells, correlating de-regulation of 
imprinting in each cluster with imprint cluster control mechanisms.  From the data in 
the present study, no correlation is clear between any particular epigenetic control 
mechanism, and the de-regulation of imprinting.  With more samples it may be 
possible to observe trends, however, it is likely that all mechanisms are affected in 
some way.  Only by analysing each cluster as a whole, focussing in turn on each 
mechanism, will the factors responsible for imprint de-regulation in vitro be 
elucidated.   
The consequence of the de-regulation of imprinted gene expression observed 
in fMSC is unclear.  It is possible that a loss of appropriate imprinting has no 
phenotypic impact on the cells and so does not reduce their value in the clinic.  The 
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biallelic expression of a growth enhancer such as IGF2 may reasonably be expected 
to improve growth parameters of the cells, and would thus be selected for, leading to 
out-competition of slower growing, but correctly imprinted, cells.  Loss of imprinting 
has been shown to correlate with tumorigenesis, and so the extent to which 
deregulation has occurred may indicate the propensity of the cells to undergo 
neoplastic transformation (Holm et al., 2005).   
With the premise that the more similar cultured cells are to their in vivo 
counterparts, the better, the maintenance of imprinting patterns is a desirable 
outcome.  It would be useful to carry out experiments across a range of culture 
conditions, to determine whether certain conditions are more conducive to the 
maintenance of imprinting patterns.  Several genetically different fMSC lines would 
have to be analysed in parallel to achieve coverage for all of the genes which have 
been observed to be biallelic or have mixed expression patterns in the current study.  
It is highly possible that imprinting is disrupted upon derivation, however, and so to 
test this, aspirate samples (from fetal bone marrow, blood or liver) would have to be 
divided at collection.  One part of the aspirate would be plated out for fMSC line 
derivation, and the remainder analysed for allelic expression as the ‘starting’ cell 
population.  Each sample would likely be informative for perhaps nine genes, the 
mean observed in this study, perhaps two or three of which are likely to fall into the 
‘biallelic’ or ‘mixed’ category, so a large number of samples would be required to 
carry out a comprehensive analysis.  The main problem is that initial cell aspirates 
contain only a very few actual fMSC cells, present at a rate of 0.4 % of the total bone 
marrow cell count (Campagnoli et al., 2001).  The final cell culture is a result of two 
passages during which all other tissue is washed away, due to being non-adherent, or 
being out competed by the fMSC population.  A starting cell population of 
necessarily unpurified aspirate would therefore not be representative. 
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8.3 Methylation 
8.3.1 Differences between fMSC and hES cells 
Comparison of differential methylation at imprinting control regions revealed 
the first striking difference between fMSC and hES cells.  Most DMRs remained 
differentially methylated, however, the NESP55 and DLK1 DMRs exhibited line-
specific hypo and hypermethylation in hES cells but not fMSC. 
hES cells are derived from the inner cell mass of human blastocysts, donated 
to research following assisted reproduction techniques (ART).  In vitro fertilisation 
(IVF) or intracytoplasmic sperm injection (ICSI) both require the in vitro culture of 
human gametes and embryos.  The effect of culture on the future growth and 
development of children resulting from ART is the topic of large scale population 
studies in the human, as well as in animal models.  Observations of human singleton 
births following ART report an increased incidence of preterm birth, low birth 
weight, neonatal mortality, and admissions to intensive care when compared to 
naturally conceived singletons (Helmerhorst et al., 2004; Jackson et al., 2004; 
McDonald et al., 2005; Schieve et al., 2007).  The incidence of congenital 
malformations, however, does not seem to be increased following ART, rather it 
correlates positively with parental infertility (Sutcliffe and Ludwig, 2007; Zhu et al., 
2006) 
Studies pertaining specifically to errors in epigenetic regulation are most 
informative in examples from other species.  The monoallelic expression of the 
imprinted IGF2R gene can be disrupted in sheep following SCNT or embryo culture, 
due to loss of maternal DMR methylation (Young et al., 2003).  Loss of imprinting of 
this gene is linked to Large Offspring Syndrome (LOS), which has been observed in 
sheep, cattle and mice following nuclear transfer or in vitro culture (Eggan et al., 
2001; Young et al., 2001; Young et al., 2003; Fernandez-Gonzalez et al., 2004).  
Epigenetic defects in mouse embryos are particularly widespread, involving changes 
in DNA methylation and the de-regulation of several imprinted gene clusters .(Dean 
et al., 2001; Humpherys et al., 2001; Khosla et al., 2001; Mann et al., 2004; Rivera et 
al., 2008). 
In humans, the incidence in the normal population of so-called imprinting 
syndromes, such as Beckwith Wiedemann syndrome (BWS; MIM 130650) and 
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Angelman Syndrome (AS; MIM 105830) is low, both currently affecting 1 in 15,000 
live births.  BWS may result from several epimutations, but the majority, and almost 
all cases following from ART, are caused by hypomethylation of the KvDMR 
(Gicquel et al., 2003; Maher et al., 2003; Lim et al., 2008).  It has been suggested that 
procedures such as IVF and ICSI may increase the risk of BWS in these children 
from as much as 3 to 6 % (Debaun et al., 2003).  AS is caused by hypomethylation at 
the SNRPN promoter, and has been linked with the ICSI procedure particularly (Cox 
et al., 2002; Orstavik et al., 2003; Ludwig et al., 2005).  As a sub-group of these rare 
populations, the small number of patients conceived through ART make statistical 
comparison difficult and it is still not clear whether the perceived increase in 
imprinting disorders following ART is significant (Lidegaard et al., 2005; Bowdin et 
al., 2007; Doornbos et al., 2007). 
These observations have led to fears that the culture medium does not provide 
adequate nutrition at this sensitive developmental stage.  The concentration of serum, 
a routine component of cell culture milieu, has been shown not only to affect 
imprinted gene expression in mouse blastocyst, but also more growth and 
development pre- and postnatally (Fernandez-Gonzalez et al., 2004).  Another 
concern regarding culture medium is the provision of a methyl donor concentration to 
mirror the in vivo environment (Steele et al., 2005).  The preimplantation embryo 
undergoes two waves of de- and remethylation, in order to reprogram the terminally 
differentiated nuclei of the sperm and oocyte into that of a pluripotent cell (Reik et 
al., 2001b).  Demethylation of pronuclei in 59 pre-cleavage human zygotes was 
measured to find that half of the zygotes mirrored the methylation pattern in the 
mouse, where the paternal pronucleus is much less methylated than the maternal one, 
as expected given the active demethylation of the paternal pronucleus.  Aberrant 
pronuclear demethylation has been shown to have adverse effects on development 
and viability (Shi and Haaf, 2002).  The remaining zygotes, however, had equal levels 
of methylation between the pronuclei (Fulka et al., 2004).  In addition to variation 
between embryos, methylation levels between early and late blastocyst expansion 
rose by 20%, introducing potential for inherent differences between hES cell lines, 
depending on the stage at which they were harvested (Fulka et al., 2004).   
As well as being cultured in vitro, ART embryos are normally produced 
following fertilisation of superovulatory oocytes. The incidence of imprinting 
disorders following ART has been suggested to be a consequence of superovulation, 
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rather than embryo culture (Chang et al., 2005; Ludwig et al., 2005).  Primordial 
follicles are arrested in dictyate during female development, and from puberty 
onwards begin a continual recruitment into maturation.  Oocyte development, 
concurrent with the stepwise methylation of imprint control regions (ICRs), thus 
occurs throughout a woman’s life (Obata and Kono, 2002).  Drugs specifically 
designed to speed up folliculogenesis and oocyte development may well have a 
negative impact upon the integrity of imprint control region methylation.  
Superovulation has been shown to cause defects in genome methylation levels, and 
specifically in the differential methylation at ICRs, notably at the those of H19 and 
MEST/Mest in human and mouse oocytes (Sato et al., 2007; Shi and Haaf, 2002).  
Careful comparisons of imprinted gene expression in superovulation derived mouse 
embryos with or without embryo transfer were able to distinguish the effects of 
superovulation and in vitro culture (Fortier et al., 2008).  Fortier and colleagues 
observed biallelic expression of H19 and Snrpn in the mouse placenta, and up-
regulation of Igf2 expression following superovulation, both in embryos which were 
transferred, and those which continued normal in vivo development.  The authors 
suggest that as both maternally- and paternally-set imprints are affected, 
superovulatory drug regimes adversely affect the oocyte cytoplasm, reducing its 
ability to maintain imprints during pre-implantation development (Fortier et al., 
2008). 
Fetal mesenchymal stem cells are derived at a point much later in gestation, 
when genome-wide epigenetic reprogramming is complete.  In addition, the fetuses 
from which the cells were derived were conceived without the use of ART.  This 
distinction between fMSC and hES cells may result in the increased stability of 
differential methylation at certain loci in fMSC, compared to hES, as observed in this 
study. 
8.3.2 Cluster specific observations 
For all imprinted gene clusters analysed, biallelic expression with maintained 
differential methylation in both fMSC and hES cells was observed.  Monoallelic 
expression with hypo- or hypermethylation was additionally observed in hES cells.  
Where possible, all samples underwent methylation analysis, whereas allelic 
expression could only be carried out if samples were informative for the intragenic 
SNPs identified for the gene of interest.  Where allelic analysis could be completed 
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alongside analysis of ICR methylation in individual samples, correlation between the 
two characteristics, e.g. hypomethylation with biallelic expression; and a lack thereof, 
were both observed scenarios.  
The lack of correlation between a loss of imprinting in cultured cells and 
allelic ICR methylation has been observed previously in other studies.  Kim et al 
analysed hES cell lines and found differential methylation was maintained at the 
KvDMR but observed similar patterns of allelic expression to those observed in the 
present study, where KCNQ1OT1, KCNQ1, and CDKN1C were monoallelically 
expressed, but SLC22A18 and PHLDA2 biallelic (Kim et al., 2007b).  Here, KvDMR 
differential methylation of a 1:1 ratio in each sample was consistent with the 
monoallelic expression of KCNQ1OT1, CDKN1C and of KCNQ1, but not with the 
observed biallelic expression of SLC22A18 and PHLDA2, and mixed expression 
pattern of SLC22A1LS.  Kim and colleagues also analysed methylation at the 
SLC22A18 promoter, and correlated findings of hypomethylation with its biallelic 
expression (Kim et al., 2007b).  Maternal expression at the KCNQ1 cluster is 
executed through allelic histone modifications, following paternal KCNQ1OT1 
ncRNA expression, and individual gene promoters are unmethylated even when 
appropriately imprinted (Monk et al., 2006a).   
In some cases, such as the hypermethylation observed in the hES line CF1 at 
the H19 DMD and promoter, the exact opposite allelic expression pattern was 
observed than would be expected, as CF1 was biallelic (see Figure 6.5 in Results 
Chapter 5).  Differential methylation at the H19 DMD results in maternal expression 
of H19, and paternal expression of IGF2.  A decoupling of this control is seen in 
fBl8+3, where H19 is monoallelic but IGF2 is biallelic.  Maintained differential 
methylation in this sample indicates that another mechanism must be responsible for 
the disruption to this region, such as CTCF, known to play an integral role in 
imprinting at the IGF2 locus (Hark et al., 2000; Kurukuti et al., 2006).   
At the MEST cluster on hChr7q32, each cell line appears to have maintained 
differential methylation of the MEST DMR, but CPA4 was found to be biallelic in all 
lines, and MEST expression was variously biallelic and monoallelic.  MEST Isoform 2 
expression is tissue specific, where preferential paternal expression has been found 
specifically in fetal kidney and placenta (Nakabayashi et al., 2002).  The finding of 
monoallelic MEST Isoform 2 in one fMSC sample, however, indicates that biallelic 
expression is not due to tissue specificity.  McMinn and colleagues also found MEST 
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Isoform 2 to be imprinted in placental tissues, and noted that this was a polymorphic 
trait, found in approximately 1/3 of the population. It is likely that the mixed pattern 
of imprinting observed for MEST Isoform 2 is due to polymorphic imprinting 
(McMinn et al., 2006).  MEST Isoform 1 is regarded as universally imprinted in the 
human, however, and the fMSC sample fBM10+4 expressed both isoforms 
biallelically, whilst maintaining differential methylation at the ICR (Kobayashi et al., 
1997; Kosaki et al., 2000).  Kim and colleagues alternately observe correlation 
between methylation and expression at this locus, where differential methylation was 
observed in all but two hypomethylated cell lines, which were also biallelic (Kim et 
al., 2007b).  It is not clear why expression is decoupled from the methylation status of 
the ICR. The long ncRNA MESTIT1 remains monoallelically expressed, although 
only one sample was informative for the SNP analysed in this gene.  This sample 
(fBM12+4) was also informative for the two MEST Isoforms and interestingly, both 
were monoallelically expressed in this sample.  Imprinted expression at several loci 
has been linked to the expression of long ncRNA molecules, e.g. KCNQ1OT1, 
NESPAS and Air in the mouse, however, no links have thus far been reported in the 
literature between MEST and MESTIT1. 
At the GNAS locus the maintenance of differential methylation at both 
germline NESPAS/XL DMR and somatic NESP55 DMR reflects the appropriate 
allelic expression of the transcripts analysed.  The methylation status of the two 
DMRs is the same in all except SHEF5 hES cells, where the NESP55 DMR is 
hypermethylated, and for WT4, which exhibits opposite methylation patterns.  WT4 
is hypomethylated at the NESPAS/XL DMR, and hypermethylated at the NESP55 
DMR.  A lack of informative samples meant that allelic analysis was not carried out 
for this cell line.  In the study by Kim et al, methylation at this cluster also correlated 
with expression, where, biallelic expression correlated with hypomethylation in the 
HUES5 hES cell line. 
The methylation status of the IG-DMR correlates with allelic expression in 
certain cell lines.  fBM10+4 and CF1 express GTL2 and DLK1 monoallelically 
respectively, and display differential allelic methylation, with a ratio of methylated to 
unmethylated alleles of 1:1.  SHEF4 expresses DLK1 biallelically, and is 
hypermethylated, consistent with the role of the IG-DMR, and the phenotype of mice 
mutant for the maternal, unmethylated, IG region (Lin et al., 2003).  hES lines SHEF2 
and SHEF5, however, also express DLK1 biallelically, but do not show any 
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hypermethylation at the IG-DMR, and were differentially methylated.  Interestingly, 
the IG-DMR retained differential methylation in all fMSC lines, but was variable in 
hES cells.  Differences in culture or derivation between these two types of cell may 
increase susceptibility of disruption at the IG-DMR in hES cells.  The lack of 
correlation in some samples between methylation and allelic expression, indicates 
that other factors, e.g. CTCF, may be involved in the execution of monoallelic 
expression, and be disrupted in these samples, causing biallelic gene expression 
despite the maintenance of differential methylation (Rosa et al., 2005).   
The KRAB zinc-finger protein Zfp57 has also been shown to be important for 
de novo imprint methylationat the Snrpn locus, and for post-fertilisation maintenance 
of differential methylation at the IG-DMR, Gtl2 promoter, Snrpn, Mest and Peg3 
DMRs in mice (Li et al., 2008b).  The IG-DMR in the human samples here exhibited 
variable methylation in hES cell lines.  It may be that Zfp57 mediated DMR 
maintenance is particularly susceptible to the cell culture environment, as compared 
to those maintained soley through PGC7/Stella, e.g.  H19 DMD, although 
methylation at SNRPN remained differential. 
In vitro culture of stem cells has profound and variable effects on phenotype; 
dependent on cell type, derivation and method of culture (Abeyta et al., 2004; 
Allegrucci and Young, 2006; Doherty et al., 2000; Sperger et al., 2003).  High 
confluency, serum concentration and exposure to dimethyl sulfoxide, used routinely 
in cryopreservation, have all been shown to alter methylation in mouse ES cells 
(Baqir and Smith, 2003; Fernandez-Gonzalez et al., 2004; Iwatani et al., 2006b).  In 
some cases the loss of allelic methylation is a candidate for the loss of imprinting 
observed in cultured cells, possibly through methyl group availability (Steele et al., 
2005). 
In order to ascertain which level of epigenetic modification is aberrantly 
controlled in cultured cells as opposed to the in vivo environment, DNA methylation 
must if possible be examined alongside histone modifications and their enzyme 
effectors, and non-coding RNAs, blocking elements such as CTCF and tissue specific 
transcription factors (Lewis and Reik, 2006).  As previously mentioned, histone 
modifications using ChIP assays would require a large amount of cellular material for 
the lines demonstrating aberrant imprinting patterns, plus control ‘normal’ lines.  
Additionally, the cell lines analysed would need to be informative for appropriate 
polymorphisms to allow SSCP distinction of alleles. 
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8.3.3 Technical limitations 
The methods used to analyse methylation levels, Combined bisulphite and 
restriction analysis (COBRA) and bisulphite sequencing, both require a PCR 
amplification step, and so utilise sequence specific primers.  The primers were all 
designed so that they bound uniquely to the target sequence before conversion.  
Optimisation was carried out to ensure that only one product was amplified, and that 
it was digested as expected.  Following bisulphite conversion, it was not possible to 
BLAST the primers and so there a chance they were no longer unique, and could be 
complimentary for non-target sequence.  All of the bisulphite PCRs were sequenced 
and verified as the target sequence, however, it is possible that a second non-target 
amplicon were present, which could interfere with downstream analysis.  In the case 
of H19 Promoter there is a large amplicon which is present before and after 
enzymatic digestion.  Optimisation of PCR conditions did not stop amplification of 
this second product, and as it did not prevent quantification of the digest products the 
primers were kept. 
COBRA is a semi-quantitative approach and allows estimation of the 
proportion of methylated to unmethylated alleles.  This method only allows analysis 
of one or two CpG dinucleotides, however, and it is possible that changes in 
methylation, or the absence of a DMR, may be masked by the characteristics of the 
base analysed (see Figure 8.3 below). 
 
Figure 8.3 Methylation analysis of an example DMR and non-DMR 
Methylated CpGs are represented as closed circles, unmethylated CpGs by open 
circles.  The DMR example shows the presence of completely methylated CpGs 
assigned to allele ‘A’ and strands containing only unmethylated CpGs assigned to 
allele ‘B’.  The non-DMR example shows a mixed pattern of methylation in each 
strand.  Using COBRA, each region would give the same result, as the CpG 
recognised by the enzyme is methylated in 50% of the alleles in each case. 
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To define a differentially methylated region (DMR), methylated and 
unmethylated strands must be assigned to one allele or the other.  As in expression 
analyses, the presence of polymorphic bases in or close to the DMR may be used to 
assign strands to different alleles, and if parental genotypes are available, to assign 
parental origin.  Cloning and sequencing bisulphite PCR products allows analysis of 
conversion rate, methylation of all of the CpG dinucleotides in the amplicon, and of 
any polymorphisms.  There were no informative SNPs in any of the 100-400bp 
amplicons in the seven genes analysed by bisulphite sequencing.  The presence of 
both either completely unmethylated or completely methylated strands is highly 
indicative of a DMR, however (Figure 8.3).  It is still possible that the methylated 
strands are from one cell sub-population, and the unmethylated strands from another, 
however the cells analysed were uniform populations which were grown and 
expanded in parallel so this is unlikely. 
8.4 Peripheral blood leukocytes 
Peripheral blood leukocytes were analysed initially due to the fact that they 
originate in the bone marrow, the canonical origin of mesenchymal stem cells.   
Expression of imprinted genes in adult PBL is very different from that of fMSC, 
where genes which are biallelic in fMSC are monoallelic in PBL, and vice versa (see 
Table 8.3).  Expression patterns characteristic of haematopoietic cells may thus not 
reflect those of neighbouring MSCs, however these results are confounded by (i) the 
in vitro nature of the fMSC analysed and (ii) the fact that PBL are a circulating 
population.  Since leaving the bone marrow, PBL are subjected to vastly different 
signalling cascades to that which they receive in their niche, and therefore to fMSC, 
with likely altered gene expression patterns.  There are some genes whose 
monoallelic expression status is shared between fMSC and PBL (Table 8.3), 
demonstrating that the imprinting status of certain genes in the human is very robust, 
concordant with previous reports (Kim et al., 2007b; Rugg-Gunn et al., 2005). 
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Table 8.3 Comparison of imprinting status between fMSC and PBL 
Allelic expression patterns of the 12 genes commonly expressed between fMSC and 
PBL.  Half of the genes share the same allelic expression between the two cells types.  
The other half tended to be biallelic in PBL but monoallelic or variable in fMSC.  The 
exception is IGF2, which was uniformly monoallelic in PBL, although the biallelic 
expression found in fMSC was highly preferential.  Variable gene sample 
distribution, fMSC: NAP1L5, 1 monoallelic, 3 biallelic; MEST Isoform 2, 1 
monoallelic, 2 biallelic; GNAS 1 monoallelic, 7 biallelic.  PBL: MEST Isoform 2, 8 
biallelic, 1 monoallelic; INPP5F_V2, 8 mononallelic, 3 biallelic.   
 
A second developmental phenomenon exclusive to mammals, and executed 
epigenetically, is the means by which females carry out dosage compensation.  X-
chromosome inactivation (XCI) occurs during pre-implantation development, and is 
characterised by the condensation of one of the X chromosomes to form 
heterochromatin (Lyon, 1961).  XCI shares several parallels with imprinting except, 
at least in humans, the parental origin of the inactivated X is random and stochastic 
(Reik and Lewis, 2005; Monkhorst et al., 2008).  The ratio of maternal inactivated X 
(Xi):paternal Xi is generally accepted to be 50:50, with substantial deviations from 
this designated as ‘skewed’.  There is a well characterised increase of inactivation 
skewing with age (Minks et al., 2008).  Tissue specific skewing, however, has been 
observed independently of this trait, with peripheral blood leukocytes (PBL) 
highlighted almost universally as the significantly skewed tissue (Sharp et al., 2000; 
Knudsen et al., 2007; Bolduc et al., 2008).  Blood is a highly plastic, regenerative and 
explorative tissue, and the skewing of X-inactivation in blood and some epithelia, is 
significantly higher when compared to mitotically inactive and anatomically 
restricted tissues such as muscle (Sharp et al., 2000; Knudsen et al., 2007; Bittel et al., 
2007).  Variation in cellular environment and a high turnover are thought to result in 
an over-representation of cells with a particular active Xi, and a similar unexplained 
mechanism may select cells with specific epigenetic profiles i.e. the down-regulated 
imprinted expression that is observed here.  
 
 
Monoallelic Variable Biallelic 
Monoallelic 
 
PEG10 
SNRPN 
NDN 
GNAS EXON 1A 
INPP5F_V2 KCNQ1 
KCNQ1OT1 
Variable 
 
 MEST Isoform 2 NAP1L5 
GNAS 
Biallelic 
 
IGF2  SLC22A18 
fMSC 
PBL 
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Such tissue specific regulation of imprinting is often through differential 
promoter usage, notably in the cases of ZAC1, GNAS and MEST.  Biallelic ZAC1 
expression, implicated in Transient Neonatal Diabetes Mellitus (TNDM) was recently 
found in PBL of healthy individuals, originating from a second PBL specific, non-
DMR, promoter (Valleley et al., 2007; Arima et al., 2001).   The data in the present 
study corroborates these observations, and MEST Isoform 2, and the canonical GNAS 
transcript are additionally found to be biallelic and highly expressed in PBL. 
One of the most common alterations in cancer development and progression is 
that of imprinted gene expression (Feinberg, 2000; Joyce and Schofield, 1998). 
Global manipulation of imprinting causes transformation of cells both in vivo and in 
vitro  (Hernandez et al., 2003; Holm et al., 2005) and the list of human imprinted 
genes over-represents both proto-oncogenes and tumour suppressors 
(http://igc.otago.ac.nz/).  The biological requirement to maintain imprinting in the 
postnatal state is not known (Constancia et al., 2004).  In a highly proliferative and 
circulatory cell type such as peripheral blood leukocytes, it may be favourable to 
down-regulate imprinted expression, as is observed here, either through alternative 
promoter use or another epigenetic regulation process, as a potentially protective 
mechanism against cancer. 
It has been suggested that biallelic expression of imprinted genes such as 
IGF2 may be a useful predictive marker for risk of cancer development, even in 
other, unaffected tissues such as blood (Cui et al., 2003).    The monoallelic status in 
normal adult blood of six of the genes analysed potentiates their use as a marker in 
this way, (PEG10, IGF2, SNRPN, NDN, IPW and GNAS EXON 1A), however, of 
these only IGF2 has been linked to tumorigenesis.  The remaining 30 imprinted genes 
were either biallelic or below detectable levels in adult peripheral blood leukocytes.  
These results demonstrate that many imprinted genes are not highly expressed in 
blood, and those that are functionally expressed are mostly biallelic.  Lack of 
imprinting in adult human blood is both common, normal and in most cases unlikely 
to provide a useful marker for disease. 
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8.5 Summary 
 
The current study initially set out to evaluate the allelic expression of genes of 
the KCNQ1 imprinted domain on hChr11/mChr7, specifically imprinted in the mouse 
placenta, using a model of early human trophoblast cells.  Data from these 
experiments revealed a lack of placental-specific imprinting in this model, in keeping 
with the extensive analysis of human tissues from the first trimester, carried out 
previously (Monk et al., 2006a).  Whilst this was novel in itself, these analyses also 
permitted the interesting observation that the in vitro culture of human cells results in 
the biallelic expression of certain imprinted genes in this region. 
To explore this finding, two types of stem cell, human embryonic stem (hES) 
cells and human fetal mesenchymal stem cells (fMSC) were available for analysis.  
The in vitro production and derivation of hES cells, in contrast to the in vivo nature of  
fMSC prior to derivation meant that it was interesting and important to compare the 
two types of cell.  The study was expanded to include the majority of the imprinted 
genes characterised in the human, as identified from the University of Otago’s 
database http://igc.otago.ac.nz/home.html.  The allelic expression of each gene was 
analysed as far as transcript expression and the presence of informative single 
nucleotide polymorphisms would allow.  In parallel with allelic expression analysis, 
the methylation at differentially methylated imprint control regions was assessed in 
each cell line.   
It was found that monoallelic expression of imprinted genes is prone to 
become biallelic in a very gene specific manner.  Some imprinted genes, notably 
PEG10, KLF14, GTL2, INPP5F_V2, KCNQ1OT1, KCNQ1, CDKN1C SNRPN, NDN, 
PEG3, and GNAS EXON1A are always expressed monoallelically, independent of cell 
type, culture method, passage or differentiation state, largely consistent with the 
current literature on this topic.  SLC22A18 is always expressed biallelically in the cell 
lines analysed here, as are ATP10C, GRB10 and CPA4.  For all other genes, mixed 
expression patterns were observed, where genes where biallelic in some samples but 
not in others, however, this variation was again independent of whether the cells were 
fMSC or hES cells, and neither cell type exhibited propensity for lack of imprinting 
over the other.   
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In contrast, methylation analysis demonstrated a difference in stability of 
differential methylation between fMSC and hES cells.  fMSC maintained differential 
methylation at all loci analysed, whereas hES cells demonstrated line-specific hyper- 
and hypomethylation.  Given that both cell lines displayed allelic expression de-
regulation to the same extent, but only hES cells exhibited methylation changes, is 
suggestive of two things.. First that de-regulation of imprinting is not due to loss of 
differential methylation, compounded by the lack of correlation of samples where 
changes in methylation occurred alongside normal allelic expression, and vice versa.  
Secondly, that the production of hES cells through ART, followed by their derivation 
during genome-wide reprogramming, does have a negative effect on the cells, 
specifically in terms of their maintenance of differential methylation at ICRs.   
Given the limitations of analysing human physiology using tissue and cell 
cultures, as exemplified in the case of genomic imprinting, above, data must be 
verified using in vivo samples.  Extraction of healthy tissue from living people has 
obvious limitations, except in the case of peripheral blood.  As imprinting can be 
temporal and tissue specific, the nucleated cell population of peripheral blood 
(peripheral blood leucocytes, PBL) may not be representative of the rest of the adult.  
To assess the extent of imprinting in PBL, and to some extent, in the adult, where 
much of the current literature is specific to fetal development, the panel of genes 
analysed in hES and fMSC was similarly analysed in PBL.  Quantitative expression 
analysis, followed by allele specific assays, revealed that of 40 imprinted genes, the 
majority were only expressed at a very low level in PBL.  Of those which were 
expressed, nine were either biallelic or displayed a sample-specific mixed pattern of 
mono- and biallelic expression.  Given the recent interest in the use of a loss-of-
imprinting of the IGF2 gene in PBL as a diagnostic marker for colon cancer, this data 
highlights the limitations of the use of imprinted genes in this way (Cui et al., 2003).  
There were six genes, including IGF2, which remained monoallelic in PBL, and so 
theoretically, albeit requiring confirmation with a much larger sample set, allelic 
expression of these genes may have a use as a marker for transformation, although at 
present only IGF2 has been linked with tumorigenesis. 
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Appendix III – Quantitative expression of imprinted genes in PBL 
Gene/ 
cluster 
Locus Transcripts 
in cluster 
UCSC SNP 
annotation 
Methylated 
DMR 
P of 
O 
dCt PBL 
A 
dCt PBL 
B 
dCtB-
dCtA 
2-dCtPBL A  
(3 s.f.) 
2-dCtPBL B  
(3 s.f.) 
QPCR RT 
PCR 
Allelic 
Exp 
DIRAS3 1p31   1Prom MAT Pat 14.411 17.017 2.61 4.59E-05 7.54E-06 BT U - 
TP73 1p36   Prom PAT Mat 11.814 14.436 2.62 0.000278 4.51E-05 BT U - 
NAP1L5 4q22  rs710834 2Prom MATG Pat 5.555 5.645 0.09 0.0213 0.0200 Highest 40 9/9 B 
Isoform 1  3Prom MATG Pat 9.759 10.977 1.22 0.00115 0.000496 Pl, Li, Br U - ZAC1 6q24 
Isoform 2 
rs9373409 
 B 11.988 13.277 1.29 0.000246 0.000101 BT 45 3/3 B 
IGF2R 6q25  rs614754  Mat 2.389 2.125 -0.26 0.191 0.229 Highest  1/1 B 
GRB10 7p11 GRB10  rs1800504 4CGI2 MATG Pat 10.593 12.13 1.54 0.000647 0.000223 BT U - 
PEG10 PEG10  rs13073 Pat 8.231 9.988 1.76 0.00333 0.000985 Pl, Li, Br 40 4/4 M 
 
7q21 
SGCE  
5Prom MATG 
Pat 9.971 10.86 0.89 0.000996 0.000538 BT U - 
CPA4  rs2171492  Mat ND ND ND ND ND - U - 
MESTIT1  rs12706940 Pat 15.879 16.034 0.15 1.66E-05 1.49E-05 BT U - 
MEST 
Isoform 1  
Pat 12.866 11.401 -1.47 0.000134 0.000370 BT U - 
MEST 
Isoform 2 
rs1050582 
 
 
6Prom MATG 
Pat 7.403 7.756 0.35 0.00591 0.00463 Br 35 8/9 B; 
1/9 M 
MEST  7q32 
KLF14  agaagcc(a/
g)gacgagg 
Sugg DMRG 
PAT 
Mat ND ND ND ND ND - U - 
INPP5F 
_V2 
10q26  rs3188055 2Prom MATG Pat 16.885 15.091 -1.79 8.26E-06 2.87E-05 BT 40 8/11 M; 
3/11 B 
WT1   Pat 17.324 U (>40) U (>40) 6.09E-06 <1x1012 BT U - 
WT1-AS 
11p13 
  
7ARR DMR 
MAT   U (>40) U (>40) U (>40) <1x10-12 <1x1012 BT U - 
PHLDA2   Mat 8.989 9.617 0.63 0.00197 0.00127 Pl, Li, Br U - 
SLC22A18  rs1048046/
7 
Mat 6.726 9.617 2.89 0.00945 0.00127 Highest 40 5/5 B 
SLC22A1LS  Mat ND ND ND ND ND - U - 
CDKN1C  Mat 6.91 8.011 1.10 0.00832 0.00388 Pl U - 
KCNQ1OT1  rs231357/9 Pat 4.991 5.77 0.78 0.0314 0.0183 Highest/Pl  40 6/6 B 
KCNQ1 11p15 
KCNQ1 rs1057128 
8KvDMRG 
MAT 
Mat 4.907 5.021 0.11 0.0333 0.0308 Highest 38 3/3 B 
IGF2/ 11p15 H19   9DMR1 PATG  Mat 11.118 11.854 0.74 0.000450 0.000270 BT U - 
  254 
H19 IGF2  rs680 P0 MATS, 
DMR2 PATS 
Pat 11.391 12.29 0.90 0.000372 0.000200 Pl, Li, Br, 
BM 
33 22/22 B 
HTRA2 13q14    Mat 12.782 14.758 1.98 0.000142 3.61E-05 BT U - 
GTL2   Mat 11.223 16.924 5.70 0.000418 8.04E-06 BT U - 
DLK1   Pat 9.569 17.139 7.57 0.00132 6.93E-06 Pl, Li U - 
DLK1/ 
DIO3 
14q32 
DIO3  
10GTL2 prom 
PATS 
IGDMRG PAT Pat U  (>40) U (>40) U (>40) <1x10-12 <1x1012 BT U - 
NDN  rs2192206 Prom MAT? Pat 14.632 12.495 -2.14 3.94E-05 0.000173 BT 40 3/3 M 
SNRPN  rs705 11Prom MATG Pat 2.344 2.499 0.16 0.197 0.177 Highest 40 3/3 M 
IPW  rs691  Pat 6.024 6.326 0.30 0.0154 0.0125 Br, Li 35 5/5M 
SNURF/ 
SNRPN 
15q11 
ATP10C    Mat ND ND ND ND ND - U - 
PEG3 19q13   12Prom MATG Pat 13.611 13.207 -0.40 7.99E-05 0.000106 BT U - 
MCTS2 20q11   2Prom MATG Pat 9.939 8.803 -1.14 0.000581 0.00102 BT U - 
NNAT 20q11    Mat 20.179 18.301 -1.88 8.42E-07 3.10E-06 BT U - 
NESP   13, 14NESP55 
PATS  
Mat U (>40) 19.255 U (>40) <1x10-12 1.60E-06 BT U - 
GNAS  151A Prom 
MATG 
Mat 0.78 -0.227 -1.01 0.582 1.17 Highest/Pl
, Br  
35 13/13 B 
Exon 1A  161A Prom 
MATG 
Pat 6.306 6.984 0.68 0.0126 0.00790 Pl 40 5/5 M 
GNAS  20q13 
GNAS XL  
 
rs7121 
13, 17XL Prom 
MATG 
Pat 19.871 20.833 0.96 1.04E-06 5.35E-07 BT U - 
Prom, promoter; MAT/PAT, maternally/paternally methylated DMR; G/S, DMR established in the germline/post fertilisation; Mat/Pat, maternal/paternal allele 
expressed; U, below QPCR detection, i.e. linear amplification was not reached within 40 cycles of PCR equivalent to a 2-dCt of less than 1x10-12; BT, below non-
quantitative RT-PCR detection up to 45 cycles; M/B, mono/biallelic;  Pl, Placenta; Li, Liver; Br, brain; BM, bone marrow; ND, not done.  dCtB-dCtA, difference 
between the dCts of PBLA and PBLB. 
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Appendix IV - Primer Tables 
Gene SNP Genotyping RT Accession  Reference 
  Size 
(bp) 
D Primer 5’-3’ Size (bp) Direction 
Isoform 
Primer 5’-3’   
F GCGGCTTCTCCTCTAACATG  NAP1L5 rs710834 389 
R GGTGAGCTCTTGGATCTTGG 
NM_153757 (Wood et al., 
2007) 
662 ISO1 F AGCCGTGCTCACAGCTCAG NM_002656 F CAAGAGGACACGCTAAGAACG 
589 ISO2 F CGGACTCCAGAACTTTCCAA 
ZAC1 rs2092894 203 
R TGGTGGACCCTACCTCAGTT 
NM_001080951 
(Valleley et al., 
2007) 
F GTTGTCTGCCCTCCAAAGAA   IGF2R rs614754 
rs1805075 
222 
R CATAGTATTCCCACTTGAG 283 R CTTTGGAGTACGTGACAAC 
NM_000876 Own 
GRB10 rs1800504 F GTCAGACACGGTGCCCCTCCT    
  
160 
R ATAAGGCCTGGACCTACCTGACA 166 R CTGGTCTTCCTCCTGAAGGCGC 
NM_001001555 (McCann et al., 
2001) 
PEG10 ACI1 F ACAGAGATGTAAGAGGCAGGC 
  
352 
R ATTCACAGCATTGTAAGAAGTTCAC 
NM_015068 (Sun et al., 
2006) 
MEST rs1050582 1214 ISO1 F ATGGGATAACGCGGCCATGGTG  
  
F GATGACCACATTAGCCACTATC 
1203 ISO2 F AGTCCTGTAGGCAAGGTCTTACCTG 
  
274 
R CTATTATGTCAACTTAGTCAG 
NM_177524 
Tycko 
2005/Own 
F GATTACTGTTGCTCATGGGAGTGG F TCCGACTGCCTGTTACGTGC INPP5F_V2 rs3188055 634 
R CTGAATTATCCGTGTCTGGCATTG 
1438 
R GGGTTTTTTGAGATGCAACTGAATG 
AK091448 (Wood et al., 
2007) 
F CCCGGATCAACTGGACTTTTG SLC22A18 rs1048046 
rs1048047 
227 
R GGCACGATGGAGAACTGCATG 295 R GCACCCCGAAGGTGGTTTGCA 
NM_183233 (Monk et al., 
2006a) 
F GCTACATCTCTCTTCCAAATC MSP1 
rs231357 
197 
R ACAATGTCTTGATAAAGGGG 
F CTTGAGAGAAACAATCCCACAG SAC1 
rs231359 
190 
R GTATGGCTTTTCAGTGTTCC 
(Monk et al., 
2006a) 
rs10832514 F GAATCAGATGCCCTCAATCTG 
KCNQ1OT1 
 
277 
R CACAAGTTGGAGAGGGCTGAG 
NM_000128 
(Weksberg et 
al., 2001) 
KCNQ1 rs1057128 F CTGTCACTGCCTGCACTTTG F CTTCGCCGAGGACCTGGACCTG 
  
190 
R GCCGTTTGGCCGTGCCCAC 
271 
R GGGAAGCCCTCACTGTTCATC 
NM_000218 (Monk et al., 
2006a) 
IGF2 APA1 F CTTGGACTTTGAGTCAAATTGG 
  
235 
R CTCCTTTGGTCTTACTGGG 
NM_001007139 (Cui et al., 
1998) 
NDN rs2192206 F GCCCGAATACGAGTTCTTTT 
  
540 
R CACACATCATCAGTCCCATA 
NM_002487 (MacDonald 
and Wevrick, 
1997) 
F CATCAGTCCTAAGTGTGTC 293 F CAGGCATTCTTAGCTGAGAC SNRPN rs705 423 
R GATCACTGCACATGCTGGCAAAC  R CATCTTGCAGGATACATCTC 
NM_022806 Own 
IPW rs691 F CTGCATGATTTTTTTTCAAAAA 
  
396  
R ATATAGGGAGGTTCATTGCACA 
U12897 (Kim et al., 
2007) 
F GTCGGGATGTCTTTATGAAAG F CTGCAAGGAGCAACAGCGATG  GNAS ALL 
ISOFORMS R CAGGGCTGTCACTCATGTTC 
291 
R GTCAATCAGCTGGTACTCGTTG  
GNAS 365 F 
 
CCACGCACCGCCTGCTGCTG NM_001077489 
EXON 1A 
rs7121 644 
 
551 F GGTTAGAAGCTCTGCTCCC  
Own 
  256 
 R CTGTGGGAGGATGAAGGAGTGC  
259 F + Ex3 GAAGAGGACCCGCAGGCTGC  
218 F – Ex3 GAAGGCAACCAAAGTGCAGGACATC  
 
Quantitative RT-PCR Tm 60 ºC 40 cycles 
Locus Transcript DIRN 5’-3’ DIRN 5’-3’ SIZE (BP) ACCESSION REFERENCE 
1p31 DIRAS3 F1 GTCTTCTAGGCTGCTTGGTTCG 
 
R1 GCAGCTTCTGTTCCTTGGAG 140 NM_004675 JF 
1p36 TP73 F2IN GCAAGCGTGCCTTCAAGCAGAG R2 GGCCTCGCACCTGAAGGTAG 108 NM_005427 
 
JF 
4q22 NAP1L5 F2 GTCATGTAGCTTTTAGGGTG R2 GGCACAGCTAATACAAGCAAAC 159 NM_153757 DM 
ZAC1 Iso 1  NOX F GGCATCTGCCATTTGTCATTCAG NOX R GTGTCTAAATCAAGGCTCGG 58 NM_001080954 JF 6q24 
ZAC1 Iso  2 F GGCGGGTAGGTAGGAAAGG COM 
ROUT 
GATGTTTATGAATCAGGCAGG 52 NM_001080951 JF 
6q25 IGF2R F GAAAACCCTGGGAACTCCTG    RIN GCATGGCACCTCCTTATTTG 118 NM_000876 JF 
7p11 GRB10 ALL ISO  FOUT GCAAACAGGACGCGTGATAGAG R GTGAATCACTGTACTTAGGG 148 NM_001001555 JF 
PEG10  1-2F AGGAGTCCTCGCGTGAAATAAG ROUT AGACCTCCCAGCTGTAGCTTCAC 115 NM_015068 DM 
SGCE F AAAATGTGGGGAAGCCAACAATC R CTGCTTGATATGGCAACGGGA 126 NM_003919 JF 
MESTIT1  F ACTGAGGAAACTACCGCCTATAAG R ATGTGGGTAGACATGTTCCATG 157 AW161444 JF 
MEST Iso 1  F GGCATGGGATAACGCGGCCATGG 107 NM_002402 JF 
7q21 
MEST Iso 2 F GGCCGAGAACCTCTGGCCTCAGG 
R GCAGGTACGCAGCAAGCAGG 
146 NM_177524 JF 
10q26 INPP5F 
_V2 
F2 GTTGACATTTTCCGACTGCCC R2 CTACTACTAATTACAGTGTTAC 144 AK091448 DM 
H19  F GGAGTTGTGGAGACGGCCTTGAGT R CCAGTCACCCGGCCCAGATGGAG 100 BC053636 (Gicquel et al., 
2005) 
11p15 
(TEL) 
IGF2  F TCGTTGAGGAGTGCTGTTTCC R ACACGTCCCTCTCGGACTTG 87 NM_000612 (Apostolidou et 
al., 2007) 
PHLDA2  F GAGCGCACGGGCAAGTA R CAGCGGAAGTCGATCTCCTT 68 NM_003311 (Apostolidou et 
al., 2007) 
SLC22A18  Ex2 GCAGGATGAGCGCTCTAGGC Ex3 R GCACCCCGAAGGTGGTTTGC 168 NM_183233 DM 
CDKN1C F CAGCTGCACTCGGGGATTTC 2R GATCTCTTGCGCTTGGCGAAG 125 NM_000076 DM 
KCNQ1OT1  F TCTCTCTTCCAAATCATAAATG R TAAACAATGTCTTGATAAAGGG 194 NM_000128 JF 
11p15 
(CENT
) 
KCNQ1 F GGATCGCGGCAGCAACACGATCGG ROUT GGTGCTGCCACCGTGCAAGG 130 NM_000218 JF 
WT1 F CGCTATTCGCAATCAGGGTTAC R ATGGGATCCTCATGCTTGAATG 142 NM_024426 (Siehl et al., 2002) 
AWT1 F GAGAAG GTTACAGCACGGTCAC R ATGGGATCCTCATGCTTGAATG 108 AK093168 DM 
11p13 
WT1-AS INF AGAGTCCGTTCAG GAATCCTTG OUTR AGGCTGCAGGGAACTCCTCCCA 112 BX394943 DM 
13q14 HTR2A F2 CCATCCAGAATCCCATCCACC R2 CCTTCGAATCGTCCTGTAGCCC 95 NM_000621 JF 
GTL2  FIN GAACTTGAAGAGGTTTAGCCGG ROUT GGACCAGCCTTCCAAATGGG 122 AF090934 JF 
DLK1  FEX2-3 ATGACAATGTTTGCAGGTGCCAG RIN TGCCCGGGTTCTCCACAGAGTC 93 NM_003836 DM 
14q32 
DIO3 FIN CCACATGAACAATCTCCCCTACC R CCGCGCTCAAAAGAGGATTTCC 103 NM_001362 JF 
  257 
NDN  F GCCCGAATACGAGTTCTTTT R GCCTCCTCCAGAGCTTCTCTGT 138 NM_002487 JF 
SNRPN  F GTCTTCAGAAGCATCAAGTTTTAAC R GCCATCTTGCAGGATACATCTC 127 NM_022806 JF 
15q11 
IPW  F OUT CCTTGCAGAAGATGACTTCC R CAAATCCACCTCTTTGTGGCC 149 U12897 JF 
19q13 PEG3 FOUT TCCAGGACAACATGGAAAACTACAG ROUT ATCACTCCGTGGGAAGATTC 211 NM_006210 DM 
20q11 MCTS2 F GTCAGTTATTAAGGGCATTAAG R GTATCTACTGCAGCAGGGTACAG 333 BC053868 DM 
20q11 NNAT FOUT TCGGCTGGTACATCTTCCGCGT ROUT AGGGAGTACCTGAACACCTCA 130 NM_005386 DM 
NESP  F AAGGGACCCATCCCCATCCGGC GNAS 
R 
ATGGTGCTTTTACCAGATTCTCC 100 NM_016592 JF 
GNAS  F CAGCGCAACGAGGAGAAGGCGCA R ATGGTGCTTTTACCAGATTCTCC 134 NM_000516 JF 
Exon 1A  FOUT GCTCTCTGGCTCCGGGCTGCG R2 GGTGCTTTTACCAGATTCTCCAG 140 X56009 JF 
20q13 
GNAS XL  FIN TACGCACCGCCTGCTGCCTC RIN CCATTAACATGCAGGATCCTC 84 NM_001077490 JF 
Bisulphite PCR primers, Hotstar Taq, 45 cycles 
Locus CpG F 5’-3’ R 5’-3’ SIZE (BP) 
/ENZYME 
ACCESSION REFERENCE 
6q24 ZAC1 GTGGATTTTATATTAGATAGG CRCTTCCCCRAATCRCCRTC 400/ 2x Tai1 AL109755 (Kamiya et al., 2000) 
7p11 GRB10  GTYGGGGTTTTTGTTAGTTTG CCAATCCCTCRAAAACTAAA 518 MboI AC004920 (Monk et al., 2003) 
PEG10/S
GCE 
GTGTTATGTTTTATAAATAGATAAG AACTCATATACCTCTACAATTC 376 Taqa1 AC069292 Own 
AAAAATAACACCCCCTCCTCAAAT 
7q21 
MEST  TYGTTGTTGGTTAGTTTTGTAYGGTT 
CCCAAAAACAACCCCAACTC 
289 Taqa1 Y10620 (Kerjean et al., 2000) 
H19 
DMD 
TGTTGAAGGTTGGGGAGATAGA CCCAAACCATAACACTAAAACCCTC 450 BstUI BC053636 (Vu et al., 2000) 
H19 
PROM 
GGTATGGTGTTTTTTGAGGGGAGAT CATCCCACCCCCTCCCTCACCCTA 323 Tai1 AC004556 (Frevel et al., 1999) 
IGF2 
DMR0 
TTGGTGTTGGAAAGTGTTTG CTATAACRTCCAAACCCTCTA 300 Taqa1 NM_00100713
9 
(Monk et al., 2006b) 
11p15 
(TEL) 
KvDMR TGTTGAGGAGTTTYGGGGAGGATTA CACCTCACACCCAACCAATACCTCAT  372 Taqa1 AJ006345 (Monk et al., 2006a) 
IG-DMR GGGTTGGGTTTTGTTAGTTGTT 
 
CCAATTACAATACCACAAAATTAC 259 Taqa1 14q32 
GTL2 
PROM 
GTAAGTTTTATAGGTTGTAAAGGGGGTGTT CCACAACTAATAACTAAAAAAATAAACATT 216 Taqa1 
AL117190 Kawakami et al., 2006 
15q11 PWS-IC GGTTTTTTTTTATTGTAATAGTGTTGTGGGG CTCCAAAACAAAAAACTTTAAAACCCAAA 408 Tai1 AC090602 (Zeschnigk et al., 1997) 
OUT – GATGGTATTTAATGGGTGGGGTTGGAATAG 19q13 PEG3 
IN - GTTGGAATAGATTATTATATTTAATG  
CTATCCTACCTATAAAAATTTTCTTTC   343 Tai1 AC006115 JF 
OUT - GAGGATAAAGATTTAAGGGATTT OUT - CTCAAACTCCCCAATTTAAC NESP55 
IN -GAAGGAGTTTAAGGAGGAGAAGTAG IN - CCATAAAAACAAAAAAAATCTAAAC 
224 Tai1 AL132655 (Bastepe et al., 2003) 
OUT - GTCGTTTTTGCGGTTGTTGAG OUT - CCAACGAAAACATCCGAAAATCCC EXON1A 
IN - GGTAGTTTATGTCGTTTTAGTTG IN - CTACTAACCACCCCTTCATC 
351 Tai1 AL121917 JF 
OUT – GTGCGGTTCGTTTTATTTTTGTCGCGAACGC   
20q13 
GNAS XL  
IN - GTTATCGGTAGTTTATTTTAAGAGGTTG 
ACTACTTCCTCCTCAACTAAAAATCTCTC   
 
291 Taqa1 AL132655 JF 
  258 
Notes: 
